tranexamic acid has been researched along with Blood Loss, Postoperative in 633 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administration of intravenous tranexamic acid significantly improved swelling, pain and lower ROM restriction in patients undergoing ACL reconstruction." | 9.69 | The effect of tranexamic acid injection during anterior cruciate ligament reconstruction surgery on postoperative bleeding, pain and swelling. ( Akbari-Aghdam, H; Entezari, R; Mousavi, H, 2023) |
| " We included controlled trials, either randomized (RCT) or non-randomized studies of intervention (NRSI) comparing the effects of intravenous tranexamic acid (TXA) treatment with placebo/no treatment on postoperative blood loss, pain VAS score, elbow ROM, and complications, in patients who underwent open or closed elbow arthrolysis surgery." | 9.41 | Does tranexamic acid diminish hemorrhage and pain in open elbow arthrolysis? a systematic review and meta-analysis. ( Daliri, M; Ebrahimzadeh, MH; Khayami, A; Moradi, A; Nejat, MH; Sadeghi, M, 2023) |
| "Tranexamic acid (TXA) is widely used in surgery for adolescent idiopathic scoliosis (AIS) and has been proved to be efficacious in reducing intraoperative blood loss (IBL) and the transfusion rate." | 9.41 | The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. ( Liu, LM; Song, YM; Wang, L; Wang, LN; Xiu, P; Yang, X; Zhang, Z; Zhou, ZJ, 2021) |
| "To indicate whether combined topical and intravenous (IV) administration of tranexamic acid (TXA) could further reduce the blood loss after surgery for adolescent idiopathic scoliosis (AIS) compared with IV-TXA alone." | 9.41 | Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial. ( Dong, Y; Li, Q; Liang, J; Shen, J; Tong, B; Zhao, H, 2021) |
| "This study was designed to compare the effect of intravenous tranexamic acid (TXA) and prostaglandin analogue on reducing PPH resulted from uterine atony in women undergoing C section or vaginal delivery." | 9.27 | The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial. ( Ahmadi, M; Nikbakht, R; Zargar, M, 2018) |
| "Preincision administration of 10 mg/kg of tranexamic acid significantly improved the surgical field during cleft palate repair." | 9.20 | Evaluation of the Efficacy of Tranexamic Acid on the Surgical Field in Primary Cleft Palate Surgery on Children-A Prospective, Randomized Clinical Study. ( Durga, P; Gunnam, P; Gurajala, I; Raavula, P; Ramachandran, G; Reddy, M; Upputuri, O; Veerabathula, P, 2015) |
| "The purpose of this systematic review and meta-analysis of randomized controlled trials (RCTs) and non-RCTs was to gather data to evaluate the efficacy and safety of tranexamic acid (TXA) versus placebo after a scoliosis surgery." | 8.95 | Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. ( Xu, BS; Yuan, QM; Zhao, ZH, 2017) |
| "To evaluate the association of treatment with nebulized tranexamic acid (TXA) with rates of operative intervention in post-tonsillectomy hemorrhage (PTH)." | 8.31 | Treatment of post-tonsillectomy hemorrhage with nebulized tranexamic acid: A retrospective study. ( Elghouche, AN; Hasnain, F; Matt, BH; Shay, EO; Shin, TJ; Ye, MJ, 2023) |
| " The purpose of this study was to compare the effects of intra-articular (IA) administration of tranexamic acid (TXA), an anti-fibrinolytic commonly used in TKA, and ALM chondroprotective solution on postoperative inflammation and joint tissue healing in a rat model of knee implant surgery." | 8.02 | Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty. ( Biros, E; Dlaska, C; Dobson, GP; Hazratwala, K; Letson, HL; McEwen, P; Morris, JL; Wilkinson, M, 2021) |
| "Tranexamic acid (TXA) has gained increasing recognition in plastic surgery as a dependable adjunct capable of minimizing blood loss, ecchymosis, and edema." | 8.02 | Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis. ( Banuelos, J; Molinar, VE; Tran, NV; Weissler, JM, 2021) |
| "Evaluate nebulized tranexamic acid (TXA) as a treatment to reduce the need for an operation to control a post-tonsillectomy hemorrhage (PTH)." | 8.02 | Post-tonsillectomy hemorrhage control with nebulized tranexamic acid: A retrospective cohort study. ( Earley, MA; Erwin, DZ; Goldstein, NA; Heichel, PD; McEvoy, TP; Meyer, AD; Wright, LM, 2021) |
| "The aim of the present study was to investigate whether an innovative way of administering tranexamic acid (TXA), that is, injecting it retrogradely through the drain and clamping it for 1 h, can reduce postoperative bleeding after degenerative lumbar scoliosis surgery." | 7.96 | Topical Injection of Tranexamic Acid via a Drain Plus Drain-Clamping to Reduce Blood Loss in Degenerative Lumbar Scoliosis Surgery. ( Chang, L; Liang, JQ; Liu, HZ; Liu, XY; Rong, TH; Tan, MS; Zhao, H, 2020) |
| "To investigate the effectiveness and safety of intravenous tranexamic acid for reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis (TSS)." | 7.88 | The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study. ( Huang, X; Huang, Y; Liu, T; Qiao, F; Xu, X; Xue, P; Yang, J, 2018) |
| "The major concern with the use of tranexamic acid is that it may promote a hypercoagulable state and increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly when chemical thromboprophylaxis is not used." | 7.85 | Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty. ( Kim, JS; Kim, YH; Park, JW, 2017) |
| "To investigate the incidence of postoperative generalized seizures in patients undergoing aortic valve replacement (AVR) under extracorporeal circulation, who received either high-dose tranexamic acid (TXA) or epsilon aminocaproic acid (EACA) as an antifibrinolytic agent." | 7.77 | High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. ( Beyersdorf, F; Keyl, C; Lehane, C; Stampf, S; Trenk, D; Uhl, R; Wiesenack, C, 2011) |
| "Tranexamic acid (TXA) has been widely applied in total knee arthroplasty (TKA) to significantly reduce perioperative blood loss and improve knee function recovery in patients after surgery." | 7.30 | Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study. ( Wang, CC; Wu, T; Zhang, GQ; Zhang, LT; Zhou, LB, 2023) |
| "No tranexamic acid was administered to the control group." | 7.30 | [Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study]. ( Hrabálek, L; Jablonský, J; Novák, V; Stejskal, P; Trnka, Š; Wanek, T, 2023) |
| " The current study aimed to determine whether tranexamic acid (TXA) in combination with pressure dressing reduce the amount of blood loss, the rate of incision-related complications, and the rate of readmission for patients undergoing surgeries to release GMC." | 7.11 | Tranexamic acid combined with compression dressing reduces blood loss in gluteal muscle contracture surgery. ( Huang, Q; Huang, Z; Ma, J; Pei, F; Shen, B; Zhou, Z, 2022) |
| "Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective orthopedic surgery." | 7.01 | Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study. ( Cheong, Y; Costain, D; Elder, G; Fera, L; Fraser, B; Kelly, A; Slagel, B, 2021) |
| "A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75." | 6.90 | Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. ( Huang, Y; Jiang, LF; Wu, LD; Xu, NW; Zhang, JJ; Zhang, Y; Zhou, D; Zhou, XD, 2019) |
| " Other secondary variables were total blood loss, hidden blood loss, transfusion rate, average hospital stay, complications, adverse events, and mortality." | 6.90 | Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). ( Aguilera, X; Bosch, A; Camacho-Carrasco, P; Castillón, P; González, JC; Hernández, JA; Jordan, M; Martínez-Zapata, MJ; Mora, JM; Prat-Fabregat, S; Rodriguez-Arias, A; Ruiz, L; Salomó, M, 2019) |
| "Administration of intravenous tranexamic acid significantly improved swelling, pain and lower ROM restriction in patients undergoing ACL reconstruction." | 5.69 | The effect of tranexamic acid injection during anterior cruciate ligament reconstruction surgery on postoperative bleeding, pain and swelling. ( Akbari-Aghdam, H; Entezari, R; Mousavi, H, 2023) |
| " Tranexamic acid was administered before the surgical incision in "pre-induction groups" (1 and 2), and just before the tourniquet release in "pre-release groups" (3 and 4)." | 5.51 | Clinical trial to determine whether the timing of tranexamic acid administration influences perioperative bleeding in total knee arthroplasty. ( Bisbe, E; Luis, C; Moreno, CE; Pardo, A; Santiveri, X; Teixell, C, 2022) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug that is used for uncontrolled bleeding of various origin." | 5.48 | Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum. ( Jud Schefer, RS; Olgiati, L; Sigrist, N, 2018) |
| " The best administration route and dosage should be further studied." | 5.48 | [Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures]. ( Lin, ZQ; Luo, GG; Xie, HF; Yao, JC; Zhang, HZ, 2018) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent that can be used to reduce blood loss in total knee arthroplasty (TKA) patients." | 5.43 | Intraarticular Administration of Tranexamic Acid is Safe and Effective in Total Knee Arthroplasty Patients at High-Risk for Thromboembolism. ( Chughtai, M; Delanois, RE; Gwam, C; Khlopas, A; Mistry, JB; Mont, MA; Mudaliar, PP; Tangri, V; Thomas, M, 2016) |
| " We included controlled trials, either randomized (RCT) or non-randomized studies of intervention (NRSI) comparing the effects of intravenous tranexamic acid (TXA) treatment with placebo/no treatment on postoperative blood loss, pain VAS score, elbow ROM, and complications, in patients who underwent open or closed elbow arthrolysis surgery." | 5.41 | Does tranexamic acid diminish hemorrhage and pain in open elbow arthrolysis? a systematic review and meta-analysis. ( Daliri, M; Ebrahimzadeh, MH; Khayami, A; Moradi, A; Nejat, MH; Sadeghi, M, 2023) |
| "Tranexamic acid (TXA) is widely used in surgery for adolescent idiopathic scoliosis (AIS) and has been proved to be efficacious in reducing intraoperative blood loss (IBL) and the transfusion rate." | 5.41 | The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. ( Liu, LM; Song, YM; Wang, L; Wang, LN; Xiu, P; Yang, X; Zhang, Z; Zhou, ZJ, 2021) |
| "To indicate whether combined topical and intravenous (IV) administration of tranexamic acid (TXA) could further reduce the blood loss after surgery for adolescent idiopathic scoliosis (AIS) compared with IV-TXA alone." | 5.41 | Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial. ( Dong, Y; Li, Q; Liang, J; Shen, J; Tong, B; Zhao, H, 2021) |
| "The aim of this study was to evaluate the effects of a high initial-dose (60 mg/kg) intravenous tranexamic acid (IV-TXA) on fibrinolysis and inflammation after total knee arthroplasty (TKA)." | 5.34 | The antifibrinolytic and anti-inflammatory effects of a high initial-dose tranexamic acid in total knee arthroplasty: a randomized controlled trial. ( Huang, Q; Huang, W; Lei, YT; Pei, FX; Xie, JW, 2020) |
| "An initial retrospective study suggested that tranexamic acid (TXA) administration increased the incidence of seizures in paediatric patients undergoing cardiac surgery." | 5.30 | Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial. ( Hu, S; Hua, Z; Jia, Y; Li, S; Liu, J; Ran, J; Shi, J; Wang, R; Wang, X; Wang, Y; Yan, F; Yan, J; Yuan, S; Zhang, Y; Zhang, Z; Zhao, Y; Zheng, Z, 2019) |
| "This study was designed to compare the effect of intravenous tranexamic acid (TXA) and prostaglandin analogue on reducing PPH resulted from uterine atony in women undergoing C section or vaginal delivery." | 5.27 | The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial. ( Ahmadi, M; Nikbakht, R; Zargar, M, 2018) |
| "Systemic administration of TXA can effectively reduce the postoperative blood loss which results in lower rate of transfusion requirement and wound hematoma in minimally invasive TKA patients when rivaroxaban is used for thromboprophylaxis." | 5.24 | The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial. ( Chen, B; Huang, CC; Kuo, FC; Lin, PC; Wang, JW; Yen, SH, 2017) |
| "Compared with intravenous application, topical application of tranexamic acid could also effectively reduce total blood loss and hidden blood loss, postoperative blood transfusion rate in primary total hip arthroplasty, while does not increase the risk of DVT." | 5.22 | [Comparison of different modes of using tranexamic acid administration on reducing hidden blood loss in total hip arthroplasty]. ( Chen, XJ; Ni, JR; Wang, LX, 2016) |
| "Preincision administration of 10 mg/kg of tranexamic acid significantly improved the surgical field during cleft palate repair." | 5.20 | Evaluation of the Efficacy of Tranexamic Acid on the Surgical Field in Primary Cleft Palate Surgery on Children-A Prospective, Randomized Clinical Study. ( Durga, P; Gunnam, P; Gurajala, I; Raavula, P; Ramachandran, G; Reddy, M; Upputuri, O; Veerabathula, P, 2015) |
| " Systematic review and meta-analysis to determine the bleeding rates associated with tranexamic acid, desmopressin, platelet transfusion, plasma transfusion and recombinant activated factor VII, for patients with unclassified bleeding disorders undergoing surgery, childbirth or with menorrhagia." | 5.12 | Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies. ( Desborough, MJR; Doree, C; Lowe, GC; Obaji, S; Thomas, W, 2021) |
| "The purpose of this systematic review and meta-analysis of randomized controlled trials (RCTs) and non-RCTs was to gather data to evaluate the efficacy and safety of tranexamic acid (TXA) versus placebo after a scoliosis surgery." | 4.95 | Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. ( Xu, BS; Yuan, QM; Zhao, ZH, 2017) |
| "To evaluate the association of treatment with nebulized tranexamic acid (TXA) with rates of operative intervention in post-tonsillectomy hemorrhage (PTH)." | 4.31 | Treatment of post-tonsillectomy hemorrhage with nebulized tranexamic acid: A retrospective study. ( Elghouche, AN; Hasnain, F; Matt, BH; Shay, EO; Shin, TJ; Ye, MJ, 2023) |
| "The use of tranexamic acid (TXA) in posterior lumbar interbody fusion (PLIF) surgery is believed to be beneficial for reducing intraoperative blood loss, postoperative drainage volume (PDV), and length of hospital stay (LOS)." | 4.31 | Postoperative clinical outcomes with and without short-term intravenous tranexamic acid after posterior lumbar interbody fusion: A prospective cohort study. ( Ji, X; Shi, L; Tian, F; Wang, X, 2023) |
| " The purpose of this study was to compare the effects of intra-articular (IA) administration of tranexamic acid (TXA), an anti-fibrinolytic commonly used in TKA, and ALM chondroprotective solution on postoperative inflammation and joint tissue healing in a rat model of knee implant surgery." | 4.02 | Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty. ( Biros, E; Dlaska, C; Dobson, GP; Hazratwala, K; Letson, HL; McEwen, P; Morris, JL; Wilkinson, M, 2021) |
| "Tranexamic acid (TXA) has gained increasing recognition in plastic surgery as a dependable adjunct capable of minimizing blood loss, ecchymosis, and edema." | 4.02 | Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis. ( Banuelos, J; Molinar, VE; Tran, NV; Weissler, JM, 2021) |
| "Evaluate nebulized tranexamic acid (TXA) as a treatment to reduce the need for an operation to control a post-tonsillectomy hemorrhage (PTH)." | 4.02 | Post-tonsillectomy hemorrhage control with nebulized tranexamic acid: A retrospective cohort study. ( Earley, MA; Erwin, DZ; Goldstein, NA; Heichel, PD; McEvoy, TP; Meyer, AD; Wright, LM, 2021) |
| "The aim of the present study was to investigate whether an innovative way of administering tranexamic acid (TXA), that is, injecting it retrogradely through the drain and clamping it for 1 h, can reduce postoperative bleeding after degenerative lumbar scoliosis surgery." | 3.96 | Topical Injection of Tranexamic Acid via a Drain Plus Drain-Clamping to Reduce Blood Loss in Degenerative Lumbar Scoliosis Surgery. ( Chang, L; Liang, JQ; Liu, HZ; Liu, XY; Rong, TH; Tan, MS; Zhao, H, 2020) |
| "To investigate the effectiveness and safety of intravenous tranexamic acid for reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis (TSS)." | 3.88 | The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study. ( Huang, X; Huang, Y; Liu, T; Qiao, F; Xu, X; Xue, P; Yang, J, 2018) |
| "The major concern with the use of tranexamic acid is that it may promote a hypercoagulable state and increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly when chemical thromboprophylaxis is not used." | 3.85 | Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty. ( Kim, JS; Kim, YH; Park, JW, 2017) |
| " We sought to determine if its reintroduction was still pertinent given the widespread administration of tranexamic acid, another antifibrinolytic shown to reduce bleeding and transfusions." | 3.83 | Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery. ( Hardy, JF; Noiseux, N; Prieto, I; Stevens, LM, 2016) |
| " In the present study we evaluated the hemostatic effects of tranexamic acid (TXA) to decrease bleeding tendency and transfusion requirements in high-risk patients following transapical aortic valve implantation (TA-AVI)." | 3.81 | Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation. ( Choi, YH; Deppe, AC; Kuhn, E; Madershahian, N; Pfister, R; Rudolph, T; Scherner, M; Slottosch, I; Wahlers, T, 2015) |
| "This case report discusses enucleation of a central dentigerous cyst in a 72-year old male on long-term low dose aspirin therapy." | 3.78 | Management of a dentigerous cyst in a medically compromised geriatric patient: a case report. ( Bains, R; Bains, VK; Loomba, A; Loomba, K, 2012) |
| "To investigate the incidence of postoperative generalized seizures in patients undergoing aortic valve replacement (AVR) under extracorporeal circulation, who received either high-dose tranexamic acid (TXA) or epsilon aminocaproic acid (EACA) as an antifibrinolytic agent." | 3.77 | High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. ( Beyersdorf, F; Keyl, C; Lehane, C; Stampf, S; Trenk, D; Uhl, R; Wiesenack, C, 2011) |
| "Tranexamic acid (TXA) has been widely applied in total knee arthroplasty (TKA) to significantly reduce perioperative blood loss and improve knee function recovery in patients after surgery." | 3.30 | Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study. ( Wang, CC; Wu, T; Zhang, GQ; Zhang, LT; Zhou, LB, 2023) |
| "No tranexamic acid was administered to the control group." | 3.30 | [Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study]. ( Hrabálek, L; Jablonský, J; Novák, V; Stejskal, P; Trnka, Š; Wanek, T, 2023) |
| "To evaluate the efficacy and safety of perioperative cryotherapy combined with intra-articular injection of tranexamic acid (TXA) in total knee arthroplasty (TKA) and explore a new strategy of enhanced recovery after TKA." | 3.30 | Efficacy of perioperative cryotherapy combined with intra-articular injection of tranexamic acid in total knee arthroplasty. ( Huang, W; Huang, X; Li, F; Liu, W; Shi, W; Yin, D, 2023) |
| "This study aimed to evaluate the effect of temperature intervention combined with tranexamic acid (TXA) on perioperative blood loss during spinal fusion and accelerated rehabilitation." | 3.30 | The efficacy of temperature intervention combined with tranexamic acid in reducing blood loss and accelerating recovery during spinal fusion. ( Huang, X; Huang, Y; Li, F; Liang, B; Yin, D, 2023) |
| "The primary outcome was postoperative blood loss, and the secondary outcomes were postoperative PRC transfusion and complications." | 3.11 | Adjunctive Topical Tranexamic Acid for Blood Salvage Does Not Reduce Postoperative Blood Loss Compared with Placebo in Patients Who Undergo Palliative Decompressive Spinal Metastasis Surgery: A Randomized Controlled Trial. ( Atthakomol, P; Maethungkul, R; Murakami, H; Phanphaisarn, A; Phinyo, P; Sangsin, A, 2022) |
| " The current study aimed to determine whether tranexamic acid (TXA) in combination with pressure dressing reduce the amount of blood loss, the rate of incision-related complications, and the rate of readmission for patients undergoing surgeries to release GMC." | 3.11 | Tranexamic acid combined with compression dressing reduces blood loss in gluteal muscle contracture surgery. ( Huang, Q; Huang, Z; Ma, J; Pei, F; Shen, B; Zhou, Z, 2022) |
| "Preoperative TXA is safe and effective in reducing blood loss during and after high-risk CD." | 3.11 | Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial. ( Al-Asmar, A; Al-Mohamady, M; El Mahy, M; Maged, AM; Rund, NMA; Shalaby, MA, 2022) |
| "Tranexamic acid is a lysine synthetic derivate that inhibits fibrinolysis and diminishes the bleeding by blocking the five lysine-binding sites for plasminogen." | 3.11 | Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial. ( Bayter, JE; Cala, L; Cardenas-Camarena, L; Domínguez-Millan, R; Duran, H; Hoyos, AE; Lopez, A; Mogollon, IR; Perez, M; Talleri, G, 2022) |
| "Tranexamic acid (TXA) has shown significant reductions in blood loss and transfusion rates in total knee arthroplasty (TKA)." | 3.01 | Multimodal Peri-articular Injection with Tranexamic Acid can reduce postoperative blood loss versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Trial. ( Lin, J; Peng, HM; Qian, WW; Wang, W; Wang, WD; Weng, XS, 2021) |
| "Tranexamic acid was topically administered to some patients." | 3.01 | Impact of direct oral anticoagulants on bleeding tendency and postoperative complications in oral surgery: a systematic review of controlled studies. ( Götrick, B; Holst, J; Johansson, K; Naimi-Akbar, A; Tranæus, S, 2023) |
| "Tranexamic acid (TXA) has drawn growing interest over the last decade for its benefit in optimizing post-operative bleeding, yet its role in bariatric surgery is poorly understood." | 3.01 | Role of Tranexamic Acid (TXA) in Preventing Bleeding Following Sleeve Gastrectomy: a Systematic Review and Meta-analysis. ( Karmali, S; Koloszvari, N; Kung, J; Mocanu, V; Neville, A; Verhoeff, K; Walsh, C; Wilson, H, 2023) |
| "Its role in reducing postoperative blood loss in breast surgery remains unclear." | 3.01 | The Effects of Tranexamic Acid in Breast Surgery: A Systematic Review and Meta-Analysis. ( Huynh, MNQ; McRae, MC; McRae, MH; Voineskos, S; Wong, CR, 2023) |
| "Intraoperative and postoperative blood loss is a major risk in head and neck (H&N) surgery." | 3.01 | A systematic review on the efficacy of tranexamic acid in head and neck surgery. ( Coulson, C; Jamshaid, M; Jamshaid, W; Muzaffar, J; Nieto, H; Sharma, N, 2023) |
| "Tranexamic acid was the only agent that demonstrated a significantly lower risk of developing postoperative bleeding events (OR 0." | 3.01 | The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy: a network meta-analysis. ( Arunjaroensuk, S; Jiaranuchart, S; Mahardawi, B; Pimkhaokham, A; Somboonsavatdee, A; Tompkins, KA, 2023) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug associated with reduced blood loss in a range of surgical specialties, including neurosurgery, orthopedic surgery, and cardiac surgery." | 3.01 | Systematic review and meta-analysis of topical tranexamic acid in spine surgery. ( Ambati, VS; Chan, AK; Chou, D; Izima, C; Sampath, SG; Tang, AJ, 2023) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent shown to decrease intraoperative bleeding, reduce transfusions, and improve outcomes across multiple specialties." | 3.01 | Effects of Intravenous Tranexamic Acid During Rhytidectomy: A Randomized, Controlled, Double-Blind Pilot Study. ( Alloju, LM; Cohen, JC; Glasgold, MJ; Glasgold, RA, 2021) |
| "This study aimed to evaluate the optimal dosage of topical tranexamic acid (TXA) considering the efficacy and safety for controlling bleeding after total knee arthroplasty (TKA)." | 3.01 | Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study. ( Han, HS; Kim, JK; Lee, DY; Lee, MC; Park, JY; Ro, DH, 2021) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce bleeding in major surgical procedures." | 3.01 | Evaluation of efficacy and safety of systemic and topical intra-articular administration of tranexamic acid in primary unilateral total hip arthroplasty. ( Gažová, A; Jaroslav, V; Juraj, M; Kyselovič, J; Šteňo, B; Žufková, V, 2021) |
| "Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective orthopedic surgery." | 3.01 | Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study. ( Cheong, Y; Costain, D; Elder, G; Fera, L; Fraser, B; Kelly, A; Slagel, B, 2021) |
| "A total of 297 patients with chronic subdural hematoma underwent initial burr hole surgery at our hospital from April 2014 to March 2018." | 2.94 | Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery. ( Natori, Y; Yamada, T, 2020) |
| "Tranexamic acid (TXA) has been shown to be effective in reducing blood loss after total knee replacement." | 2.94 | Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study. ( Bustamante Suarez de Puga, D; Martínez Gimenez, E; Mas Martinez, J; Morales Santias, M; Sanz-Reig, J; Verdu Román, C, 2020) |
| "However, there was significantly lower postoperative blood loss with TXA (29." | 2.94 | Tranexamic acid for the Latarjet procedure: a randomized controlled trial. ( Hurley, ET; Lim Fat, D; Mullett, H; Pauzenberger, L, 2020) |
| "Tranexamic acid (TXA) has been shown to reduce blood loss and transfusion requirements in patients undergoing orthopaedic surgery." | 2.94 | Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy. ( DelPizzo, K; Dodwell, E; Levack, AE; McLawhorn, AS; Nguyen, J; Sink, E, 2020) |
| "To explore the hemostatic effect of intra-articular administration of tranexamic acid (TXA) combined with knee flexion in total knee arthroplasty (TKA)." | 2.94 | Reduction of Blood Loss by Intra-articular Injection of Tranexamic Acid Combined with Knee and Hip Flexion at 45° During Primary Total Knee Arthroplasty: A Randomized Controlled Trial. ( Cai, DZ; Huo, KP; Tan, JS; Yang, JQ; Yang, L; Zhao, L, 2020) |
| "A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75." | 2.90 | Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. ( Huang, Y; Jiang, LF; Wu, LD; Xu, NW; Zhang, JJ; Zhang, Y; Zhou, D; Zhou, XD, 2019) |
| " Other secondary variables were total blood loss, hidden blood loss, transfusion rate, average hospital stay, complications, adverse events, and mortality." | 2.90 | Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). ( Aguilera, X; Bosch, A; Camacho-Carrasco, P; Castillón, P; González, JC; Hernández, JA; Jordan, M; Martínez-Zapata, MJ; Mora, JM; Prat-Fabregat, S; Rodriguez-Arias, A; Ruiz, L; Salomó, M, 2019) |
| "Tranexamic acid (TXA) has been widely used in total knee arthroplasty (TKA) for blood loss reduction." | 2.90 | Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial. ( Galassi, M; Laoruengthana, A; Pongpirul, K; Rasamimongkol, S; Rattanaprichavej, P; Weerakul, S, 2019) |
| " However, the optimal oral dosage regimen to achieve maximum blood-loss reduction remains unclear." | 2.90 | Finding the Optimal Regimen for Oral Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial. ( Luo, ZY; Pei, FX; Wang, D; Wang, HY; Zeng, WN; Zhou, ZK, 2019) |
| "Eligible patients with trochanteric fractures surgically treated by dynamic hip screw and proximal anti-rotating intramedullary nail between March 2016 and October 2017 were enrolled in the study." | 2.90 | Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. ( Chen, F; Jiang, Z; Li, M; Zhu, X, 2019) |
| "Additional reduction of postoperative blood loss may further reduce exposure to allogeneic blood products." | 2.90 | Reduced perioperative blood loss in children undergoing craniosynostosis surgery using prolonged tranexamic acid infusion: a randomised trial. ( D'Amore Lindholm, A; Fenger-Eriksen, C; Hvas, AM; Juul, N; Krogh, L; Nørholt, SE; Rasmussen, M; Tarpgaard, M; von Oettingen, G, 2019) |
| "Postoperative nasal bleeding is a common complication of septoplasty and may lead to painful procedure of nasal packing to stop bleeding." | 2.90 | Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty. ( Adeel, M; Akhtar, S; Faraz, Q; Nawaz, A; Zakir, I; Zaman, SU, 2019) |
| "Tranexamic acid (TXA) is proven to reduce blood loss following total knee arthroplasty (TKA), but there are limited data on the impact of similar dosing regimens in revision TKA." | 2.90 | 2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?. ( Abdel, MP; Bini, S; Calkins, TE; Culvern, C; Darrith, B; Della Valle, CJ; Fillingham, YA; Malkani, AL; Padgett, DE; Schwarzkopf, R; Sershon, RA, 2019) |
| "Outcomes assessed are intraoperative and postoperative blood loss, hematocrit, allogenic blood transfusion, and deep vein thrombosis (DVT), postoperatively." | 2.87 | Effectiveness and Safety of Batroxobin, Tranexamic Acid and a Combination in Reduction of Blood Loss in Lumbar Spinal Fusion Surgery. ( Dumpa, SR; Kanna, RM; Nagabhushan, RM; Shanmuganathan, R; Shetty, AP; Subramanian, B, 2018) |
| "Tranexamic acid has been shown to be effective for minimizing perioperative blood loss in liposuction." | 2.87 | Use of Tranexamic Acid to Reduce Blood Loss in Liposuction. ( Cansancao, AL; Cansancao, B; Condé-Green, A; David, JA; Vidigal, RA, 2018) |
| "TRAC-24 will help to determine whether an extended TXA dosing regimen can further reduce blood loss following primary THA and TKA." | 2.87 | Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a ( Adams, C; Agus, A; Bell, J; Benson, G; Beverland, D; Bryce, L; Campbell, C; Dorman, A; Eggleton, A; Gardner, E; Hill, J; Hogg, R; Magill, P; Martin, U; McFarland, M; Mockford, B; Molloy, D; Murphy, L; O'Hagan, S; Phair, G, 2018) |
| "Only one patient in IV group exhibited deep venous thrombosis." | 2.87 | Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration. ( Cao, C; Li, DH; Li, LL; Meng, WK; Pei, FX; Wang, D; Wang, HY; Zeng, WN; Zhou, ZK, 2018) |
| "To compare postoperative blood loss after intravenous and intraarticular tranexamic acid injection in patients of bilateral total knee arthroplasty." | 2.87 | Blood loss after intraarticular and intravenous tranexamic acid in total knee arthroplasty. ( Ahmad, S; Ahmed, A; Ahmed, S; Aziz, A; Javed, S, 2018) |
| " Secondary outcomes were calculated blood loss, number of units transfused during hospitalization, and incidence of adverse events at 30 and 90 days including thromboembolic event, wound complications, reoperation, hospital readmission, and all-cause mortality." | 2.84 | Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial. ( Cross, WW; Houdek, MT; Pagnano, MW; Sems, SA; Watts, CD, 2017) |
| "Tranexamic acid is a proven drug used for reduction of intraoperative blood loss in spinal surgery." | 2.84 | The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. ( Hey, HWD; Hong, SJ; Juh, HS; Kim, CK; Kim, HJ; Kim, HS; Kim, KT; Kim, YC, 2017) |
| "The total blood loss and postoperative blood loss were significantly lower in groups B and C without any difference between them." | 2.84 | Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty. ( Cai, M; Ge, W; Li, S; Sun, Q; Wu, J; Yu, X, 2017) |
| "Tranexamic acid has been used both topically and systemically and plays a vital role in pediatric cardiac surgery by reducing blood loss and blood product requirement." | 2.84 | Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery. ( Deodhar, S; Gandhi, H; Pandya, H; Patel, H; Patel, J; Prajapati, M, 2017) |
| "v, a maintenance dosage of 2 mg/kg/h TA, or an equivalent volume of normal saline." | 2.84 | Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial. ( Jiang, D; Ou, Y; Quan, Z; Shi, H; Zhao, Z; Zhu, Y, 2017) |
| "The combined (IV (intravenous) + topical) use of tranexamic acid (TXA) has been shown to be a safe method and more effective than single (IV or topical) application." | 2.84 | The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. ( Akkaya, M; Basaran, SH; Bozkurt, M; Cankaya, D; Dasar, U; Satilmis, AB, 2017) |
| "Tranexamic acid results in lower bleeding irrespective of the mode of administration compared to control group." | 2.84 | A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty. ( Jin, C; Park, YJ; Prakash, J; Seon, JK; Song, EK, 2017) |
| "Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss and the need for transfusions when administered intravenously in total hip arthroplasty." | 2.84 | Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial. ( Della Valle, CJ; Fillingham, YA; Gerlinger, TL; Kayupov, E; Moric, M; Okroj, K; Plummer, DR, 2017) |
| " Antifibrinolytic drugs are part of a multifaceted approach aimed at reducing bleeding, though sufficiently sized pediatric studies are sparse, and dosing algorithms are heterogeneous." | 2.82 | Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis. ( Hunt, BJ; Murdoch, IA; Sangaran, DP; Siemens, K; Tibby, SM, 2022) |
| "Tranexamic acid has been increasingly used for blood conservation in cardiac surgery." | 2.82 | Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis. ( He, LX; Yao, YT; Zou, ZY, 2022) |
| " Moreover, TXA use is safe in terms of incidence of symptomatic DVT and TE." | 2.82 | Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial. ( Jain, NP; Nisthane, PP; Shah, NA, 2016) |
| "Tranexamic acid is an antifibrinolytic agent that has shown to effectively reduce bleeding complications within other surgical and medical areas." | 2.82 | Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. ( Bergholt, T; Moeller, C; Ottesen, B; Ravn, P; Schouenborg, L; Settnes, A; Topsoee, MF, 2016) |
| "Tranexamic acid can be effective at decreasing blood loss and transfusion requirements associated with total hip arthroplasty (THA), but few studies have compared the efficacy of different intravenous dosing regimes." | 2.82 | Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses. ( Kang, P; Ma, J; Pei, F; Wang, C; Xie, J; Yue, C, 2016) |
| "Tranexamic acid (TXA) is a synthetic antifibrinolytic agent successfully used intravenously (IV) to reduce blood loss after total knee arthroplasty (TKA)." | 2.82 | The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost? ( Della Valle, CJ; Fillingham, YA; Gerlinger, TL; Kayupov, E; Moric, M; Plummer, DR, 2016) |
| "Fixed dose of TXA for patients undergoing simultaneous bilateral TKAs was effective and safe in reducing total blood loss and allogeneic blood transfusion needs without any additional thromboembolic risk." | 2.82 | Effectiveness and Safety of Fixed-Dose Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial. ( Cao, X; Chen, X; Guo, K; Yang, C; Zhu, J; Zhu, Q, 2016) |
| "The optimal dosage and timing of tranexamic acid (TXA) in total knee arthroplasty (TKA) are undetermined." | 2.82 | Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial. ( Ma, J; Pei, F; Xie, J; Yao, H; Yue, C, 2016) |
| " The objective of this trial was to assess the efficacy and safety of intravenous (IV) administration combined with topical administration of TXA regarding postoperative blood loss and transfusion rates in patients treated with primary unilateral total hip arthroplasty." | 2.82 | Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration. ( Bin, S; Fuxing, P; Jing, Y; Pengde, K; Yi, Z; Zongke, Z, 2016) |
| "No deep vein thrombosis was detected through Doppler ultrasound examination." | 2.80 | The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. ( Ding, PJ; Li, J; Lv, YM; Yang, Y; Ying-Ze, Z, 2015) |
| "TXA treatment without drainage during TKA reduces the amount of blood transfusions required without increasing the rate of adverse events." | 2.80 | Safety and efficacy of intra-articular tranexamic acid injection without drainage on blood loss in total knee arthroplasty: A randomized clinical trial. ( Cao, JG; Li, ZJ; Liu, J; Sun, ZH; Wang, CG, 2015) |
| "Tranexamic acid is an antifibrinolytic agent which blocks plasmin-mediated fibrin degradation." | 2.80 | [The Effect of Tranexamic Acid on Blood Loss after Primary Unilateral Total Knee Arthroplasty. Prospective Single-Centre Study]. ( Mezera, V; Musil, D; Pertlíček, J; Sadovský, P; Stehlík, J, 2015) |
| "27 %, p = 0." | 2.79 | Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. ( Chang, CB; Kang, YG; Kim, TK; Lee, JH; Lee, SH; Seo, ES; Yun, JH, 2014) |
| "Tranexamic acid resulted in a lower mean maximum decline in postoperative hemoglobin levels when compared to placebo (P = 0." | 2.79 | Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. ( Cassatt, KB; Garton, AS; Kincaid-Cinnamon, KA; Lemke, JH; Martin, JG; Westendorf, DS, 2014) |
| "Tranexamic acid is an antifibrinolytic drug used widely to prevent bleeding." | 2.79 | Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. ( Bhatty, S; Gulati, A; Paul, R; Rajoli, SR; Saini, R; Soni, A, 2014) |
| "Intraoperative and postoperative blood loss were compared between the two groups." | 2.78 | Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. ( Bi, Y; Chen, Y; Fan, R; Guo, M; Hua, Z; Liu, J; Piao, M; Ren, W; Wang, Q; Xiang, L; Yu, H, 2013) |
| "234." | 2.78 | Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. ( Cho, CH; Kim, JS; Lee, YC; Park, SJ, 2013) |
| "The tranexamic acid regimen was a bolus of 10 mg/kg followed by a maintenance of 10 mg·kg(-1)·h(-1) throughout the surgery." | 2.78 | [Effectiveness and safety of tranexamic acid in patients receiving on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation]. ( Li, LH; Shi, J; Wang, GY; Wang, YF; Xue, QH; Yuan, S, 2013) |
| " Secondary outcomes were the calculated hidden blood loss, transfusion rate, preoperative and postoperative hemoglobin, number of blood units transfused, adverse events, and mortality." | 2.78 | Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. ( Aguilera, X; Bosch, A; Celaya, F; Fernández, JA; Gich, I; González, JC; Jordan, M; Martínez, N; Martinez-Zapata, MJ; Maymó, RM; Monllau, JC; Urrútia, G, 2013) |
| "Recently, a number of studies using intra-articular application of tranexamic acid (IA-TXA), with different dosage and techniques, successfully reduced postoperative blood loss in total knee replacement (TKR)." | 2.78 | Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. ( Chanplakorn, P; Kawinwonggowit, V; Mulpruek, P; Sa-Ngasoongsong, P; Wechmongkolgorn, S; Wibulpolprasert, B; Wongsak, S; Woratanarat, P, 2013) |
| "The objective of this study was to conduct a population pharmacokinetic analysis and develop a model to predict an effective TXA dosing regimen for children with craniosynostosis undergoing cranial remodelling procedures." | 2.78 | Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery. ( Goobie, SM; Meier, PM; Pereira, LM; Samant, S; Sethna, NF; Soriano, SG; Zurakowski, D, 2013) |
| "Ecallantide is a recombinant peptide in the same class as aprotinin that inhibits plasma kallikrein, a major component of the contact coagulation and inflammatory cascades." | 2.77 | A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial). ( Bokesch, PM; Grocott, HP; Levy, JH; Mazer, CD; Smith, PK; Szabo, G; Vetticaden, S; Wheeler, A; Wojdyga, R, 2012) |
| "Tranexamic acid is a simple means of reducing postoperative blood loss in THR, without increased risk of thromboembolism when associated to rivaroxaban thromboprophylaxis." | 2.77 | Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients. ( Clavé, A; Dumser, D; Fazilleau, F; Lacroix, J, 2012) |
| " However, controversy persists regarding the dosage and timing of administration of this drug during surgery." | 2.77 | The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective? ( Chen, WS; Hsu, CH; Huang, CC; Lin, PC; Wang, JW, 2012) |
| "Several methods reportedly reduce postoperative blood loss and avoid homologous blood transfusion with traditional TKA approaches, but it is unclear these reductions apply to a minimally invasive technique." | 2.76 | Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. ( Charoencholvanich, K; Siriwattanasakul, P, 2011) |
| "The postoperative blood loss was reduced in the 1." | 2.75 | Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. ( Abrishami, A; Chung, F; De Silva, Y; El Beheiry, H; Gandhi, R; Mahomed, NN; Muhammad Ovais Hasan, S; Roderick Davey, J; Syed, KA; Wong, J, 2010) |
| "Twenty-four-hour postoperative blood loss was significantly less in the tranexamic acid group compared with the control group (471 +/- 182 v 844 +/- 303)." | 2.74 | Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. ( Attar, AS; Mirzaee, A; Shirdel, A; Taghaddomi, RJ, 2009) |
| "Tranexamic acid has been suggested to be as effective as aprotinin in reducing blood loss and transfusion requirements after cardiac surgery." | 2.74 | Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. ( Bruggemans, EF; Dion, RA; Engbers, FH; Klautz, RJ; Later, AF; Maas, JJ; Versteegh, MI, 2009) |
| "Tranexamic acid was more effective than autotransfusion in reducing postoperative blood loss and allogeneic transfusions after coronary bypass." | 2.73 | Effects of tranexamic acid and autotransfusion in coronary artery bypass. ( Davoodi, S; Madani-Civi, M; Mehr-Aein, A, 2007) |
| "Tranexamic acid does not seem to be a useful adjunct in myomectomy if given according to the described protocol in this study." | 2.73 | Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. ( Caglar, GS; Haberal, A; Kayikcioglu, F; Tasci, Y, 2008) |
| "Tranexamic acid was used to reduce postoperative drainage and allogenic blood transfusion requirements in patients undergoing on-pump primary coronary bypass surgery." | 2.73 | Tranexamic acid and primary coronary artery bypass surgery: a prospective study. ( Maddali, MM; Rajakumar, MC, 2007) |
| " In Group A, 1 g of tranexamic acid dissolved in 250 ml of normal saline was intravenously infused before deflation of the tourniquet; another intravenous administration of the same drug of the same dosage was given 3 hours later." | 2.73 | [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty]. ( Gao, Z; Yu, J; Zhang, F, 2007) |
| " Few studies found adverse events, and no difference in incidence or type of adverse events was seen between the antifibrinolytic and the placebo group." | 2.72 | Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review. ( Fenger-Eriksen, C; Hansen, AK; Hovgesen, NT; Hvas, AM; Larsen, JB, 2021) |
| "The placebo group had a greater postoperative blood loss (median (25th to 75th percentile) 12 h after surgery (540 (350-750) vs 300 (250-455) mL, P = 0." | 2.72 | A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. ( Bauemann, C; Kalil, RA; Nesralla, IA; Pereira, JB; Santos, AT, 2006) |
| "Sixteen patients with haemophilia who required dental scaling participated in this pilot study." | 2.71 | Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash. ( Boyle, CA; Fiske, J; Lee, AP; Savidge, GF, 2005) |
| "The volume of postoperative blood loss was recorded at two-hour intervals for the first twelve hours and then again at twenty-four hours, and the values were compared between the two groups." | 2.71 | Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. ( Fuji, T; Masuhara, K; Yamasaki, S, 2005) |
| "Tranexamic acid appears to be an effective and economic drug for reduction of blood loss in cemented primary hip arthroplasty for osteoarthritis." | 2.71 | Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. ( Korkala, OL; Niskanen, RO, 2005) |
| "Case material included 25 patients with hemophilia (9 children and 16 adults) with high-responding inhibitors and 3 patients with acquired factor VIII inhibitors." | 2.70 | Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. ( Baudo, F; Gringeri, A; Morfini, M; Rocino, A; Santagostino, E; Scaraggi, FA, 2001) |
| "Tranexamic acid has traditionally been used to treat post-operative bleeding." | 2.69 | The effect of tranexamic acid (cyclokapron) on blood loss after third molar extraction under a day case general anaesthetic. ( Harris, M; Senghore, N, 1999) |
| "Tranexamic acid was given at the end of the operation and 3 hours later." | 2.69 | Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. ( Benoni, G; Fredin, H; Lethagen, S; Nilsson, P, 2000) |
| "Tranexamic acid (TXA) has been widely used during on-pump coronary artery bypass graft (CABG) surgery owing to its antifibrinolytic effect." | 2.66 | Intravenous Tranexamic Acid Decreases Blood Transfusion in Off-Pump Coronary Artery Bypass Surgery: A Meta-analysis. ( An, H; Feng, Y; Sun, L, 2020) |
| "Tranexamic acid (TXA) is a widely used antifibrinolytic agent worldwide and whether TXA influences ACT value in cardiac surgical patients remains unknown." | 2.66 | The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis. ( He, LX; Tan, JC; Yao, YT, 2020) |
| " Furthermore, it is safe and does not increase the risk of thrombotic events." | 2.61 | The Efficacy and Safety of Intravenous Tranexamic Acid in Reducing Surgical Blood Loss in Posterior Lumbar Interbody Fusion for the Adult: A Systematic Review and a Meta-Analysis. ( Chen, L; Chen, R; Gong, M; Liu, G; Xiang, Z, 2019) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent that reduces bleeding and transfusion in a broad number of adult and pediatric surgeries, as well as in trauma and obstetrics." | 2.61 | Tranexamic acid and perioperative bleeding in children: what do we still need to know? ( Faraoni, D; Goobie, SM, 2019) |
| "Tranexamic acid (TXA) is an antifibrinolytic medication that can reduce perioperative blood loss in TKA." | 2.58 | Intra-articular Tranexamic Acid in Primary Total Knee Arthroplasty: Meta-analysis. ( Capps, SG; Moskal, JT, 2018) |
| "Tranexamic acid (TXA) has been widely used to decrease transfusion rate in joint replacement surgery." | 2.58 | A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. ( Bai, J; Chen, P; He, J; Liang, Y; Wang, J; Zhang, P, 2018) |
| "A total of 59 participants with haemophilia undergoing dental extraction were involved." | 2.55 | Preventing perioperative bleeding in patients with inherited bleeding disorders. ( Beacher, N; Watterson, C, 2017) |
| "Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent commonly used for the prevention and treatment of bleeding disorders." | 2.55 | Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature. ( Chow, KM; Kwan, BC; Leung, CB; Li, PK; Ma, TK; Szeto, CC, 2017) |
| "Correction of craniosynostosis may require extensive surgical interventions with related intra and postoperative complications especially hemorrhage." | 2.53 | Surgical treatment of craniosynostosis in infants: open vs closed repair. ( Erb, TO; Meier, PM, 2016) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug widely used to reduce blood loss during joint replacements, including total knee arthroplasty (TKA) and total hip arthroplasty (THA)." | 2.53 | Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. ( Chen, Y; Chen, Z; Cui, S; Li, Z; Yuan, Z, 2016) |
| " No significant difference in deep vein thrombosis (DVT), pulmonary embolism, or other adverse events among the study groups." | 2.52 | Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. ( Liu, SL; Meng, T; Wang, P; Wu, Q; Zhang, HA; Zhou, X, 2015) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug used to reduce bleeding in mortality risk situations such as trauma." | 2.52 | Efficiency of tranexamic acid in perioperative blood loss in hip arthroplasty: a systematic literature review and meta-analysis. ( Díaz Quijano, DM; Pinzón-Florez, CE; Vélez Cañas, KM, 2015) |
| " The question addressed was: what dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? Altogether 586 papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question." | 2.52 | What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? ( Dearman, C; Hodgson, S; Larvin, JT, 2015) |
| " Both topical and intravenous administration of TXA, in a variety of dosing regimens, has proven effective." | 2.52 | Tranexamic Acid in Hip and Knee Arthroplasty. ( Melvin, JS; Sierra, RJ; Stryker, LS, 2015) |
| "The present meta-analysis indicated that intra-articular injection of TXA in patients undergoing TKA may reduce total blood loss and the need for blood transfusions, particularly when a high dosage of TXA is used (≥30 mg/ml), without any increase in the risk of post-operative DVT." | 2.50 | Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. ( Wei, C; Yan, G; Ying-Ze, Z; Yuejv, L; Zhao-Yu, C, 2014) |
| "Tranexamic acid is a synthetic antifibrinolytic drug." | 2.50 | Tranexamic acid - a useful drug in ENT surgery? ( Robb, PJ, 2014) |
| "Meanwhile TA is recommended to reduce deep vein thrombosis and pulmonary embolism following TKA." | 2.49 | Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. ( Chen, C; Fu, DJ; Guo, L; Yang, L, 2013) |
| " Analysis of data is complicated as the dosing scheme, especially for tranexamic acid, varies extremely and the agents are highly overdosed in most relevant trials." | 2.47 | Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. ( Koster, A; Schirmer, U, 2011) |
| " A total of 19 trials were eligible: 18 used intravenous administration, one also evaluated oral dosing and one trial evaluated topical use." | 2.47 | Tranexamic acid in total knee replacement: a systematic review and meta-analysis. ( Alshryda, S; Blenkinsopp, J; Mason, JM; Nargol, A; Sarda, P; Sukeik, M, 2011) |
| " Further studies are needed to clarify the neurological risk, appropriate indications and dosing of tranexamic acid." | 2.46 | Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. ( Bland, JM; Ngaage, DL, 2010) |
| "Tranexamic acid was usually added for mucosal surgery." | 2.41 | Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease. ( Griffioen, A; Harrington, C; Lee, CA; Nitu-Whalley, IC, 2001) |
| "However, hemarthrosis is the most common complication in arthroscopic surgery, which has potential adverse effects on postoperative rehabilitation." | 1.91 | Topical administration of tranexamic acid reduces postoperative blood loss and inflammatory response in knee arthroscopic arthrolysis: a retrospective comparative study. ( Chen, G; Fu, W; Li, J; Li, Q; Tang, X; Xiong, Y; Yao, L; You, M, 2023) |
| "The primary outcomes were postoperative blood loss and the composite incidence of mortality and morbidities during hospitalization." | 1.91 | The efficacy and safety of intravenous administration of tranexamic acid in patients undergoing cardiac surgery: Evidence from a single cardiovascular center. ( He, LX; Jiang, JJ; Lin, PS; Ma, J; Tian, LJ; Yao, YT; Yu, YP; Zhang, Y, 2023) |
| "Tranexamic acid (TXA) has long been the antifibrinolytic hemostatic drug of choice for orthopedic surgery." | 1.91 | Efficacy and safety of using aminocaproic acid and tranexamic acid during the perioperative period for treating trochanteric fractures in elderly femurs. ( Haibier, A; Qin, Q; Ran, J; Ren, Z; Yusufu, A; Zhang, Z; Zhou, Y, 2023) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug that reduces blood loss in patients that undergo Total knee arthroplasty (TKA)." | 1.91 | Benefits of Tranexamic Acid in Total Knee Arthroplasty: A Classification and Regression Tree Analysis in Function of Instrumentation, BMI, and Gender. ( Carvalho, MM; Cruz, H; Fontes, AP; Marreiros, A; Oliveira, T; Pereira, EG; Sacramento, T; Sousa, JP; Viegas, R, 2023) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent for reducing blood loss and allogenic blood transfusion." | 1.72 | The Efficiency of Simultaneous Systemic and Topical Use of Tranexamic Acid in Spinal Fusion Surgery. ( Akbas, A; Erdogan, U; Sari, S, 2022) |
| "Intraoperative blood loss and postoperative drain collection of the TXA group, ANH combined with TXA group were statistically lower than those in the control group and ANH group (P < 0." | 1.72 | Acute normovolemic hemodilution in combination with tranexamic acid is an effective strategy for blood management in lumbar spinal fusion surgery. ( Fang, X; Li, Y; Zhang, Y, 2022) |
| "Tranexamic acid (TXA) has been shown to decrease perioperative blood loss, transfusions, and cost in patients undergoing resection of aggressive bone tumors and endoprosthetic reconstruction." | 1.72 | Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction. ( Bombardier, B; Haase, DR; Kimbrel, B; Mersereau, EJ; Rosenthal, HG; Sweeney, KR; Templeton, KJ, 2022) |
| "This study aimed to evaluate the efficacy and safety of intravenous combined with topical application of tranexamic acid (TXA) in reducing blood loss in opening wedge high tibial osteotomy (OWHTO)." | 1.72 | Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss in opening wedge high tibial osteotomy procedure: A retrospective case-control study. ( Fu, X; Huang, JM; Luo, W; Ma, XL; Wu, J, 2022) |
| "The aim of the study is to compare weight-based versus standard dosing of intravenous (IV) tranexamic acid (TXA) for blood loss and transfusion amount in total knee arthroplasty (TKA) without a tourniquet." | 1.72 | Comparison of weight-based versus standard dosing of tranexamic acid for blood loss and transfusion amount in knee arthroplasty without tourniquet. ( Çarkcı, E; Çerci, MH; Guler, O; Gümüşsuyu, G; Öztürk, Ç, 2022) |
| "Ninety-two hemophilia A patients who underwent total knee arthroplasty in our center were included." | 1.72 | Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors. ( Lv, SJ; Shen, SN; Tong, PJ; Wu, DX, 2022) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug that can be used to treat and prevent bleeding." | 1.72 | ( Bosselmann, K; Keck, M; Lohmeyer, JA; Müller-Wittig, S; Wittig, KS, 2022) |
| "Tranexamic acid (1 g) was administered intravenously to all patients in both study groups." | 1.72 | Use of tranexamic acid may reduce the need for routine tourniquet use in total knee arthroplasty. ( Akdoğan, BM; Akdoğan, M; Atilla, HA; Çatma, MF; Gülsoy, A; Öztürk, A, 2022) |
| "Tranexamic acid (TXA) has proven to be safe in elective and traumatic femoral hemiarthroplasty; however, its use has not been investigated in oncologic patients." | 1.62 | Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease. ( Houdek, MT; Owen, A; Rose, PS; Wellings, EP; Wyles, CC; Yuan, BJ, 2021) |
| "Disusing CSD significantly reduced postoperative blood loss and transfusion requirement without increasing postoperative pain and surgical wound complications in cementless SBTHA with concurrent administration of intravenous TXA." | 1.62 | Effects of disusing closed suction drainage in simultaneous bilateral total hip arthroplasty: A retrospective cohort study. ( Lee, Y; Lim, SJ; Park, CW; Park, YS; Won, JY; Yoo, I, 2021) |
| "0, was employed to analyze demographics including surgical traits, blood loss, drainage, length of hospital stays (LOS), blood biochemical indices, prethrombotic state molecular markers, coagulation function, and adverse events." | 1.62 | Safety and Efficacy of Topical Administration of Tranexamic Acid in High-Risk Patients Undergoing Posterior Lumbar Interbody Fusion Surgery. ( Cai, T; Chen, D; Feng, X; Shi, P; Wang, J; Wang, S; Wang, Y; Zhang, L; Zhang, W, 2021) |
| "Tranexamic acid (TXA) is an effective blood management strategy, as it competitively inhibits the activation process of plasminogen and prevents fibrinolytic enzymes from degrading fibrin." | 1.62 | Comparison of topical and intravenous Tranexamic acid for high tibial osteotomy: A retrospective study. ( Bian, J; Deng, B; Li, S; Wang, G; Wang, Z; Yuan, L; Zhang, Y; Zhao, X, 2021) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss in orthopaedic procedures." | 1.56 | Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review. ( Haase, DR; Rosenthal, HG; Sweeney, KR; Templeton, KJ, 2020) |
| "To investigate whether intravenous combined with topical administration of tranexamic acid (TXA) is superior to intravenous administration alone in terms of blood loss, incision complications, functional recovery, and pain relief in high tibial osteotomy (HTO)." | 1.56 | Intravenous Combined with Topical Tranexamic Acid Administration Has No Additional Benefits Compared with Intravenous Administration Alone in High Tibial Osteotomy: A Retrospective Case-Control Study. ( Guo, X; Li, S; Liu, P; Lu, Q; Luo, D; Miao, Z; Zhang, M, 2020) |
| " Our study indicates that the local administration of TXA/DEP is safe and more effective than the administration of TXA alone in treating trochanteric femoral fractures." | 1.56 | Safety and efficacy of tranexamic acid with epinephrine for prevention of blood loss following surgery for trochanteric femoral fractures. ( Hu, Y; Xie, L; Xu, X; Yu, H, 2020) |
| "Primary endpoint was the postoperative blood loss within 24 hours." | 1.56 | Postoperative administration of tranexamic acid as approach to reduce blood loss after open-heart surgery. ( Matschke, K; Meissner, F; Plötze, K; Waldow, T, 2020) |
| " Previous studies have established the efficacy of TXA in TKA, however here are limited direct comparison studies available and the dosing regimens vary." | 1.56 | Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty. ( Tan, C; Wang, L; Wu, C, 2020) |
| "There was no significant difference in postoperative blood loss between the tranexamic acid group and the control group." | 1.56 | [Analysis of hemostatic effect of intra-articular injection of tranexamic acid after minimally invasive unicompartmental knee arthroplasty]. ( Dong, F; Qian, PK; Sun, BF; Wu, XF; Xu, F; Yin, ZF; Zhang, JB, 2020) |
| "Thirty-four patients with haemophilia A undergoing 24 TKA and 18 THA were evaluated in this retrospective study (No." | 1.51 | Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia. ( Huang, Q; Huang, ZY; Ma, J; Pei, FX; Shen, B; Zeng, HJ; Zhou, ZK, 2019) |
| "A young girl with constant exotropia was planned for surgery." | 1.51 | Factor XIII deficiency leading to preseptal haematoma post-strabismus surgery. ( Badakere, A; Jain, M; Kekunnaya, R, 2019) |
| "Tranexamic acid (TXA) is an effective blood salvage agent that reduces perioperative blood loss in conventional total knee arthroplasty (TKA)." | 1.51 | Tranexamic Acid Reduces Total Blood Loss and Inflammatory Response in Computer-Assisted Navigation Total Knee Arthroplasty. ( Chou, WY; Hsu, YH; Ko, JY; Kuo, SJ; Siu, KK; Wu, KT, 2019) |
| " The incidence of adverse events was evaluated in the perioperative period and at 1 month follow-up." | 1.51 | Short-term safety of tranexamic acid use in posterior cervical decompression and fusion surgery. ( Burks, JD; Gjolaj, JP; Green, BA; Lugo-Pico, JG; Madhavan, K; Perez-Roman, RJ; Sheinberg, D, 2019) |
| "This study demonstrated that intra-articular 1 g TXA administration during TKA is safe and effective for reducing blood loss and blood transfusion without increasing VTE risk." | 1.51 | Intra-articular 1 g tranexamic acid administration during total knee arthroplasty is safe and effective for the reduction of blood loss and blood transfusion. ( Furumatsu, T; Hino, T; Kamatsuki, Y; Kodama, Y; Masuda, S; Miyazawa, S; Okazaki, Y; Ozaki, T, 2019) |
| "Tranexamic acid has been shown to be effective in reducing blood loss after total hip replacement." | 1.48 | Matched cohort study of topical tranexamic acid in cementless primary total hip replacement. ( Bustamante Suarez de Puga, D; Martínez Gimenez, E; Mas Martinez, J; Morales Santias, M; Sanz-Reig, J; Verdu Román, C, 2018) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug that is used for uncontrolled bleeding of various origin." | 1.48 | Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum. ( Jud Schefer, RS; Olgiati, L; Sigrist, N, 2018) |
| "Postoperative hemorrhage was managed successfully by repacking with Gelfoam impregnated with tranexamic acid powder in most patients." | 1.48 | Management of dental extractions in patients on warfarin and antiplatelet therapy. ( Hsue, SS; Lin, LH; Lu, SY, 2018) |
| "The intravenous TXA would reduce postoperative blood loss and transfusion requirements without increasing thromboembolic complications in open-wedge HTO." | 1.48 | Tranexamic acid is effective for blood management in open-wedge high tibial osteotomy. ( Bae, SH; Kim, GB; Kim, HJ; Kim, KI, 2018) |
| "Male appeared to suffer more surgical blood loss than female." | 1.48 | Blood loss of total knee arthroplasty in osteoarthritis: an analysis of influential factors. ( Hu, Y; Li, Q; Shi, ZJ; Torsha, TT; Wei, BG; Xiao, J; Zhang, XS, 2018) |
| " The best administration route and dosage should be further studied." | 1.48 | [Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures]. ( Lin, ZQ; Luo, GG; Xie, HF; Yao, JC; Zhang, HZ, 2018) |
| "Tranexamic acid (TXA) has been associated with decreased blood loss and transfusion after total hip arthroplasty (THA) and total knee arthroplasty (TKA)." | 1.46 | Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty. ( Barfield, WR; Demos, HA; Lin, ZX; Pellegrini, VD; Robertson, DC; Wilson, SH, 2017) |
| "To compare postoperative blood loss, amount of allogeneic blood transfusion, removal time of drainage tube, length of hospital stay, and complications associated with tranexamic acid (TXA)." | 1.46 | Efficacy and Safety of Topical Use of Tranexamic Acid in Reducing Blood Loss During Primary Lumbar Spinal Surgery: A Retrospective Case Control Study. ( Chen, X; Jiang, P; Li, S; Li, Z; Ren, Z; Sheng, L; Xu, D; Zhang, X; Zhuang, Q, 2017) |
| " This study used a low-dose pharmacokinetic TXA dosing protocol and assessed its ability to limit perioperative blood loss for craniosynostosis repairs." | 1.46 | Reducing Postoperative Bleeding After Craniosynostosis Repair Utilizing a Low-Dose Transexamic Acid Infusion Protocol. ( Andrews, BT; Hansen, JK; Lydick, AM; Wyatt, MM, 2017) |
| "TISSEEL fibrin sealant does not reduce postoperative blood loss or transfusions; however, IV TXA reduced postoperative transfusions compared with TISSEEL and control." | 1.46 | An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty. ( Bohl, DD; Kearns, SM; Kuhar, HN; Levine, BR, 2017) |
| " However, the optimal dosing regimen remains undetermined." | 1.46 | Quantitative efficacy of topical administration of tranexamic acid on postoperative bleeding in total knee arthroplasty. ( Ge, W; Jiang, Q; Shi, D; Xu, R, 2017) |
| "Parameters associated with postoperative blood loss were compared to the prolongation of closure time and medication use." | 1.46 | Limitations of Preoperative PFA-200 as a Predictor of Postoperative Blood Loss in Total Knee Arthroplasty: According to Use of Tranexamic Acid. ( Jeon, Y; Kang, SY; Kim, MH; Lee, WI, 2017) |
| "This study aimed to compare the efficacy of intravenous administration of tranexamic acid for reducing blood loss in total knee arthroplasty at different dosage time." | 1.46 | The Efficacy Comparison of Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty at Different Dosage Time. ( Cai, M; Gong, J; Nie, X; Sun, Q; Yu, X, 2017) |
| "Intra- and postoperative blood loss was compared between the groups." | 1.46 | High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion. ( Iwasaki, M; Kushioka, J; Maeno, T; Matsumoto, T; Okuda, S; Yamasaki, R; Yamashita, T, 2017) |
| "Tranexamic acid was superior to fibrin sealant in decreasing allogeneic transfusion requirements (0 vs." | 1.46 | Tranexamic acid versus fibrin sealant in primary total hip replacement: a comparative study. ( Borbora, A; Kumar, G; Mahmood, A; Peter, V; Sawalha, S, 2017) |
| "Tranexamic acid has been reported to be safer with topical administration than with intravenous administration in total knee arthroplasty." | 1.43 | Comparison between topical and intravenous administration of tranexamic acid in primary total hip arthroplasty. ( Fukumori, N; Kawano, S; Kitajima, M; Mawatari, M; Sonohata, M; Ueno, M, 2016) |
| "Tranexamic acid (TXA) has proven its efficacy in reducing blood loss and the need for blood transfusions in patients who have undergone a total knee arthroplasty (TKA) surgical procedure." | 1.43 | Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty? ( Pongcharoen, B; Ruetiwarangkoon, C, 2016) |
| "There were no deep venous thrombosis or thromboembolic complications in any group." | 1.43 | A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty. ( Dai, K; Mao, Z; Wang, Y; Yan, M; Yue, B, 2016) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent that can be used to reduce blood loss in total knee arthroplasty (TKA) patients." | 1.43 | Intraarticular Administration of Tranexamic Acid is Safe and Effective in Total Knee Arthroplasty Patients at High-Risk for Thromboembolism. ( Chughtai, M; Delanois, RE; Gwam, C; Khlopas, A; Mistry, JB; Mont, MA; Mudaliar, PP; Tangri, V; Thomas, M, 2016) |
| "Tranexamic acid (TXA) has shown safety and efficacy in reducing blood loss associated with various surgical procedures." | 1.42 | Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy? ( Baca, GR; Clohisy, JC; Keith, AD; Schoenecker, PL; Wingerter, SA, 2015) |
| "Low-dose IA-TXA application in TKR with prolonged clamping drain method is a safe and effective blood conservative technique with only minimal systemic absorption and without significant increase in systemic absorption over time." | 1.42 | An In Vivo Study of Low-Dose Intra-Articular Tranexamic Acid Application with Prolonged Clamping Drain Method in Total Knee Replacement: Clinical Efficacy and Safety. ( Angchaisukisiri, P; Aryurachai, K; Chanplakorn, P; Jittorntam, P; Kawinwonggowit, V; Panpikoon, T; Sa-ngasoongsong, P; Uthadorn, K; Wongsak, S, 2015) |
| "Tranexamic acid (TXA) is an antifibrinolytic that reduces blood loss and transfusion rates in total joint arthroplasty." | 1.40 | Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. ( Adams, MJ; Dalury, DF; Kelley, TC; Tucker, KK, 2014) |
| "Tranexamic acid (TA) has been reported to reduce blood loss after total joint arthroplasty; however, the literature is sparse in evaluating its efficacy in simultaneous bilateral total knee arthroplasty (TKA)." | 1.40 | Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. ( Bloomfield, MR; DiIorio, TM; Irizarry, AM; Karam, JA; Sharkey, PF, 2014) |
| " Intravenous administration of 1 g of TXA pre-operatively and administration of 1 g before tourniquet release is an effective and safe method of reducing blood loss in TKA." | 1.40 | Repeated doses of intravenous tranexamic acid are effective and safe at reducing perioperative blood loss in total knee arthroplasty. ( Dai, W; Shi, P; Xu, Q; Yang, Y; Yao, Z; Zhang, C; Zhou, J, 2014) |
| "When tranexamic acid was administered, the need for transfusions was lower (difference statistically significant)." | 1.40 | Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. ( Atzori, F; Debiasi, F; Massè, A; Revello, S; Sabatini, L; Scotti, L, 2014) |
| "Tranexamic acid was routinely given to all patients repaired on ECMO for 24 hours perioperatively after 2003." | 1.38 | Congenital diaphragmatic hernia: to repair on or off extracorporeal membrane oxygenation? ( Bax, KM; Houmes, RJ; Keijzer, R; Rycus, P; Sluijter, I; Tibboel, D; van de Ven, KP; van den Hout, L; Wilschut, DE, 2012) |
| "The rate of avoidance of ABTs, postoperative blood loss, and complications (DVT/PE, skin problems) were examined." | 1.37 | Efficient strategy for controlling postoperative hemorrhage in total knee arthroplasty. ( Hoshino, Y; Sasanuma, H; Sekiya, H; Sugimoto, N; Takada, H; Takatoku, K, 2011) |
| "Although the fourfold risk for seizures using TXA was not significant, we currently use EACA in paediatric cardiac surgery." | 1.37 | Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. ( Breuer, T; Gertler, R; Hapfelmeier, A; Hess, J; Lange, R; Martin, K; Schreiber, C; Wiesner, G, 2011) |
| "IV tranexamic acid was also administered to reduce intraoperative blood loss." | 1.35 | Routine preoperative coagulation screening detects a rare bleeding disorder. ( Anne, KK; Durga, P; Jonnavithula, N; Pochiraju, R; Ramachandran, G, 2009) |
| " All the patients received specific hemostasis/coagulation management based on (a) routine use of tranexamic acid, (b) heparin dose-response monitoring, thromboelastography, platelet (PLT) function analysis in a select population of patients, and (c) use of fresh frozen plasma (FFP), PLTs, and desmopressin according to the hemostasis/coagulation profile." | 1.35 | Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery. ( Ballotta, A; Castelvecchio, S; Conti, D; Isgrò, G; Ranucci, M; Romitti, F, 2009) |
| "Aprotinin treatment was associated with an increased use of plasma and platelet transfusion and an increased risk for postoperative dialysis, but not with other adverse outcomes, including short-term mortality." | 1.35 | Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study. ( Hjortdal, VE; Jakobsen, CJ; Johnsen, SP; Søndergaard, F, 2009) |
| "The postoperative blood loss was significantly higher in all tirofiban-patients (A-C) compared to a group of CABG-patients without tirofiban." | 1.35 | CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management? ( Boeken, U; Feindt, P; Gams, E; Kurt, M; Litmathe, J, 2008) |
| "Dental extraction in hemophiliacs is associated with a high risk of bleeding." | 1.33 | Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002). ( Berthier, AM; De Mello, G; Frachon, X; Garnier, J; Hourdin-Eude, S; Lejeune, S; Mézière, X; Pommereuil, M; Quéro, J, 2005) |
| "Glanzmann's thrombasthenia is a congenital hemorrhagic disorder transmitted as an autosomal recessive trait and characterized by altered production and/or assembly of the platelet membrane glycoprotein IIb/IIIa receptor." | 1.33 | Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass. ( Barbato, L; Casati, V; D'Angelo, A; Grasso, MA; Panzeri, E; Rossi, E; Spagnolo, S, 2006) |
| "A 42-year-old female with von Willebrand's disease was managed with desmopressin and tranexamic acid to aid haemostasis following a vaginal hysterectomy." | 1.31 | Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease. ( Bertholini, DM; Butler, CS, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (2.69) | 18.2507 |
| 2000's | 92 (14.53) | 29.6817 |
| 2010's | 363 (57.35) | 24.3611 |
| 2020's | 161 (25.43) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, HM | 1 |
| Wang, W | 5 |
| Lin, J | 2 |
| Weng, XS | 1 |
| Qian, WW | 1 |
| Wang, WD | 1 |
| Kuo, CC | 1 |
| DeGiovanni, JC | 1 |
| Carr, MM | 1 |
| Lee, MJ | 1 |
| Kim, JK | 2 |
| Tang, J | 1 |
| Ming, JM | 1 |
| Chua, ME | 1 |
| Jiang, W | 2 |
| Fu, M | 3 |
| Dong, W | 1 |
| Zhou, N | 1 |
| Shen, J | 3 |
| Zhang, X | 7 |
| Hao, J | 2 |
| Siemens, K | 1 |
| Sangaran, DP | 1 |
| Hunt, BJ | 1 |
| Murdoch, IA | 1 |
| Tibby, SM | 1 |
| Alsubaie, HM | 1 |
| Abu-Zaid, A | 1 |
| Sayed, SI | 1 |
| Pathak, KA | 1 |
| Almayouf, MA | 1 |
| Albarrak, M | 1 |
| Aldhahri, SF | 1 |
| Al-Qahtani, KH | 1 |
| Xue, CX | 1 |
| Yao, YF | 1 |
| Lv, H | 3 |
| Cheng, L | 3 |
| Jing, JH | 1 |
| Wang, Z | 2 |
| Huang, Q | 6 |
| Liu, L | 1 |
| Lu, Y | 1 |
| Zhang, C | 3 |
| Ma, T | 1 |
| Li, Z | 9 |
| Wang, Q | 2 |
| Xue, H | 1 |
| Zhang, K | 3 |
| Erdogan, U | 1 |
| Sari, S | 1 |
| Akbas, A | 1 |
| Xu, H | 2 |
| Xie, J | 6 |
| Yang, J | 4 |
| Huang, Z | 5 |
| Wang, D | 6 |
| Pei, F | 10 |
| Maethungkul, R | 1 |
| Atthakomol, P | 1 |
| Phinyo, P | 1 |
| Phanphaisarn, A | 1 |
| Murakami, H | 1 |
| Sangsin, A | 1 |
| Peña Borras, JJ | 1 |
| Pajares Moncho, A | 1 |
| Puig, J | 1 |
| Mateo Rodríguez, E | 1 |
| López Forte, C | 1 |
| Peña Pérez, L | 1 |
| Moreno Pachón, J | 1 |
| Gabaldón Conejos, T | 1 |
| Pérez Artacho, J | 1 |
| Ferrer Gómez, C | 1 |
| Férez Martí, A | 1 |
| López Cantero, M | 1 |
| de Andrés Ibáñez, J | 1 |
| Yee, DK | 1 |
| Wong, JSH | 1 |
| Fang, E | 1 |
| Wong, TM | 1 |
| Fang, C | 1 |
| Leung, F | 1 |
| Morris, JL | 1 |
| Letson, HL | 1 |
| McEwen, P | 1 |
| Biros, E | 1 |
| Dlaska, C | 1 |
| Hazratwala, K | 1 |
| Wilkinson, M | 1 |
| Dobson, GP | 1 |
| Liu, J | 7 |
| Lei, Y | 5 |
| Liao, J | 1 |
| Liang, X | 2 |
| Hu, N | 2 |
| Huang, W | 5 |
| Zins, JE | 1 |
| Dutton, JW | 1 |
| Wang, H | 5 |
| Wu, X | 1 |
| Li, Y | 4 |
| Zhang, Y | 8 |
| Fang, X | 1 |
| Ma, J | 7 |
| Zhou, Z | 2 |
| Shen, B | 7 |
| Haase, DR | 2 |
| Mersereau, EJ | 1 |
| Kimbrel, B | 1 |
| Bombardier, B | 1 |
| Templeton, KJ | 2 |
| Rosenthal, HG | 2 |
| Sweeney, KR | 2 |
| Zou, ZY | 1 |
| He, LX | 3 |
| Yao, YT | 3 |
| Shalaby, MA | 1 |
| Maged, AM | 1 |
| Al-Asmar, A | 1 |
| El Mahy, M | 1 |
| Al-Mohamady, M | 1 |
| Rund, NMA | 1 |
| Bierke, S | 1 |
| Häner, M | 1 |
| Bentzin, M | 1 |
| Park, HU | 1 |
| Petersen, W | 1 |
| Luo, W | 1 |
| Fu, X | 1 |
| Huang, JM | 1 |
| Wu, J | 3 |
| Ma, XL | 2 |
| Guler, O | 1 |
| Çarkcı, E | 1 |
| Çerci, MH | 1 |
| Gümüşsuyu, G | 1 |
| Öztürk, Ç | 1 |
| Shen, SN | 1 |
| Wu, DX | 1 |
| Lv, SJ | 1 |
| Tong, PJ | 1 |
| Balik, M | 1 |
| Kosina, J | 1 |
| Husek, P | 1 |
| Pacovsky, J | 1 |
| Brodak, M | 1 |
| Cecka, F | 1 |
| Hoyos, AE | 1 |
| Duran, H | 1 |
| Cardenas-Camarena, L | 1 |
| Bayter, JE | 1 |
| Cala, L | 1 |
| Perez, M | 1 |
| Lopez, A | 1 |
| Talleri, G | 1 |
| Domínguez-Millan, R | 1 |
| Mogollon, IR | 1 |
| Mousavi, H | 1 |
| Akbari-Aghdam, H | 1 |
| Entezari, R | 1 |
| Chen, C | 6 |
| Ye, YY | 1 |
| Chen, YF | 1 |
| Yang, XX | 1 |
| Liang, JQ | 2 |
| Liang, GY | 1 |
| Zheng, XQ | 1 |
| Chang, YB | 1 |
| Kanhere, AP | 1 |
| Lambrechts, MJ | 1 |
| Issa, TZ | 1 |
| Karamian, BA | 1 |
| Hendow, CJ | 1 |
| Reddy, YC | 1 |
| Slota, PJ | 1 |
| D'Antonio, ND | 1 |
| Kaye, ID | 1 |
| Canseco, JA | 1 |
| Woods, BI | 1 |
| Hilibrand, AS | 1 |
| Kepler, CK | 1 |
| Vaccaro, AR | 1 |
| Schroeder, GD | 1 |
| Lech, P | 1 |
| Michalik, M | 1 |
| Waczyński, K | 1 |
| Osowiecka, K | 1 |
| Dowgiałło-Gornowicz, N | 1 |
| Qi, MT | 1 |
| Wang, SY | 1 |
| Wang, LT | 1 |
| Chen, XW | 1 |
| Zhan, WH | 1 |
| Zhu, XF | 1 |
| Schertz, K | 1 |
| Karam, O | 1 |
| Demetres, M | 1 |
| Mayadunna, S | 1 |
| Faraoni, D | 6 |
| Nellis, ME | 1 |
| Khadivi, M | 1 |
| Saghebdoust, S | 1 |
| Moghadam, N | 1 |
| Zarei, M | 1 |
| Moosavi, M | 1 |
| Ataei, H | 1 |
| Jafarieh, A | 1 |
| Borghei, A | 1 |
| Shafizadeh, M | 1 |
| Eslamian, M | 1 |
| Jouibari, MF | 1 |
| Kordi, R | 1 |
| Rostami, M | 1 |
| Keck, M | 1 |
| Bosselmann, K | 1 |
| Müller-Wittig, S | 1 |
| Wittig, KS | 1 |
| Lohmeyer, JA | 1 |
| Johansson, K | 1 |
| Götrick, B | 1 |
| Holst, J | 1 |
| Tranæus, S | 1 |
| Naimi-Akbar, A | 1 |
| Kim, MK | 1 |
| Ko, SH | 1 |
| Nam, YC | 1 |
| Jeon, YS | 1 |
| Kwon, DG | 1 |
| Ryu, DJ | 1 |
| Turan, K | 1 |
| Muratoğlu, OG | 1 |
| Ergün, T | 1 |
| Çabuk, H | 1 |
| Ertürer, RE | 1 |
| Brito, RM | 1 |
| Oliveira, CMB | 1 |
| Moura, ECR | 1 |
| Campelo, GP | 1 |
| Lima, RC | 1 |
| Fe, CSM | 1 |
| Sousa, TM | 1 |
| Oliveira, EJSG | 1 |
| Dibai Filho, AV | 1 |
| Leal, PDC | 1 |
| Luis, C | 1 |
| Pardo, A | 1 |
| Moreno, CE | 1 |
| Teixell, C | 1 |
| Santiveri, X | 1 |
| Bisbe, E | 1 |
| Zhao, CC | 1 |
| Chen, LY | 1 |
| Chen, CJ | 1 |
| Wang, QR | 1 |
| Li, QH | 1 |
| Kang, PD | 1 |
| Hanke, J | 1 |
| Mendel, T | 1 |
| Wingert, M | 1 |
| Schenk, P | 1 |
| Heinecke, M | 1 |
| Wilharm, A | 1 |
| Akdoğan, M | 1 |
| Öztürk, A | 3 |
| Çatma, MF | 1 |
| Akdoğan, BM | 1 |
| Gülsoy, A | 1 |
| Atilla, HA | 1 |
| Weng, N | 3 |
| Gou, Y | 3 |
| Kuang, F | 3 |
| Lotan, R | 2 |
| Lengenova, S | 2 |
| Rijini, N | 2 |
| Hershkovich, O | 2 |
| Ye, L | 1 |
| Guan, J | 1 |
| Wang, X | 4 |
| Chen, X | 6 |
| Lu, H | 2 |
| Xiao, Y | 1 |
| Dai, X | 1 |
| Wu, M | 1 |
| Ma, S | 1 |
| Sun, X | 1 |
| Li, L | 5 |
| Tan, Y | 1 |
| Xia, Y | 1 |
| Bailey, CR | 1 |
| Zhou, LB | 1 |
| Wang, CC | 2 |
| Zhang, LT | 1 |
| Wu, T | 1 |
| Zhang, GQ | 1 |
| Anyaehie, UE | 1 |
| Eyichukwu, GO | 1 |
| Muoghalu, ON | 1 |
| Emina, BK | 1 |
| Ede, O | 1 |
| Anetekhai, WI | 1 |
| G Nwosu, AD | 1 |
| Iseki, T | 3 |
| Kanto, R | 1 |
| Onishi, S | 1 |
| Yoshiya, S | 2 |
| Tachibana, T | 1 |
| Nakayama, H | 1 |
| Hao, S | 1 |
| Li, H | 2 |
| Liu, S | 3 |
| Meng, S | 1 |
| Wang, L | 5 |
| Yang, H | 2 |
| Zhang, L | 5 |
| Dong, S | 1 |
| Mocanu, V | 1 |
| Wilson, H | 1 |
| Verhoeff, K | 1 |
| Kung, J | 1 |
| Walsh, C | 1 |
| Koloszvari, N | 1 |
| Neville, A | 1 |
| Karmali, S | 1 |
| Huynh, MNQ | 1 |
| Wong, CR | 1 |
| McRae, MC | 1 |
| Voineskos, S | 1 |
| McRae, MH | 1 |
| Li, J | 4 |
| You, M | 1 |
| Yao, L | 1 |
| Fu, W | 1 |
| Li, Q | 5 |
| Chen, G | 2 |
| Tang, X | 2 |
| Xiong, Y | 1 |
| Jamshaid, W | 1 |
| Jamshaid, M | 1 |
| Coulson, C | 1 |
| Sharma, N | 1 |
| Muzaffar, J | 1 |
| Nieto, H | 1 |
| Xiao, C | 1 |
| Gao, Z | 2 |
| Yu, W | 1 |
| Yao, K | 1 |
| Cao, Y | 1 |
| Long, N | 1 |
| Zhang, S | 2 |
| Jiang, Y | 1 |
| Sipos, K | 1 |
| Kämäräinen, S | 1 |
| Kauhanen, S | 1 |
| Lin, PS | 1 |
| Tian, LJ | 1 |
| Jiang, JJ | 1 |
| Yu, YP | 1 |
| Ye, S | 1 |
| Chen, M | 1 |
| Luo, Y | 2 |
| Zhao, C | 2 |
| Kang, P | 4 |
| Stejskal, P | 1 |
| Trnka, Š | 1 |
| Hrabálek, L | 1 |
| Wanek, T | 1 |
| Jablonský, J | 1 |
| Novák, V | 1 |
| 't Hart, JWH | 1 |
| Noordman, BJ | 1 |
| Wijnand, JMA | 2 |
| Biter, LU | 2 |
| Verbrugge, SJC | 2 |
| Birnie, E | 1 |
| Dunkelgrun, M | 2 |
| Huisbrink, J | 2 |
| Apers, JA | 2 |
| Yusufu, A | 1 |
| Haibier, A | 1 |
| Ren, Z | 3 |
| Qin, Q | 1 |
| Zhang, Z | 3 |
| Zhou, Y | 2 |
| Ran, J | 2 |
| de Abreu de Vasconcellos, SJ | 1 |
| Souza Dos Santos Marques, R | 1 |
| Gomes Magalhães de Melo, E | 1 |
| Silva de Almeida, C | 1 |
| de Almeida Góes Silva, JV | 1 |
| de Almeida Souza, LM | 1 |
| Martins-Filho, PR | 2 |
| Shin, TJ | 1 |
| Hasnain, F | 1 |
| Shay, EO | 1 |
| Ye, MJ | 1 |
| Matt, BH | 1 |
| Elghouche, AN | 1 |
| Huang, X | 5 |
| Li, F | 2 |
| Shi, W | 1 |
| Liu, W | 3 |
| Yin, D | 2 |
| Mahardawi, B | 1 |
| Jiaranuchart, S | 1 |
| Arunjaroensuk, S | 1 |
| Tompkins, KA | 1 |
| Somboonsavatdee, A | 1 |
| Pimkhaokham, A | 1 |
| Dawoud, M | 1 |
| Al-Husseiny, M | 1 |
| Helal, O | 1 |
| Elsherbini, M | 1 |
| Abdel-Rasheed, M | 1 |
| Sediek, M | 1 |
| Izima, C | 1 |
| Sampath, SG | 1 |
| Tang, AJ | 1 |
| Ambati, VS | 1 |
| Chou, D | 1 |
| Chan, AK | 1 |
| Nejat, MH | 1 |
| Khayami, A | 1 |
| Daliri, M | 1 |
| Ebrahimzadeh, MH | 1 |
| Sadeghi, M | 2 |
| Moradi, A | 1 |
| Sermet, M | 1 |
| Ozsoy, MS | 1 |
| Ji, X | 1 |
| Shi, L | 2 |
| Tian, F | 1 |
| Huang, Y | 3 |
| Liang, B | 2 |
| Zhou, XD | 1 |
| Jiang, LF | 1 |
| Zhang, JJ | 1 |
| Zhou, D | 1 |
| Wu, LD | 1 |
| Xu, NW | 1 |
| Yao, RZ | 1 |
| Gao, WQ | 1 |
| Wang, BW | 1 |
| Wang, GL | 1 |
| Wu, CX | 1 |
| A-Mu, YD | 1 |
| Bai, J | 2 |
| Zhang, P | 3 |
| Liang, Y | 3 |
| Wang, J | 4 |
| Wang, Y | 9 |
| Zhao, X | 2 |
| Releken, Y | 1 |
| Yang, Z | 2 |
| Bradley, KE | 1 |
| Ryan, SP | 1 |
| Penrose, CT | 1 |
| Grant, SA | 1 |
| Wellman, SS | 3 |
| Attarian, DE | 2 |
| Green, CL | 3 |
| Risoli, T | 1 |
| Bolognesi, MP | 2 |
| Huang, ZY | 1 |
| Zeng, HJ | 1 |
| Zhou, ZK | 6 |
| Pei, FX | 7 |
| Morales-Avalos, R | 2 |
| Ramos-Morales, T | 2 |
| Espinoza-Galindo, AM | 2 |
| Garay-Mendoza, D | 1 |
| Peña-Martínez, VM | 2 |
| Marfil-Rivera, LJ | 1 |
| Garza-Ocañas, L | 1 |
| Acosta-Olivo, C | 2 |
| Cerda-Barbosa, JK | 1 |
| Valdés-González, NL | 1 |
| Vílchez-Cavazos, F | 2 |
| Meshram, P | 1 |
| Palanisamy, JV | 2 |
| Seo, JY | 1 |
| Lee, JG | 1 |
| Kim, TK | 4 |
| Pan, DQ | 1 |
| Chen, LL | 1 |
| Sun, B | 1 |
| Yu, Z | 1 |
| Ge, JB | 1 |
| Miao, MF | 1 |
| Lostak, J | 1 |
| Gallo, J | 1 |
| Slavik, L | 1 |
| Zapletalova, J | 1 |
| Balaz, L | 1 |
| Barzilai, M | 1 |
| Kirgner, I | 1 |
| Steimatzky, A | 1 |
| Salzer Gotler, D | 1 |
| Belnick, Y | 1 |
| Shacham-Abulafia, A | 1 |
| Avivi, I | 1 |
| Raanani, P | 1 |
| Yahalom, V | 1 |
| Nakav, S | 1 |
| Varon, D | 1 |
| Yussim, E | 1 |
| Bachar, GN | 1 |
| Spectre, G | 1 |
| Wang, HY | 4 |
| Luo, ZY | 4 |
| Ockerman, A | 2 |
| Vanhaverbeke, M | 2 |
| Miclotte, I | 2 |
| Belmans, A | 2 |
| Vanassche, T | 2 |
| Politis, C | 2 |
| Jacobs, R | 2 |
| Verhamme, P | 2 |
| Richards, JE | 1 |
| Samet, RE | 1 |
| Koerner, AK | 1 |
| Grissom, TE | 1 |
| Yamada, T | 1 |
| Natori, Y | 1 |
| Jain, M | 1 |
| Kekunnaya, R | 1 |
| Badakere, A | 1 |
| Thakur, A | 1 |
| Gupta, S | 1 |
| Thakur, JS | 1 |
| Minhas, RS | 1 |
| Azad, RK | 1 |
| Vasanthalakshmi, MS | 1 |
| Sharma, DR | 1 |
| Mohindroo, NK | 1 |
| Jia, Y | 2 |
| Shi, J | 6 |
| Yuan, S | 3 |
| Wang, R | 1 |
| Zhao, Y | 1 |
| Hua, Z | 2 |
| Yan, J | 1 |
| Li, S | 6 |
| Zheng, Z | 3 |
| Hu, S | 1 |
| Yan, F | 2 |
| Rong, TH | 1 |
| Liu, HZ | 1 |
| Tan, MS | 1 |
| Zhao, H | 3 |
| Liu, XY | 1 |
| Chang, L | 1 |
| Fishman, J | 1 |
| Hussain, M | 1 |
| Fisher, E | 1 |
| Lei, YT | 1 |
| Xie, JW | 1 |
| Wu, KT | 1 |
| Siu, KK | 1 |
| Ko, JY | 1 |
| Chou, WY | 1 |
| Kuo, SJ | 1 |
| Hsu, YH | 1 |
| Yu, X | 3 |
| Xie, L | 2 |
| Zheng, W | 1 |
| Clarius, M | 1 |
| Clarius, LM | 1 |
| Rodriguez-Merchan, EC | 1 |
| Assadi, T | 1 |
| Leeman, M | 1 |
| Zhou, C | 1 |
| Sun, H | 1 |
| Pan, W | 1 |
| Sun, L | 1 |
| An, H | 1 |
| Feng, Y | 1 |
| Lu, Q | 1 |
| Guo, X | 1 |
| Zhang, M | 1 |
| Miao, Z | 1 |
| Luo, D | 1 |
| Liu, P | 1 |
| Tandogan, RN | 1 |
| Polat, M | 1 |
| Beyzadeoglu, T | 1 |
| Karabulut, E | 1 |
| Yildirim, K | 1 |
| Kayaalp, A | 1 |
| Cohen, JC | 1 |
| Glasgold, RA | 1 |
| Alloju, LM | 1 |
| Glasgold, MJ | 1 |
| Morales Santias, M | 2 |
| Mas Martinez, J | 2 |
| Sanz-Reig, J | 2 |
| Martínez Gimenez, E | 2 |
| Verdu Román, C | 2 |
| Bustamante Suarez de Puga, D | 2 |
| Ausen, K | 2 |
| Hagen, AI | 1 |
| Østbyhaug, HS | 1 |
| Olafsson, S | 1 |
| Kvalsund, BJ | 1 |
| Spigset, O | 2 |
| Pleym, H | 4 |
| Xu, X | 2 |
| Yu, H | 2 |
| Hu, Y | 2 |
| Teoh, WY | 1 |
| Tan, TG | 1 |
| Ng, KT | 1 |
| Ong, KX | 1 |
| Chan, XL | 1 |
| Hung Tsan, SE | 1 |
| Wang, CY | 1 |
| Ma, H | 1 |
| Yao, H | 2 |
| Zhang, T | 1 |
| Wan, C | 1 |
| Hurley, ET | 1 |
| Lim Fat, D | 1 |
| Pauzenberger, L | 1 |
| Mullett, H | 1 |
| Gómez-Aparicio, MDS | 1 |
| Gómez-Barbero, P | 1 |
| Blas-Dobón, JA | 1 |
| Villar-Blanco, A | 1 |
| Morales-Suárez-Varela, M | 1 |
| Rodrigo-Pérez, JL | 1 |
| Qi, X | 1 |
| Xiao, W | 1 |
| Xue, Q | 2 |
| Meissner, F | 1 |
| Plötze, K | 2 |
| Matschke, K | 2 |
| Waldow, T | 2 |
| Zhang, B | 3 |
| Zhang, W | 3 |
| Xu, J | 3 |
| Ding, J | 1 |
| Abdallah, AA | 1 |
| Sallam, AA | 1 |
| Arafa, MS | 1 |
| Henawy, AT | 1 |
| Ma, QM | 1 |
| Han, GS | 1 |
| Li, BW | 1 |
| Li, XJ | 1 |
| Jiang, T | 2 |
| Jeong, JH | 1 |
| Chang, MJ | 1 |
| Kang, SB | 1 |
| Park, HJ | 1 |
| Lee, KH | 1 |
| Chang, CB | 2 |
| Deng, Z | 1 |
| Sheng, P | 1 |
| Xu, D | 4 |
| He, A | 1 |
| Liao, W | 1 |
| Kang, Y | 1 |
| Ni, J | 1 |
| Zhang, J | 5 |
| Jiang, J | 1 |
| Dang, X | 1 |
| Shi, Z | 1 |
| Grzelecki, D | 1 |
| Dudek, P | 1 |
| Okoń, T | 1 |
| Marczak, D | 1 |
| Kordasiewicz, B | 1 |
| Sibiński, M | 1 |
| Kowalczewski, J | 1 |
| Ashkenazi, I | 2 |
| Schermann, H | 2 |
| Gold, A | 2 |
| Lin, R | 1 |
| Pardo, I | 1 |
| Steinberg, E | 1 |
| Sternheim, A | 1 |
| Snir, N | 2 |
| Klement, MR | 2 |
| Padua, FG | 1 |
| Li, WT | 1 |
| Detweiler, M | 1 |
| Parvizi, J | 1 |
| Joy, SM | 1 |
| Karthikeyan, P | 1 |
| Ma, D | 2 |
| Wen, L | 2 |
| Pan, J | 2 |
| He, B | 1 |
| Xu, S | 1 |
| Ou, Y | 3 |
| Zhao, J | 1 |
| Wu, C | 1 |
| Tan, C | 1 |
| Levack, AE | 1 |
| McLawhorn, AS | 1 |
| Dodwell, E | 1 |
| DelPizzo, K | 1 |
| Nguyen, J | 1 |
| Sink, E | 1 |
| Park, JY | 1 |
| Lee, DY | 1 |
| Ro, DH | 1 |
| Han, HS | 1 |
| Lee, MC | 1 |
| Weissmann, KA | 1 |
| Lafage, V | 1 |
| Barrios Pitaque, C | 1 |
| Lafage, R | 1 |
| Descazeaux, FM | 1 |
| Tan, JC | 1 |
| Yang, L | 6 |
| Jia, X | 1 |
| Kang, J | 1 |
| Turan, S | 1 |
| Bingöl, O | 1 |
| Khiabani, K | 1 |
| Ahmadfar, M | 1 |
| Labafchi, A | 1 |
| Gosheh, MR | 1 |
| Samieirad, S | 1 |
| Gurel, R | 1 |
| Chechik, O | 1 |
| Warschawski, Y | 1 |
| Schwarzkopf, R | 2 |
| Wang, LN | 1 |
| Yang, X | 1 |
| Liu, LM | 1 |
| Xiu, P | 1 |
| Zhou, ZJ | 1 |
| Song, YM | 1 |
| Yang, JQ | 1 |
| Tan, JS | 1 |
| Huo, KP | 1 |
| Zhao, L | 1 |
| Cai, DZ | 1 |
| Hayward, CPM | 1 |
| Tasneem, S | 1 |
| Rivard, GE | 1 |
| Wu, XF | 1 |
| Yin, ZF | 1 |
| Sun, BF | 1 |
| Dong, F | 1 |
| Qian, PK | 1 |
| Zhang, JB | 1 |
| Xu, F | 1 |
| Zufferey, PJ | 1 |
| Lanoiselée, J | 1 |
| Graouch, B | 1 |
| Vieille, B | 1 |
| Delavenne, X | 1 |
| Ollier, E | 1 |
| Touzopoulos, P | 1 |
| Arvanitidis, K | 1 |
| Filidou, E | 1 |
| Tilkeridis, K | 1 |
| Karanikas, M | 1 |
| Kolios, G | 1 |
| Ververidis, A | 1 |
| Owen, A | 1 |
| Wellings, EP | 1 |
| Wyles, CC | 1 |
| Yuan, BJ | 1 |
| Rose, PS | 1 |
| Houdek, MT | 2 |
| Weissler, JM | 1 |
| Banuelos, J | 1 |
| Molinar, VE | 1 |
| Tran, NV | 1 |
| García-Pedro, JA | 1 |
| Morcos-Sandino, M | 1 |
| Silva-Ramos, HNG | 1 |
| Rodríguez-Torres, RA | 1 |
| Yen, SH | 2 |
| Lin, PC | 3 |
| Wu, CT | 1 |
| Wang, JW | 3 |
| Yi, Z | 2 |
| Yan, L | 1 |
| Haibo, S | 1 |
| Yuangang, W | 1 |
| Mingyang, L | 1 |
| Yuan, L | 2 |
| Bin, S | 2 |
| Ayan, NRS | 1 |
| Akalın, Y | 2 |
| Çevik, N | 1 |
| Sağlıcak, H | 1 |
| Güler, BO | 1 |
| Othman, Y | 1 |
| Melebeck, F | 1 |
| Daubresse, F | 1 |
| Burton, H | 1 |
| Mossadegh, S | 1 |
| McCarthy, R | 1 |
| Park, CW | 1 |
| Lim, SJ | 1 |
| Yoo, I | 1 |
| Lee, Y | 1 |
| Won, JY | 1 |
| Park, YS | 1 |
| Kizilkurt, T | 1 |
| Bayram, S | 1 |
| Ekinci, M | 2 |
| Ayik, Ö | 1 |
| Ergin, ÖN | 1 |
| Öztürk, İ | 1 |
| Wang, F | 2 |
| Wang, C | 3 |
| Chu, P | 1 |
| Vanhove, J | 1 |
| Meyns, J | 1 |
| Nadjmi, N | 1 |
| Van Hemelen, G | 1 |
| Winderickx, P | 1 |
| Shi, P | 2 |
| Cai, T | 1 |
| Chen, D | 1 |
| Wang, S | 3 |
| Feng, X | 1 |
| Cui, H | 1 |
| Yu, S | 1 |
| Ruan, J | 1 |
| Sun, Z | 1 |
| Chen, S | 1 |
| Fan, C | 1 |
| Desborough, MJR | 1 |
| Obaji, S | 1 |
| Lowe, GC | 1 |
| Doree, C | 1 |
| Thomas, W | 1 |
| Kopitkó, C | 1 |
| Czermann, R | 1 |
| Orosz, M | 1 |
| Hangody, G | 1 |
| Kiss, D | 1 |
| Szabó, Z | 1 |
| Hangody, L | 1 |
| Erwin, DZ | 1 |
| Heichel, PD | 1 |
| Wright, LM | 1 |
| Goldstein, NA | 1 |
| McEvoy, TP | 1 |
| Earley, MA | 1 |
| Meyer, AD | 1 |
| Hui, S | 1 |
| Peng, Y | 1 |
| Tao, L | 1 |
| Yang, Y | 3 |
| Du, Y | 2 |
| Zhuang, Q | 3 |
| Juraj, M | 1 |
| Jaroslav, V | 1 |
| Gažová, A | 1 |
| Žufková, V | 1 |
| Kyselovič, J | 1 |
| Šteňo, B | 1 |
| Hovgesen, NT | 1 |
| Larsen, JB | 1 |
| Fenger-Eriksen, C | 2 |
| Hansen, AK | 1 |
| Hvas, AM | 2 |
| Pereira, EG | 1 |
| Carvalho, MM | 1 |
| Oliveira, T | 1 |
| Sacramento, T | 1 |
| Cruz, H | 1 |
| Viegas, R | 1 |
| Fontes, AP | 1 |
| Marreiros, A | 1 |
| Sousa, JP | 1 |
| Chen, Q | 1 |
| Zhou, Q | 2 |
| Feng, J | 1 |
| Zhang, Q | 1 |
| Ren, Y | 1 |
| Chen, L | 3 |
| Wei, P | 1 |
| Lin, JA | 1 |
| Cui, HD | 1 |
| Hong, Y | 1 |
| Lyu, SJ | 1 |
| Dong, Y | 1 |
| Liang, J | 2 |
| Tong, B | 1 |
| Costain, D | 1 |
| Elder, G | 1 |
| Fraser, B | 1 |
| Slagel, B | 1 |
| Kelly, A | 1 |
| Cheong, Y | 1 |
| Fera, L | 1 |
| Bian, J | 1 |
| Deng, B | 1 |
| Wang, G | 4 |
| Lin, YK | 1 |
| Tsai, SW | 1 |
| Wu, PK | 1 |
| Chen, CM | 1 |
| Yang, JC | 1 |
| Chen, CF | 1 |
| Chen, WM | 1 |
| Watterson, C | 1 |
| Beacher, N | 1 |
| Essola, L | 1 |
| Kouégnigan Rérambiah, L | 1 |
| Obame, R | 1 |
| Issembè, H | 1 |
| Sima Zué, A | 1 |
| Demos, HA | 1 |
| Lin, ZX | 1 |
| Barfield, WR | 2 |
| Wilson, SH | 1 |
| Robertson, DC | 1 |
| Pellegrini, VD | 1 |
| Lopez-Picado, A | 2 |
| Albinarrate, A | 2 |
| Barrachina, B | 2 |
| Moskal, JT | 2 |
| Capps, SG | 1 |
| Biedermann, JS | 1 |
| Rademacher, WMH | 1 |
| Hazendonk, HCAM | 1 |
| van Diermen, DE | 1 |
| Leebeek, FWG | 1 |
| Rozema, FR | 1 |
| Kruip, MJHA | 1 |
| Yang, C | 3 |
| Liu, R | 1 |
| Dawes, TJ | 1 |
| Price, S | 1 |
| Milojevic, M | 1 |
| Kappetein, AP | 1 |
| Head, SJ | 1 |
| Myles, PS | 1 |
| Smith, JA | 1 |
| Painter, T | 1 |
| Jimenez-Rivera, JJ | 1 |
| Iribarren-Sarrías, JL | 1 |
| Martínez-Sanz, R | 1 |
| Wang, DS | 1 |
| Mazer, CD | 3 |
| Orser, BA | 1 |
| Prieto, HA | 1 |
| Vincent, HK | 1 |
| Deen, JT | 1 |
| Iams, DA | 1 |
| Parvataneni, HK | 1 |
| Sheng, L | 2 |
| Jiang, P | 2 |
| Xu, B | 1 |
| Xie, X | 1 |
| Hansen, JK | 1 |
| Lydick, AM | 1 |
| Wyatt, MM | 1 |
| Andrews, BT | 1 |
| Watts, CD | 1 |
| Sems, SA | 1 |
| Cross, WW | 1 |
| Pagnano, MW | 1 |
| Kearns, SM | 1 |
| Kuhar, HN | 1 |
| Bohl, DD | 1 |
| Levine, BR | 1 |
| Nagabhushan, RM | 1 |
| Shetty, AP | 1 |
| Dumpa, SR | 1 |
| Subramanian, B | 1 |
| Kanna, RM | 1 |
| Shanmuganathan, R | 1 |
| Xu, R | 1 |
| Shi, D | 1 |
| Ge, W | 2 |
| Jiang, Q | 1 |
| Kim, KT | 1 |
| Kim, CK | 1 |
| Kim, YC | 1 |
| Juh, HS | 1 |
| Kim, HJ | 2 |
| Kim, HS | 1 |
| Hong, SJ | 1 |
| Hey, HWD | 1 |
| Lacko, M | 1 |
| Cellar, R | 1 |
| Schreierova, D | 1 |
| Vasko, G | 1 |
| Peres-Da-Silva, A | 1 |
| Nickel, BT | 1 |
| Seyler, TM | 1 |
| Jeon, Y | 1 |
| Lee, WI | 1 |
| Kang, SY | 1 |
| Kim, MH | 1 |
| Li, GL | 1 |
| Li, YM | 1 |
| Lei, J | 1 |
| Cong, Y | 1 |
| Zhuang, Y | 1 |
| Wei, X | 1 |
| Fu, Y | 1 |
| Wei, W | 1 |
| Wang, P | 2 |
| Wen, S | 1 |
| Huang, H | 1 |
| Han, S | 1 |
| Dai, WL | 1 |
| Zhou, AG | 1 |
| Zhang, H | 2 |
| Yozawa, S | 1 |
| Ogawa, H | 1 |
| Matsumoto, K | 1 |
| Akiyama, H | 1 |
| Cornell, C | 1 |
| Hobbs, JC | 1 |
| Welsby, IJ | 1 |
| Dhakal, IB | 1 |
| Boese, CK | 1 |
| Centeno, L | 1 |
| Walters, RW | 1 |
| Dai, Z | 1 |
| Chu, H | 1 |
| Liu, JL | 2 |
| Zeng, WN | 6 |
| Wang, FY | 2 |
| Gong, XY | 1 |
| Tan, ZJ | 1 |
| Jia, XL | 1 |
| Ni, JR | 1 |
| Wang, LX | 1 |
| Chen, XJ | 1 |
| Ji, JJ | 1 |
| Yang, ZQ | 1 |
| Zhao, YL | 1 |
| Tan, L | 1 |
| Wei, J | 1 |
| Li, R | 2 |
| Qiu, D | 1 |
| Wei, M | 2 |
| Mu, X | 1 |
| Zeng, Y | 4 |
| Si, H | 1 |
| Li, C | 1 |
| Wu, Y | 3 |
| Tian, S | 1 |
| Shen, Z | 1 |
| Liu, Y | 2 |
| Peng, A | 1 |
| Sierra, RJ | 3 |
| Smith, HM | 2 |
| Junejo, F | 1 |
| Akhtar, MI | 1 |
| Hamid, M | 1 |
| Ahmed, SS | 1 |
| Minai, F | 1 |
| Amanullah, M | 1 |
| Arora, M | 1 |
| Singh, S | 1 |
| Gupta, V | 1 |
| Dongre, A | 1 |
| Shetty, V | 1 |
| Zirk, M | 1 |
| Zinser, M | 1 |
| Buller, J | 1 |
| Bilinsky, V | 1 |
| Dreiseidler, T | 1 |
| Zöller, JE | 1 |
| Kreppel, M | 1 |
| Tsukada, S | 1 |
| Wakui, M | 1 |
| Cansancao, AL | 1 |
| Condé-Green, A | 1 |
| David, JA | 1 |
| Cansancao, B | 1 |
| Vidigal, RA | 1 |
| Li, YS | 1 |
| Chen, CY | 1 |
| Chen, CH | 2 |
| Yao, ZK | 1 |
| Sung, YH | 1 |
| Lin, KC | 1 |
| Tarng, YW | 1 |
| Hsu, CJ | 1 |
| Renn, JH | 1 |
| Sigrist, N | 1 |
| Olgiati, L | 1 |
| Jud Schefer, RS | 1 |
| White, CC | 1 |
| Eichinger, JK | 1 |
| Friedman, RJ | 2 |
| Zargar, M | 1 |
| Nikbakht, R | 1 |
| Ahmadi, M | 1 |
| Yin, S | 1 |
| Zhong, H | 1 |
| Mu, P | 1 |
| El Beheiry, H | 2 |
| Lubberdink, A | 1 |
| Clements, N | 1 |
| Dihllon, K | 1 |
| Sharma, V | 1 |
| Chaudhary, FA | 1 |
| Pervaz, Z | 1 |
| Ilyas, S | 1 |
| Niaz, MN | 1 |
| Polanco-García, M | 1 |
| Capielo, AM | 1 |
| Miret, X | 1 |
| Chamero, A | 1 |
| Sainz, J | 1 |
| Revilla, E | 1 |
| Guinjoan, A | 1 |
| Arranz, T | 1 |
| Mariani, P | 1 |
| Buttaro, MA | 1 |
| Slullitel, PA | 1 |
| Comba, FM | 1 |
| Zanotti, G | 1 |
| Ali, P | 1 |
| Piccaluga, F | 1 |
| Tarabrin, OA | 1 |
| Tyutrin, II | 1 |
| Gavrichenkov, DG | 1 |
| Shcherbakov, SS | 1 |
| Mazurenko, AI | 1 |
| Turenko, AV | 1 |
| Das, S | 1 |
| Moon, KH | 2 |
| Kim, DH | 2 |
| Passarelli, PC | 1 |
| De Angelis, P | 1 |
| Pasquantonio, G | 1 |
| Manicone, PF | 1 |
| Verdugo, F | 1 |
| D'Addona, A | 1 |
| Akman, B | 1 |
| Şaylı, U | 1 |
| Güven, M | 1 |
| Altıntaş, F | 1 |
| Meng, WK | 3 |
| Hill, J | 1 |
| Magill, P | 1 |
| Dorman, A | 1 |
| Hogg, R | 1 |
| Eggleton, A | 1 |
| Benson, G | 1 |
| McFarland, M | 1 |
| Murphy, L | 1 |
| Gardner, E | 1 |
| Bryce, L | 1 |
| Martin, U | 1 |
| Adams, C | 1 |
| Bell, J | 1 |
| Campbell, C | 1 |
| Agus, A | 1 |
| Phair, G | 1 |
| Molloy, D | 1 |
| Mockford, B | 1 |
| O'Hagan, S | 1 |
| Beverland, D | 1 |
| Maak, TG | 1 |
| Lu, SY | 1 |
| Lin, LH | 1 |
| Hsue, SS | 1 |
| Zhao, KC | 1 |
| Zhao, MM | 1 |
| Zhao, DX | 1 |
| Cao, C | 1 |
| Li, LL | 1 |
| Li, DH | 1 |
| Karampinas, PK | 1 |
| Megaloikonomos, PD | 1 |
| Lampropoulou-Adamidou, K | 1 |
| Papadelis, EG | 1 |
| Mavrogenis, AF | 1 |
| Vlamis, JA | 1 |
| Pneumaticos, SG | 1 |
| He, J | 1 |
| Chen, P | 1 |
| Kim, KI | 2 |
| Kim, GB | 1 |
| Bae, SH | 1 |
| Cao, G | 1 |
| Yamaguchi, A | 1 |
| Goto, K | 1 |
| Kawai, T | 1 |
| Kuroda, Y | 1 |
| Sano, K | 1 |
| Matsuda, S | 1 |
| Arslan, A | 1 |
| Görmeli, G | 1 |
| Schwarz, W | 1 |
| Ruttan, T | 1 |
| Bundick, K | 1 |
| Filipek, DR | 1 |
| Hu, Q | 1 |
| Li, M | 2 |
| Bao, X | 1 |
| Zhong, J | 1 |
| Ahmed, S | 1 |
| Ahmed, A | 1 |
| Ahmad, S | 1 |
| Javed, S | 1 |
| Aziz, A | 1 |
| Gong, M | 1 |
| Liu, G | 1 |
| Chen, R | 1 |
| Xiang, Z | 1 |
| Gao, X | 1 |
| Guo, J | 1 |
| Ji, H | 2 |
| Koizumi, M | 1 |
| Ishimaru, M | 1 |
| Matsui, H | 1 |
| Fushimi, K | 1 |
| Yamasoba, T | 1 |
| Yasunaga, H | 1 |
| Wu, YG | 1 |
| Hu, QS | 1 |
| Bao, XC | 1 |
| Xiong, HZ | 1 |
| Bai, L | 1 |
| Fang, Z | 1 |
| Yu, ZP | 1 |
| Liu, LX | 1 |
| Yu, QP | 1 |
| Sagiv, O | 1 |
| Rosenfeld, E | 1 |
| Kalderon, E | 1 |
| Barazani, TB | 2 |
| Zloto, O | 1 |
| Martinowitz, U | 4 |
| Ben Simon, GJ | 1 |
| Zilinsky, I | 2 |
| Jordan, M | 3 |
| Aguilera, X | 3 |
| González, JC | 3 |
| Castillón, P | 1 |
| Salomó, M | 1 |
| Hernández, JA | 1 |
| Ruiz, L | 1 |
| Mora, JM | 1 |
| Camacho-Carrasco, P | 1 |
| Prat-Fabregat, S | 1 |
| Bosch, A | 2 |
| Rodriguez-Arias, A | 2 |
| Martínez-Zapata, MJ | 3 |
| Xue, P | 1 |
| Liu, T | 1 |
| Qiao, F | 1 |
| Wei, BG | 1 |
| Zhang, XS | 1 |
| Torsha, TT | 1 |
| Xiao, J | 1 |
| Shi, ZJ | 1 |
| Luo, GG | 1 |
| Lin, ZQ | 1 |
| Xie, HF | 1 |
| Yao, JC | 1 |
| Zhang, HZ | 1 |
| Felli, L | 1 |
| Revello, S | 2 |
| Burastero, G | 1 |
| Gatto, P | 1 |
| Carletti, A | 1 |
| Formica, M | 1 |
| Alessio-Mazzola, M | 1 |
| Wolfson, TS | 1 |
| Novikov, D | 1 |
| Chen, KK | 1 |
| Kim, KY | 1 |
| Anoushiravani, AA | 1 |
| Deshmukh, AJ | 1 |
| Lajam, CM | 1 |
| Visentin, D | 1 |
| Ahuja, K | 1 |
| Haik, J | 1 |
| Sahu, J | 1 |
| Mishra, N | 1 |
| Concina, C | 1 |
| Crucil, M | 1 |
| Fabbro, S | 1 |
| Gherlinzoni, F | 1 |
| Steinhaus, ME | 1 |
| Buksbaum, J | 1 |
| Eisenman, A | 1 |
| Kohli, M | 1 |
| Fragomen, AT | 1 |
| Rozbruch, SR | 1 |
| Laoruengthana, A | 1 |
| Rattanaprichavej, P | 1 |
| Rasamimongkol, S | 1 |
| Galassi, M | 1 |
| Weerakul, S | 1 |
| Pongpirul, K | 1 |
| Yuan, Y | 1 |
| Zhang, HJ | 1 |
| Luo, H | 1 |
| Chen, Y | 3 |
| Gombár, C | 1 |
| Gálity, H | 1 |
| Bácsi, M | 1 |
| Sisák, K | 1 |
| Durgut, F | 2 |
| Erkocak, OF | 2 |
| Aydin, BK | 2 |
| Ozdemir, A | 1 |
| Gulec, A | 1 |
| Tugrul, AI | 1 |
| Goobie, SM | 2 |
| Kashyap, S | 1 |
| Mahajan, S | 1 |
| Lal, M | 1 |
| Habbab, LM | 2 |
| Hussain, S | 1 |
| Power, P | 1 |
| Bashir, S | 1 |
| Gao, P | 1 |
| Semelhago, L | 2 |
| VanHelder, T | 1 |
| Parry, D | 1 |
| Chu, V | 1 |
| Lamy, A | 2 |
| Chen, F | 1 |
| Jiang, Z | 1 |
| Zhu, X | 1 |
| D'Amore Lindholm, A | 1 |
| Nørholt, SE | 1 |
| von Oettingen, G | 1 |
| Tarpgaard, M | 1 |
| Krogh, L | 1 |
| Juul, N | 1 |
| Rasmussen, M | 1 |
| Anthony, SG | 1 |
| Patterson, DC | 1 |
| Cagle, PJ | 1 |
| Poeran, J | 1 |
| Zubizarreta, N | 1 |
| Mazumdar, M | 1 |
| Galatz, LM | 1 |
| Kwak, DK | 1 |
| Jang, CY | 1 |
| Rhyu, SH | 1 |
| Hwang, JH | 1 |
| Yoo, JH | 1 |
| Perez-Roman, RJ | 1 |
| Lugo-Pico, JG | 1 |
| Burks, JD | 1 |
| Madhavan, K | 1 |
| Sheinberg, D | 1 |
| Green, BA | 1 |
| Gjolaj, JP | 1 |
| Zaman, SU | 1 |
| Zakir, I | 1 |
| Faraz, Q | 1 |
| Akhtar, S | 1 |
| Nawaz, A | 1 |
| Adeel, M | 1 |
| Kaplan, A | 1 |
| Wisniewski, M | 1 |
| Waters, JH | 2 |
| Yazer, MH | 1 |
| Fillingham, YA | 3 |
| Darrith, B | 1 |
| Calkins, TE | 1 |
| Abdel, MP | 1 |
| Malkani, AL | 3 |
| Padgett, DE | 1 |
| Culvern, C | 1 |
| Sershon, RA | 1 |
| Bini, S | 1 |
| Della Valle, CJ | 3 |
| Feng, S | 1 |
| Lv, Z | 1 |
| Qu, Z | 1 |
| Chen, H | 1 |
| Xue, C | 1 |
| Zhu, M | 1 |
| Guo, K | 2 |
| Wu, P | 1 |
| Riaz, O | 1 |
| Aqil, A | 1 |
| Asmar, S | 1 |
| Vanker, R | 1 |
| Hahnel, J | 1 |
| Brew, C | 1 |
| Grogan, R | 1 |
| Radcliffe, G | 1 |
| Tille, E | 1 |
| Mysliwietz, J | 1 |
| Beyer, F | 1 |
| Postler, A | 1 |
| Lützner, J | 1 |
| Tammachote, N | 1 |
| Raphiphan, R | 1 |
| Kanitnate, S | 1 |
| Kamatsuki, Y | 1 |
| Miyazawa, S | 1 |
| Furumatsu, T | 1 |
| Kodama, Y | 1 |
| Hino, T | 1 |
| Okazaki, Y | 2 |
| Masuda, S | 1 |
| Ozaki, T | 1 |
| Craik, JD | 1 |
| Ei Shafie, SA | 1 |
| Kidd, AG | 1 |
| Twyman, RS | 1 |
| Kelley, TC | 1 |
| Tucker, KK | 1 |
| Adams, MJ | 1 |
| Dalury, DF | 2 |
| Fu, DJ | 1 |
| Guo, L | 1 |
| Abdel-Aleem, H | 1 |
| Alhusaini, TK | 1 |
| Abdel-Aleem, MA | 1 |
| Menoufy, M | 1 |
| Gülmezoglu, AM | 1 |
| Ma, YQ | 1 |
| Zhang, YC | 1 |
| Godier, A | 2 |
| Samama, CM | 3 |
| Susen, S | 1 |
| Kang, YG | 1 |
| Seo, ES | 1 |
| Lee, JH | 1 |
| Yun, JH | 1 |
| Lee, SH | 2 |
| Oremus, K | 1 |
| Sostaric, S | 1 |
| Trkulja, V | 1 |
| Haspl, M | 1 |
| Wang, JJ | 1 |
| Chen, GJ | 1 |
| Huang, YG | 1 |
| Luo, AL | 1 |
| Miao, Q | 1 |
| Ortmann, E | 1 |
| Besser, MW | 1 |
| Klein, AA | 1 |
| Albirmawy, OA | 1 |
| Saafan, ME | 1 |
| Shehata, EM | 1 |
| Basuni, AS | 1 |
| Eldaba, AA | 1 |
| Fan, R | 1 |
| Bi, Y | 1 |
| Piao, M | 1 |
| Guo, M | 1 |
| Ren, W | 1 |
| Xiang, L | 1 |
| Wind, TC | 1 |
| Panteli, M | 1 |
| Papakostidis, C | 1 |
| Dahabreh, Z | 1 |
| Giannoudis, PV | 1 |
| Shahid, A | 1 |
| Khan, A | 1 |
| Guerrero-Domínguez, R | 1 |
| Padilla-Morales, V | 1 |
| Montero-López, N | 1 |
| Marenco de la Fuente, ML | 1 |
| Konig, G | 1 |
| Hamlin, BR | 2 |
| Tarabarin, OA | 1 |
| Tkachenko, AI | 1 |
| Salekh, EN | 1 |
| Kushnir, OS | 1 |
| Zarutskiĭ, IaL | 1 |
| Tuchkov, AV | 1 |
| Lee, YC | 1 |
| Park, SJ | 1 |
| Kim, JS | 2 |
| Cho, CH | 1 |
| Karam, JA | 1 |
| Bloomfield, MR | 1 |
| DiIorio, TM | 1 |
| Irizarry, AM | 1 |
| Sharkey, PF | 1 |
| Antinolfi, P | 1 |
| Innocenti, B | 1 |
| Caraffa, A | 1 |
| Peretti, G | 1 |
| Cerulli, G | 1 |
| Wang, YF | 1 |
| Xue, QH | 1 |
| Wang, GY | 1 |
| Li, LH | 1 |
| Gilbody, J | 1 |
| Dhotar, HS | 1 |
| Perruccio, AV | 1 |
| Davey, JR | 1 |
| Blanié, A | 2 |
| Rosencher, N | 4 |
| Fisher, C | 1 |
| Mo, A | 1 |
| Warrillow, S | 1 |
| Smith, C | 1 |
| Jones, D | 1 |
| Dahuja, A | 1 |
| Dahuja, G | 1 |
| Jaswal, V | 1 |
| Sandhu, K | 1 |
| Flanagan, D | 1 |
| Martin, JG | 1 |
| Cassatt, KB | 1 |
| Kincaid-Cinnamon, KA | 1 |
| Westendorf, DS | 1 |
| Garton, AS | 1 |
| Lemke, JH | 1 |
| Urrútia, G | 1 |
| Gich, I | 1 |
| Maymó, RM | 1 |
| Martínez, N | 1 |
| Monllau, JC | 2 |
| Celaya, F | 2 |
| Fernández, JA | 2 |
| Delanois, RE | 2 |
| Mont, MA | 4 |
| Ripollés-de Ramón, J | 1 |
| Muñoz-Corcuera, M | 1 |
| Bravo-Llatas, C | 1 |
| Bascones-Martínez, A | 1 |
| Sa-Ngasoongsong, P | 2 |
| Wongsak, S | 2 |
| Chanplakorn, P | 2 |
| Woratanarat, P | 1 |
| Wechmongkolgorn, S | 1 |
| Wibulpolprasert, B | 1 |
| Mulpruek, P | 1 |
| Kawinwonggowit, V | 2 |
| Jauregui, JJ | 1 |
| Issa, K | 1 |
| Kapadia, BH | 1 |
| Banerjee, S | 1 |
| Harwin, SF | 1 |
| Zhao-Yu, C | 1 |
| Yan, G | 1 |
| Wei, C | 1 |
| Yuejv, L | 1 |
| Ying-Ze, Z | 2 |
| Chang, CH | 1 |
| Chang, Y | 1 |
| Chen, DW | 1 |
| Ueng, SW | 1 |
| Lee, MS | 1 |
| Raveendran, R | 1 |
| Wong, J | 2 |
| Shi, S | 1 |
| Ji, B | 1 |
| Broekema, FI | 1 |
| van Minnen, B | 1 |
| Jansma, J | 1 |
| Bos, RR | 1 |
| Chen, JY | 2 |
| Rikhraj, IS | 1 |
| Tay, DK | 1 |
| Chin, PL | 2 |
| Chia, SL | 2 |
| Lo, NN | 2 |
| Yeo, SJ | 2 |
| Esfandiari, BR | 1 |
| Bistgani, MM | 1 |
| Kabiri, M | 1 |
| Panni, AS | 1 |
| Cerciello, S | 1 |
| Vasso, M | 1 |
| Del Regno, C | 1 |
| Patel, JN | 1 |
| Spanyer, JM | 1 |
| Smith, LS | 2 |
| Huang, J | 1 |
| Yakkanti, MR | 1 |
| Yue, C | 3 |
| Yang, P | 1 |
| Soni, A | 1 |
| Saini, R | 1 |
| Gulati, A | 1 |
| Paul, R | 1 |
| Bhatty, S | 1 |
| Rajoli, SR | 1 |
| Lv, YM | 1 |
| Ding, PJ | 1 |
| Hinder, D | 1 |
| Tschopp, K | 1 |
| Bagsby, DT | 1 |
| Hur, J | 1 |
| Robb, PJ | 1 |
| Xu, Q | 1 |
| Zhou, J | 1 |
| Dai, W | 1 |
| Yao, Z | 1 |
| Olmos Rodríguez, M | 1 |
| Ballester Hernández, JA | 1 |
| Arteta Bárcenas, MT | 1 |
| Rodríguez Cerezo, A | 1 |
| Vidarte Ortiz de Artiñano, MA | 1 |
| Veiga Alameda, C | 1 |
| Fischer, Q | 1 |
| Huisse, MG | 1 |
| Voiriot, G | 1 |
| Caron, C | 1 |
| Lepage, L | 1 |
| Dilly, MP | 1 |
| Nataf, P | 1 |
| Ajzenberg, N | 1 |
| Kirsch, M | 1 |
| Alshryda, S | 3 |
| Sukeik, M | 3 |
| Sarda, P | 2 |
| Blenkinsopp, J | 2 |
| Haddad, FS | 2 |
| Mason, JM | 3 |
| Jang, B | 1 |
| Kao, M | 1 |
| Bohm, MT | 1 |
| Harris, IA | 2 |
| Chen, DB | 2 |
| MacDessi, SJ | 3 |
| Sabatini, L | 1 |
| Atzori, F | 1 |
| Scotti, L | 1 |
| Debiasi, F | 1 |
| Massè, A | 1 |
| Izvin, AI | 1 |
| Kuznetsova, NE | 1 |
| Siniakov, AIu | 1 |
| Slover, J | 1 |
| Bosco, J | 1 |
| Oiartzabal, I | 1 |
| López-Ariznabarreta, C | 1 |
| Molano, J | 1 |
| Wu, Q | 1 |
| Zhang, HA | 1 |
| Liu, SL | 1 |
| Meng, T | 1 |
| Zhou, X | 1 |
| DiGioia, AM | 1 |
| Plakseychuk, AY | 1 |
| Levison, TJ | 1 |
| Soares, EC | 2 |
| Costa, FW | 1 |
| Bezerra, TP | 1 |
| Nogueira, CB | 1 |
| de Barros Silva, PG | 1 |
| Batista, SH | 1 |
| Sousa, FB | 2 |
| Sá Roriz Fonteles, C | 1 |
| Durga, P | 2 |
| Raavula, P | 1 |
| Gurajala, I | 1 |
| Gunnam, P | 1 |
| Veerabathula, P | 1 |
| Reddy, M | 1 |
| Upputuri, O | 1 |
| Ramachandran, G | 2 |
| Lin, SY | 1 |
| Fu, YC | 1 |
| Huang, PJ | 1 |
| Chang, JK | 1 |
| Huang, HT | 1 |
| Carvalho, LH | 1 |
| Frois Temponi, E | 1 |
| Machado Soares, LF | 1 |
| Gonçalves, MB | 1 |
| Paiva Costa, L | 1 |
| Tavares de Souza, ML | 1 |
| Pinzón-Florez, CE | 1 |
| Vélez Cañas, KM | 1 |
| Díaz Quijano, DM | 1 |
| Upadhyay, S | 1 |
| Raza, HK | 1 |
| Xu, GJ | 1 |
| Han, Z | 1 |
| Ma, JX | 1 |
| Jiang, X | 1 |
| Xie, S | 1 |
| Wang, K | 1 |
| Nawabi, DH | 1 |
| Ali Shah, MU | 1 |
| Asghar, MI | 1 |
| Siddiqi, R | 1 |
| Chaudhri, MS | 1 |
| Janjua, AM | 1 |
| Iqbal, A | 1 |
| Rozen, L | 1 |
| Willems, A | 1 |
| Torres, CS | 1 |
| Pereira, LM | 2 |
| Demulder, A | 1 |
| Van der Linden, P | 1 |
| Warner, CG | 1 |
| Gao, F | 3 |
| Sun, W | 3 |
| Guo, W | 3 |
| Ishii, Y | 1 |
| Noguchi, H | 1 |
| Sato, J | 1 |
| Tsuchiya, C | 1 |
| Toyabe, S | 1 |
| Madershahian, N | 1 |
| Scherner, M | 1 |
| Pfister, R | 1 |
| Rudolph, T | 1 |
| Deppe, AC | 1 |
| Slottosch, I | 1 |
| Kuhn, E | 1 |
| Choi, YH | 1 |
| Wahlers, T | 1 |
| Hinarejos, P | 1 |
| Leal, J | 1 |
| Pelfort, X | 1 |
| Puig-Verdie, Ll | 1 |
| Wingerter, SA | 1 |
| Keith, AD | 1 |
| Schoenecker, PL | 1 |
| Baca, GR | 1 |
| Clohisy, JC | 1 |
| Hodgson, S | 1 |
| Larvin, JT | 1 |
| Dearman, C | 1 |
| Wang, CG | 1 |
| Sun, ZH | 1 |
| Cao, JG | 1 |
| Li, ZJ | 1 |
| Averbukh, VM | 1 |
| Dzhafarova, MZ | 1 |
| Bebchuk, GB | 1 |
| Avdeeva, KS | 1 |
| Fossmark, R | 1 |
| Maruyama, M | 1 |
| Holt, JB | 1 |
| Miller, BJ | 1 |
| Callaghan, JJ | 1 |
| Clark, CR | 1 |
| Willenborg, MD | 1 |
| Noiseux, NO | 1 |
| Sizer, SC | 1 |
| Cherian, JJ | 1 |
| Elmallah, RD | 1 |
| Pierce, TP | 1 |
| Beaver, WB | 1 |
| Li, W | 1 |
| Bai, G | 1 |
| Henry, J | 1 |
| McFarland, A | 1 |
| Wu, H | 1 |
| Fu, P | 1 |
| Ding, Z | 1 |
| Melvin, JS | 1 |
| Stryker, LS | 1 |
| Jain, NP | 1 |
| Nisthane, PP | 1 |
| Shah, NA | 1 |
| Uthadorn, K | 1 |
| Panpikoon, T | 1 |
| Jittorntam, P | 1 |
| Aryurachai, K | 1 |
| Angchaisukisiri, P | 1 |
| Choudhuri, P | 1 |
| Biswas, BK | 1 |
| Gordon, E | 1 |
| Butler, RB | 1 |
| Mock, L | 1 |
| Dumas, B | 1 |
| Eftekharian, HR | 1 |
| Rajabzadeh, Z | 1 |
| Chakravartty, S | 1 |
| Sarma, DR | 1 |
| Chang, A | 1 |
| Patel, AG | 1 |
| Simonazzi, G | 1 |
| Bisulli, M | 1 |
| Saccone, G | 1 |
| Moro, E | 1 |
| Marshall, A | 1 |
| Berghella, V | 1 |
| North, WT | 2 |
| Mehran, N | 2 |
| Davis, JJ | 2 |
| Silverton, CD | 2 |
| Weir, RM | 2 |
| Laker, MW | 2 |
| van Galen, KP | 1 |
| Engelen, ET | 1 |
| Mauser-Bunschoten, EP | 1 |
| van Es, RJ | 1 |
| Schutgens, RE | 1 |
| Ueno, M | 1 |
| Sonohata, M | 1 |
| Fukumori, N | 1 |
| Kawano, S | 1 |
| Kitajima, M | 1 |
| Mawatari, M | 1 |
| Pongcharoen, B | 1 |
| Ruetiwarangkoon, C | 1 |
| Prakash, J | 4 |
| Chand, S | 1 |
| Pertlíček, J | 1 |
| Stehlík, J | 1 |
| Sadovský, P | 1 |
| Musil, D | 1 |
| Mezera, V | 1 |
| Öztaş, S | 1 |
| Şahin, N | 1 |
| Özkan, Y | 1 |
| Otuzbir, A | 1 |
| Avcu, B | 1 |
| Goyal, N | 1 |
| Kaul, R | 1 |
| Topsoee, MF | 1 |
| Bergholt, T | 1 |
| Ravn, P | 1 |
| Schouenborg, L | 1 |
| Moeller, C | 1 |
| Ottesen, B | 1 |
| Settnes, A | 1 |
| Liu, KL | 1 |
| Chen, IH | 1 |
| Wen, SH | 1 |
| Serrano Mateo, L | 1 |
| Goudarz Mehdikhani, K | 1 |
| Cáceres, L | 1 |
| Lee, YY | 1 |
| Gonzalez Della Valle, A | 1 |
| Whiting, DR | 1 |
| Duncan, CM | 1 |
| Erb, TO | 1 |
| Meier, PM | 2 |
| Appelmann, I | 1 |
| Kreher, S | 1 |
| Parmentier, S | 1 |
| Wolf, HH | 1 |
| Bisping, G | 1 |
| Kirschner, M | 1 |
| Bergmann, F | 1 |
| Schilling, K | 1 |
| Brümmendorf, TH | 1 |
| Petrides, PE | 1 |
| Tiede, A | 1 |
| Matzdorff, A | 1 |
| Griesshammer, M | 1 |
| Riess, H | 1 |
| Koschmieder, S | 1 |
| Aggarwal, AK | 1 |
| Singh, N | 1 |
| Sudesh, P | 1 |
| Ma, TK | 1 |
| Chow, KM | 1 |
| Kwan, BC | 1 |
| Leung, CB | 1 |
| Szeto, CC | 1 |
| Li, PK | 1 |
| Ranta, S | 1 |
| Blombäck, M | 1 |
| Magnusson, M | 1 |
| He, S | 1 |
| Drakos, A | 1 |
| Raoulis, V | 1 |
| Karatzios, K | 1 |
| Doxariotis, N | 1 |
| Kontogeorgakos, V | 1 |
| Malizos, K | 1 |
| Varitimidis, SE | 1 |
| Reina, N | 1 |
| Fennema, P | 1 |
| Hourlier, H | 1 |
| Stowers, MD | 1 |
| Munro, JT | 1 |
| Hill, AG | 1 |
| Kang, JS | 1 |
| Kim, BS | 1 |
| Yang, SJ | 1 |
| Stevens, LM | 1 |
| Noiseux, N | 1 |
| Prieto, I | 1 |
| Hardy, JF | 1 |
| Kayupov, E | 2 |
| Plummer, DR | 2 |
| Moric, M | 2 |
| Gerlinger, TL | 2 |
| Uğurlu, M | 1 |
| Aksekili, MA | 1 |
| Çağlar, C | 1 |
| Yüksel, K | 1 |
| Şahin, E | 1 |
| Akyol, M | 1 |
| Ma, X | 1 |
| Zhu, Y | 2 |
| Cao, X | 1 |
| Zhu, Q | 1 |
| Zhu, J | 1 |
| Nielsen, CS | 1 |
| Jans, Ø | 1 |
| Ørsnes, T | 1 |
| Foss, NB | 1 |
| Troelsen, A | 2 |
| Husted, H | 3 |
| May, JH | 1 |
| Rieser, GR | 1 |
| Williams, CG | 1 |
| Markert, RJ | 1 |
| Bauman, RD | 1 |
| Lawless, MW | 1 |
| Tzatzairis, TK | 1 |
| Drosos, GI | 1 |
| Kotsios, SE | 1 |
| Ververidis, AN | 1 |
| Vogiatzaki, TD | 1 |
| Kazakos, KI | 1 |
| Jing, Y | 1 |
| Zongke, Z | 1 |
| Pengde, K | 1 |
| Fuxing, P | 1 |
| Babis, GC | 1 |
| Liu, H | 1 |
| Xiong, W | 1 |
| Chua, S | 1 |
| Shin, YS | 1 |
| Yoon, JR | 1 |
| Lee, HN | 1 |
| Park, SH | 1 |
| Lee, DH | 1 |
| Akgül, T | 1 |
| Büget, M | 1 |
| Salduz, A | 1 |
| Edipoğlu, İS | 1 |
| Küçükay, S | 1 |
| Şen, C | 1 |
| Sun, Q | 2 |
| Nie, X | 1 |
| Gong, J | 1 |
| Cai, M | 2 |
| Pinsornsak, P | 1 |
| Rojanavijitkul, S | 1 |
| Chumchuen, S | 1 |
| Guzel, Y | 1 |
| Gurcan, OT | 1 |
| Golge, UH | 1 |
| Dulgeroglu, TC | 1 |
| Metineren, H | 1 |
| Kim, YH | 1 |
| Park, JW | 1 |
| Song, EK | 2 |
| Seon, JK | 2 |
| Seol, YJ | 1 |
| Park, YJ | 2 |
| Jin, C | 2 |
| Silvetti, S | 1 |
| Crivellari, M | 1 |
| Castiglioni, A | 1 |
| Landoni, G | 1 |
| Zangrillo, A | 1 |
| Alfieri, O | 4 |
| Koster, A | 2 |
| Bolliger, D | 1 |
| Tanaka, KA | 1 |
| Chen, B | 1 |
| Huang, CC | 2 |
| Kuo, FC | 1 |
| Weng, K | 1 |
| Bi, Q | 1 |
| Liu, F | 1 |
| Queiroz, SI | 1 |
| Alves, HS | 1 |
| de Assis, GM | 1 |
| Conceicao, TS | 1 |
| Germano, AR | 1 |
| da Silva, JS | 1 |
| Spanyer, J | 1 |
| Patel, J | 2 |
| Emberton, E | 1 |
| Chen, Z | 1 |
| Cui, S | 1 |
| Yuan, Z | 1 |
| Mao, Z | 1 |
| Yue, B | 1 |
| Yan, M | 1 |
| Dai, K | 1 |
| Lim, GB | 1 |
| de Vasconcellos, SJ | 1 |
| de Santana Santos, T | 1 |
| Reinheimer, DM | 1 |
| Faria-E-Silva, AL | 1 |
| de Melo, MF | 1 |
| Blaine, KP | 1 |
| Press, C | 1 |
| Lau, K | 1 |
| Sliwa, J | 1 |
| Rao, VK | 1 |
| Hill, C | 1 |
| Kushioka, J | 1 |
| Yamashita, T | 1 |
| Okuda, S | 1 |
| Maeno, T | 1 |
| Matsumoto, T | 1 |
| Yamasaki, R | 1 |
| Iwasaki, M | 1 |
| Maniar, RN | 2 |
| Singhi, T | 2 |
| Patil, A | 1 |
| Kumar, G | 3 |
| Maniar, P | 1 |
| Singh, J | 1 |
| Yuan, QM | 1 |
| Zhao, ZH | 1 |
| Xu, BS | 1 |
| Taksaudom, N | 1 |
| Siwachat, S | 1 |
| Tantraworasin, A | 1 |
| Amour, J | 1 |
| Garnier, M | 1 |
| Szymezak, J | 1 |
| Le Manach, Y | 1 |
| Helley, D | 1 |
| Bertil, S | 1 |
| Ouattara, A | 1 |
| Riou, B | 1 |
| Gaussem, P | 1 |
| Gwam, C | 1 |
| Mistry, JB | 1 |
| Chughtai, M | 1 |
| Thomas, M | 1 |
| Mudaliar, PP | 1 |
| Khlopas, A | 1 |
| Tangri, V | 1 |
| Baruah, RK | 1 |
| Borah, PJ | 1 |
| Haque, R | 1 |
| Nakura, N | 1 |
| Hirakawa, K | 1 |
| Takayanagi, S | 1 |
| Saito, A | 1 |
| Tsuji, K | 1 |
| Tamaki, Y | 1 |
| Ochiai, S | 1 |
| Mihara, M | 1 |
| Prajapati, M | 1 |
| Patel, H | 1 |
| Gandhi, H | 1 |
| Deodhar, S | 1 |
| Pandya, H | 1 |
| Shi, H | 1 |
| Jiang, D | 2 |
| Quan, Z | 1 |
| Zhao, Z | 1 |
| Mahmood, A | 1 |
| Sawalha, S | 1 |
| Borbora, A | 1 |
| Peter, V | 1 |
| Hu, KZ | 1 |
| Sun, HY | 1 |
| Sui, C | 1 |
| Yu, CC | 1 |
| Gao, WJ | 1 |
| Yang, JS | 1 |
| Gu, H | 1 |
| Md, MZ | 1 |
| Sun, K | 1 |
| Hao, DJ | 1 |
| Vara, AD | 1 |
| Koueiter, DM | 1 |
| Pinkas, DE | 1 |
| Gowda, A | 1 |
| Wiater, BP | 1 |
| Wiater, JM | 1 |
| Cankaya, D | 1 |
| Dasar, U | 1 |
| Satilmis, AB | 1 |
| Basaran, SH | 1 |
| Akkaya, M | 1 |
| Bozkurt, M | 1 |
| Badenoch, A | 1 |
| Sharma, A | 1 |
| Gower, S | 1 |
| Selzner, M | 1 |
| Srinivas, C | 1 |
| Wąsowicz, M | 1 |
| McCluskey, SA | 1 |
| Moo, IH | 1 |
| Pang, HN | 1 |
| Tay, DKJ | 1 |
| Okroj, K | 1 |
| Mehtani, A | 1 |
| Lee, SY | 1 |
| Chong, S | 1 |
| Balasubramanian, D | 1 |
| Na, YG | 1 |
| Acar, MA | 1 |
| Casati, V | 6 |
| Romano, A | 1 |
| D'Angelo, A | 5 |
| Mengistu, AM | 1 |
| Röhm, KD | 1 |
| Boldt, J | 1 |
| Mayer, J | 1 |
| Suttner, SW | 1 |
| Piper, SN | 1 |
| Taneja, R | 1 |
| Fernandes, P | 1 |
| Marwaha, G | 1 |
| Cheng, D | 2 |
| Bainbridge, D | 1 |
| Bellamy, L | 3 |
| Chabbouh, T | 1 |
| Arnaout, L | 1 |
| Ozier, Y | 1 |
| Elwatidy, S | 1 |
| Jamjoom, Z | 1 |
| Elgamal, E | 1 |
| Zakaria, A | 1 |
| Turkistani, A | 1 |
| El-Dawlatly, A | 1 |
| Breuer, T | 2 |
| Martin, K | 3 |
| Wilhelm, M | 1 |
| Wiesner, G | 3 |
| Schreiber, C | 3 |
| Hess, J | 2 |
| Lange, R | 2 |
| Tassani, P | 2 |
| Henry, D | 1 |
| Carless, P | 1 |
| Fergusson, D | 1 |
| Laupacis, A | 1 |
| Jonnavithula, N | 1 |
| Pochiraju, R | 1 |
| Anne, KK | 1 |
| Taghaddomi, RJ | 1 |
| Mirzaee, A | 1 |
| Attar, AS | 1 |
| Shirdel, A | 1 |
| Wiseman, DM | 1 |
| Meidler, R | 1 |
| Lyahovetsky, Y | 1 |
| Kurman, E | 1 |
| Horn, S | 1 |
| Nur, I | 1 |
| Katznelson, R | 1 |
| Djaiani, GN | 1 |
| Karski, J | 2 |
| Sekhavat, L | 1 |
| Tabatabaii, A | 1 |
| Dalili, M | 1 |
| Farajkhoda, T | 1 |
| Tafti, AD | 1 |
| Ranucci, M | 1 |
| Castelvecchio, S | 1 |
| Romitti, F | 1 |
| Isgrò, G | 1 |
| Ballotta, A | 1 |
| Conti, D | 1 |
| Later, AF | 1 |
| Maas, JJ | 1 |
| Engbers, FH | 1 |
| Versteegh, MI | 1 |
| Bruggemans, EF | 1 |
| Dion, RA | 1 |
| Klautz, RJ | 1 |
| Fuentes García, D | 1 |
| Ramírez Muñoz, G | 1 |
| Gram, J | 1 |
| Sirgo, G | 1 |
| Morales, P | 1 |
| Rello, J | 1 |
| Fawzy, H | 1 |
| Elmistekawy, E | 1 |
| Bonneau, D | 1 |
| Latter, D | 1 |
| Errett, L | 1 |
| Krutzsch, D | 1 |
| Wils, M | 1 |
| Madrid, C | 1 |
| Sanz, M | 1 |
| Colomina, MJ | 1 |
| Bagó, J | 1 |
| Fuentes, I | 1 |
| Jakobsen, CJ | 1 |
| Søndergaard, F | 1 |
| Hjortdal, VE | 1 |
| Johnsen, SP | 1 |
| Kazemi, SM | 1 |
| Mosaffa, F | 1 |
| Eajazi, A | 1 |
| Kaffashi, M | 1 |
| Daftari Besheli, L | 1 |
| Bigdeli, MR | 1 |
| Zanganeh, RF | 1 |
| McMullan, V | 1 |
| Alston, RP | 2 |
| Fritsch, N | 1 |
| Pouquet, O | 1 |
| Roux, B | 1 |
| Abdelmoumen, Y | 1 |
| Janvier, G | 1 |
| Ngaage, DL | 1 |
| Bland, JM | 1 |
| MacGillivray, RG | 1 |
| Tarabichi, SB | 1 |
| Hawari, MF | 1 |
| Raoof, NT | 1 |
| Eubanks, JD | 1 |
| Senay, S | 1 |
| Toraman, F | 1 |
| Karabulut, H | 1 |
| Alhan, C | 1 |
| Royston, D | 1 |
| Sasanuma, H | 1 |
| Sekiya, H | 1 |
| Takatoku, K | 1 |
| Takada, H | 1 |
| Sugimoto, N | 1 |
| Hoshino, Y | 1 |
| Raghunathan, K | 1 |
| Connelly, NR | 1 |
| Kanter, GJ | 1 |
| Schirmer, U | 1 |
| Gungorduk, K | 1 |
| Yıldırım, G | 1 |
| Asıcıoğlu, O | 1 |
| Gungorduk, OC | 1 |
| Sudolmus, S | 1 |
| Ark, C | 1 |
| Abrishami, A | 1 |
| Mahomed, NN | 1 |
| Roderick Davey, J | 1 |
| Gandhi, R | 1 |
| Syed, KA | 1 |
| Muhammad Ovais Hasan, S | 1 |
| De Silva, Y | 1 |
| Chung, F | 1 |
| Vonk, AB | 1 |
| Meesters, MI | 1 |
| Schats, J | 1 |
| Romijn, JW | 1 |
| Jansen, EK | 1 |
| Boer, C | 1 |
| Gertler, R | 2 |
| Hapfelmeier, A | 1 |
| Adler Ma, SC | 1 |
| Brindle, W | 1 |
| Burton, G | 1 |
| Gallacher, S | 1 |
| Hong, FC | 1 |
| Manelius, I | 1 |
| Smith, A | 1 |
| Ho, W | 1 |
| Bhattacharya, K | 1 |
| Chevet, I | 1 |
| Remérand, F | 1 |
| Couvret, C | 1 |
| Baud, A | 1 |
| Pouplard, C | 1 |
| Rosset, P | 1 |
| Laffon, M | 1 |
| Fusciardi, J | 1 |
| Keyl, C | 1 |
| Uhl, R | 1 |
| Beyersdorf, F | 1 |
| Stampf, S | 1 |
| Lehane, C | 1 |
| Wiesenack, C | 1 |
| Trenk, D | 1 |
| Wahba, A | 3 |
| Vonk, A | 1 |
| Bidstrup, B | 1 |
| Bonnet, MP | 1 |
| Tesnière, A | 1 |
| Mignon, A | 1 |
| Sterner, A | 1 |
| MacGuill, M | 1 |
| Hörer, J | 1 |
| Vogt, M | 1 |
| Charoencholvanich, K | 1 |
| Siriwattanasakul, P | 1 |
| Sepah, YJ | 1 |
| Umer, M | 1 |
| Ahmad, T | 1 |
| Nasim, F | 1 |
| Chaudhry, MU | 1 |
| Umar, M | 1 |
| Spegar, J | 1 |
| Vanek, T | 2 |
| Snircova, J | 1 |
| Fajt, R | 2 |
| Straka, Z | 2 |
| Pazderkova, P | 1 |
| Maly, M | 2 |
| Bokesch, PM | 1 |
| Szabo, G | 1 |
| Wojdyga, R | 1 |
| Grocott, HP | 1 |
| Smith, PK | 1 |
| Vetticaden, S | 1 |
| Wheeler, A | 1 |
| Levy, JH | 2 |
| Xie, G | 1 |
| Liu, M | 1 |
| Greiff, G | 1 |
| Stenseth, R | 2 |
| Videm, V | 1 |
| Lydersen, S | 1 |
| Irgens, W | 1 |
| Bjella, L | 2 |
| Shimizu, K | 1 |
| Toda, Y | 1 |
| Iwasaki, T | 1 |
| Takeuchi, M | 1 |
| Morimatsu, H | 1 |
| Egi, M | 1 |
| Suemori, T | 1 |
| Suzuki, S | 1 |
| Morita, K | 1 |
| Sano, S | 1 |
| Graham, EM | 1 |
| Atz, AM | 1 |
| Gillis, J | 1 |
| Desantis, SM | 1 |
| Haney, AL | 1 |
| Deardorff, RL | 1 |
| Uber, WE | 1 |
| Reeves, ST | 1 |
| McGowan, FX | 1 |
| Bradley, SM | 1 |
| Spinale, FG | 1 |
| Nargol, A | 1 |
| Van Aelbrouck, C | 1 |
| Cacheux, C | 1 |
| Ipema, HJ | 1 |
| Tanzi, MG | 1 |
| Pasquali, SK | 1 |
| Li, JS | 1 |
| He, X | 1 |
| Jacobs, ML | 1 |
| O'Brien, SM | 1 |
| Hall, M | 1 |
| Jaquiss, RD | 1 |
| Welke, KF | 1 |
| Peterson, ED | 1 |
| Shah, SS | 1 |
| Jacobs, JP | 1 |
| Perdigão, JP | 1 |
| de Almeida, PC | 1 |
| Rocha, TD | 1 |
| Mota, MR | 1 |
| Alves, AP | 1 |
| Roy, SP | 1 |
| Tanki, UF | 1 |
| Dutta, A | 1 |
| Jain, SK | 1 |
| Nagi, ON | 1 |
| Nayak, RM | 1 |
| Maniar, PR | 1 |
| Keijzer, R | 1 |
| Wilschut, DE | 1 |
| Houmes, RJ | 1 |
| van de Ven, KP | 1 |
| van den Hout, L | 1 |
| Sluijter, I | 1 |
| Rycus, P | 1 |
| Bax, KM | 1 |
| Tibboel, D | 1 |
| Mansouri, M | 1 |
| Attary, M | 1 |
| Bagheri, K | 1 |
| Massoumi, G | 1 |
| Ghavami, B | 1 |
| Clavé, A | 1 |
| Fazilleau, F | 1 |
| Dumser, D | 1 |
| Lacroix, J | 1 |
| Loomba, A | 1 |
| Loomba, K | 1 |
| Bains, R | 1 |
| Bains, VK | 1 |
| Domschke, C | 1 |
| Strowitzki, T | 1 |
| Huth-Kuehne, A | 1 |
| Staritz, P | 1 |
| Sohn, C | 1 |
| Schuetz, F | 1 |
| Hsu, CH | 1 |
| Chen, WS | 1 |
| Abrams, J | 1 |
| Peña, JJ | 1 |
| Mateo, E | 1 |
| Martín, E | 1 |
| Llagunes, J | 1 |
| Carmona, P | 1 |
| Blasco, L | 1 |
| Giordano, R | 1 |
| Palma, G | 1 |
| Poli, V | 1 |
| Palumbo, S | 1 |
| Russolillo, V | 1 |
| Cioffi, S | 1 |
| Mucerino, M | 1 |
| Mannacio, VA | 1 |
| Vosa, C | 1 |
| Martin, J | 1 |
| Dell'Amore, A | 1 |
| Caroli, G | 1 |
| Nizar, A | 1 |
| Cassanelli, N | 1 |
| Luciano, G | 1 |
| Greco, D | 1 |
| Dolci, G | 1 |
| Bini, A | 1 |
| Stella, F | 1 |
| Chan, CC | 1 |
| Chan, YY | 1 |
| Tanweer, F | 1 |
| Mutsuzaki, H | 1 |
| Ikeda, K | 1 |
| de Jonge, T | 1 |
| Cho, KY | 1 |
| Khurana, S | 1 |
| Gao, W | 1 |
| Ju, Y | 1 |
| Beckerman, Z | 1 |
| Shopen, Y | 1 |
| Alon, H | 1 |
| Cohen, O | 1 |
| Nir, RR | 1 |
| Adler, Z | 1 |
| Bolotin, G | 1 |
| Sammartino, G | 1 |
| Marenzi, G | 1 |
| Miro, A | 1 |
| Ungaro, F | 1 |
| Nappi, A | 1 |
| Sammartino, JC | 1 |
| Quaglia, F | 1 |
| Mortellaro, C | 1 |
| Rhayem, Y | 1 |
| Flaujac, C | 1 |
| Fontenay, M | 1 |
| Irisson, E | 1 |
| Kerbaul, F | 1 |
| Parratte, S | 1 |
| Hémon, Y | 1 |
| Argenson, JN | 1 |
| Skovgaard, C | 1 |
| Holm, B | 1 |
| Lunn, TH | 1 |
| Gaarn-Larsen, L | 1 |
| Kehlet, H | 1 |
| Sethna, NF | 1 |
| Soriano, SG | 1 |
| Zurakowski, D | 1 |
| Samant, S | 1 |
| Jiménez-Yuste, V | 1 |
| Prim, MP | 1 |
| De Diego, JI | 1 |
| Villar, A | 1 |
| Quintana, M | 2 |
| Rabanal, I | 1 |
| Sastre, N | 1 |
| Hernández-Navarro, F | 1 |
| Karevold, A | 1 |
| Dale, O | 1 |
| Good, L | 1 |
| Peterson, E | 1 |
| Lisander, B | 1 |
| Piot, B | 1 |
| Sigaud-Fiks, M | 1 |
| Huet, P | 1 |
| Fressinaud, E | 1 |
| Trossaërt, M | 1 |
| Mercier, J | 1 |
| Keiani Motlagh, K | 1 |
| Loeb, I | 1 |
| Legrand, W | 1 |
| Daelemans, P | 1 |
| Van Reck, J | 1 |
| Dodson, TB | 1 |
| Durán de la Fuente, P | 1 |
| García-Fernández, J | 1 |
| Pérez-López, C | 1 |
| Carceller, F | 1 |
| Gilsanz Rodríguez, F | 1 |
| Carter, G | 2 |
| Goss, A | 2 |
| Lloyd, J | 1 |
| Tocchetti, R | 1 |
| Gai, MY | 1 |
| Wu, LF | 1 |
| Su, QF | 1 |
| Tatsumoto, K | 1 |
| Armellin, G | 1 |
| Vinciguerra, A | 1 |
| Bonato, R | 1 |
| Pittarello, D | 1 |
| Giron, GP | 1 |
| Chauhan, S | 1 |
| Das, SN | 1 |
| Bisoi, A | 1 |
| Kale, S | 1 |
| Kiran, U | 1 |
| Benussi, S | 4 |
| Sandrelli, L | 1 |
| Grasso, MA | 2 |
| Spagnolo, S | 2 |
| Krohn, CD | 1 |
| Sørensen, R | 1 |
| Lange, JE | 1 |
| Riise, R | 1 |
| Bjørnsen, S | 1 |
| Brosstad, F | 1 |
| Della Valle, P | 1 |
| Franco, A | 3 |
| Gerli, C | 3 |
| Baili, P | 1 |
| Andreasen, JJ | 1 |
| Nielsen, C | 1 |
| Roberts, HR | 1 |
| Escobar, M | 1 |
| Monroe, DM | 1 |
| Arora, RC | 1 |
| Légaré, JF | 1 |
| Buth, KJ | 1 |
| Sullivan, JA | 1 |
| Hirsch, GM | 1 |
| Frachon, X | 1 |
| Pommereuil, M | 1 |
| Berthier, AM | 1 |
| Lejeune, S | 1 |
| Hourdin-Eude, S | 1 |
| Quéro, J | 1 |
| Mézière, X | 1 |
| De Mello, G | 1 |
| Garnier, J | 1 |
| Lee, AP | 1 |
| Boyle, CA | 1 |
| Savidge, GF | 1 |
| Fiske, J | 1 |
| De Bels, D | 1 |
| Demeere, JL | 1 |
| Dugauquier, J | 1 |
| Louis, P | 1 |
| Van der Vorst, E | 1 |
| Yasim, A | 1 |
| Aşik, R | 1 |
| Atahan, E | 1 |
| Yamasaki, S | 1 |
| Masuhara, K | 1 |
| Fuji, T | 1 |
| Huvers, F | 1 |
| Slappendel, R | 1 |
| Benraad, B | 1 |
| van Hellemondt, G | 1 |
| van Kraaij, M | 1 |
| Morimoto, Y | 1 |
| Yoshioka, A | 1 |
| Sugimoto, M | 1 |
| Imai, Y | 1 |
| Kirita, T | 1 |
| Jares, M | 1 |
| Jirasek, K | 1 |
| Kolesar, M | 1 |
| Brucek, P | 1 |
| Szekely, E | 1 |
| Baralle, MM | 1 |
| Raoul, G | 1 |
| Marey, A | 1 |
| Ferri, J | 1 |
| Santos, AT | 1 |
| Kalil, RA | 1 |
| Bauemann, C | 1 |
| Pereira, JB | 1 |
| Nesralla, IA | 1 |
| Arango, M | 1 |
| Mangano, DT | 1 |
| Tudor, IC | 1 |
| Dietzel, C | 1 |
| Abul-Azm, A | 1 |
| Abdullah, KM | 1 |
| Sacco, R | 2 |
| Sacco, M | 1 |
| Carpenedo, M | 2 |
| Moia, M | 1 |
| Niskanen, RO | 1 |
| Korkala, OL | 1 |
| Orpen, NM | 1 |
| Little, C | 1 |
| Walker, G | 1 |
| Crawfurd, EJ | 1 |
| Ickx, BE | 1 |
| van der Linden, PJ | 1 |
| Melot, C | 1 |
| Wijns, W | 1 |
| de Pauw, L | 1 |
| Vandestadt, J | 1 |
| Hut, F | 1 |
| Pradier, O | 1 |
| Jian, K | 1 |
| Guo, Z | 1 |
| Tarkka, M | 1 |
| Barbato, L | 1 |
| Rossi, E | 1 |
| Panzeri, E | 1 |
| Alberca, I | 1 |
| Asuero, MS | 1 |
| Bóveda, JL | 1 |
| Carpio, N | 1 |
| Contreras, E | 1 |
| Fernández-Mondéjar, E | 1 |
| Forteza, A | 1 |
| García-Erce, JA | 1 |
| García de Lorenzo, A | 1 |
| Gomar, C | 1 |
| Gómez, A | 1 |
| Llau, JV | 1 |
| López-Fernández, MF | 1 |
| Moral, V | 1 |
| Muñoz, M | 1 |
| Páramo, JA | 1 |
| Torrabadella, P | 1 |
| Sánchez, C | 1 |
| Weiskopf, RB | 1 |
| Zufferey, P | 1 |
| Merquiol, F | 1 |
| Laporte, S | 1 |
| Decousus, H | 1 |
| Mismetti, P | 1 |
| Auboyer, C | 1 |
| Molliex, S | 1 |
| Kuitunen, AH | 1 |
| Suojaranta-Ylinen, RT | 1 |
| Kukkonen, SI | 1 |
| Niemi, TT | 1 |
| Baric, D | 1 |
| Biocina, B | 1 |
| Unic, D | 1 |
| Sutlic, Z | 1 |
| Rudez, I | 1 |
| Vrca, VB | 1 |
| Brkic, K | 1 |
| Ivkovic, M | 1 |
| Bechstein, WO | 1 |
| Strey, C | 1 |
| Mehr-Aein, A | 2 |
| Davoodi, S | 1 |
| Madani-Civi, M | 2 |
| Varela Crespo, CA | 1 |
| Sanabria Carretero, P | 1 |
| Palomero Rodríguez, MA | 1 |
| Tormo las de Heras, C | 1 |
| Rodríguez Pérez, E | 1 |
| Goldman Tarlousky, L | 1 |
| Boeken, U | 1 |
| Litmathe, J | 1 |
| Kurt, M | 1 |
| Feindt, P | 1 |
| Gams, E | 1 |
| Caglar, GS | 1 |
| Tasci, Y | 1 |
| Kayikcioglu, F | 1 |
| Haberal, A | 1 |
| Maddali, MM | 1 |
| Rajakumar, MC | 1 |
| Ait Houssa, M | 1 |
| Selkane, C | 1 |
| Amahzoune, B | 1 |
| El Bekkali, Y | 1 |
| Wahid, FA | 1 |
| Moutaki Allah, Y | 1 |
| Boulahya, A | 1 |
| Ibat, D | 1 |
| Drissi, M | 1 |
| Azendour, H | 1 |
| Elkirat, A | 1 |
| Jimenez, JJ | 2 |
| Iribarren, JL | 2 |
| Lorente, L | 2 |
| Rodriguez, JM | 1 |
| Hernandez, D | 2 |
| Nassar, I | 2 |
| Perez, R | 2 |
| Brouard, M | 2 |
| Milena, A | 1 |
| Martinez, R | 2 |
| Mora, ML | 2 |
| Zhang, F | 1 |
| Yu, J | 1 |
| Castaman, G | 1 |
| Ruggeri, M | 1 |
| Rodeghiero, F | 1 |
| Riverol, D | 1 |
| de La Llana, R | 1 |
| Dunning, J | 1 |
| Versteegh, M | 1 |
| Fabbri, A | 1 |
| Pavie, A | 1 |
| Kolh, P | 1 |
| Lockowandt, U | 1 |
| Nashef, SA | 1 |
| Trudell, J | 1 |
| McMurdy, N | 1 |
| Fergusson, DA | 1 |
| Hébert, PC | 1 |
| Fremes, S | 1 |
| MacAdams, C | 1 |
| Murkin, JM | 1 |
| Teoh, K | 1 |
| Duke, PC | 1 |
| Arellano, R | 1 |
| Blajchman, MA | 1 |
| Bussières, JS | 1 |
| Côté, D | 1 |
| Martineau, R | 1 |
| Robblee, JA | 1 |
| Rodger, M | 1 |
| Wells, G | 1 |
| Clinch, J | 1 |
| Pretorius, R | 1 |
| Chen, CC | 1 |
| Wang, CP | 1 |
| Lin, TH | 1 |
| Lin, WD | 1 |
| Liu, SA | 1 |
| Penta de Peppo, A | 1 |
| Pierri, MD | 1 |
| Scafuri, A | 1 |
| De Paulis, R | 1 |
| Colantuono, G | 1 |
| Caprara, E | 1 |
| Tomai, F | 1 |
| Chiariello, L | 1 |
| Benoni, G | 2 |
| Fredin, H | 2 |
| Shore-Lesserson, L | 1 |
| Reich, DL | 1 |
| Vela-Cantos, F | 1 |
| Ammar, T | 1 |
| Ergin, MA | 1 |
| Menichetti, A | 1 |
| Tritapepe, L | 1 |
| Ruvolo, G | 1 |
| Speziale, G | 1 |
| Cogliati, A | 1 |
| Di Giovanni, C | 1 |
| Pacilli, M | 1 |
| Criniti, A | 1 |
| Bandrowsky, T | 1 |
| Vorono, AA | 1 |
| Borris, TJ | 1 |
| Marcantoni, HW | 1 |
| Landymore, RW | 1 |
| Murphy, JT | 1 |
| Lummis, H | 1 |
| Carter, C | 1 |
| Dryden, PJ | 1 |
| O'Connor, JP | 1 |
| Jamieson, WR | 1 |
| Reid, I | 1 |
| Ansley, D | 1 |
| Sadeghi, H | 1 |
| Burr, LH | 1 |
| Munro, AI | 1 |
| Merrick, PM | 1 |
| Gaspar, R | 1 |
| Brenner, B | 1 |
| Ardekian, L | 1 |
| Peled, M | 1 |
| Laufer, D | 1 |
| Lambert, W | 1 |
| Brisebois, FJ | 1 |
| Wharton, TJ | 1 |
| Carrier, RC | 1 |
| Boyle, D | 1 |
| Rowe, BH | 1 |
| Mongan, PD | 1 |
| Brown, RS | 1 |
| Thwaites, BK | 1 |
| Bernardoni-Socorro, C | 1 |
| Arteaga-Vizcaino, M | 1 |
| Villamizar, Y | 1 |
| Diez-Ewald, M | 1 |
| Vizcaíno-Salazar, G | 1 |
| Torres-Guerra, E | 1 |
| Quintero, J | 1 |
| Okuyama, K | 1 |
| Matsukawa, T | 1 |
| Abe, F | 1 |
| Kumazawa, T | 1 |
| Davies, R | 1 |
| Sindet-Pedersen, S | 1 |
| Senghore, N | 1 |
| Harris, M | 1 |
| Blinder, D | 2 |
| Manor, Y | 2 |
| Taicher, S | 2 |
| Hashomer, T | 1 |
| Levi, M | 1 |
| Cromheecke, ME | 1 |
| de Jonge, E | 1 |
| Prins, MH | 1 |
| de Mol, BJ | 1 |
| Briët, E | 1 |
| Büller, HR | 1 |
| Wong, BI | 1 |
| McLean, RF | 1 |
| Fremes, SE | 1 |
| Deemar, KA | 1 |
| Harrington, EM | 1 |
| Christakis, GT | 1 |
| Goldman, BS | 1 |
| Federici, AB | 1 |
| Stabile, F | 1 |
| Zingaro, E | 1 |
| Mannucci, PM | 1 |
| Bertholini, DM | 1 |
| Butler, CS | 1 |
| Lethagen, S | 1 |
| Nilsson, P | 1 |
| Bublitz, R | 1 |
| Sommer, S | 1 |
| Weingart, D | 1 |
| Bäuerle, K | 1 |
| Both, A | 1 |
| Maineri, P | 1 |
| Covaia, G | 1 |
| Realini, M | 1 |
| Caccia, G | 1 |
| Ucussich, E | 1 |
| Luraschi, M | 1 |
| Crosta, A | 1 |
| Foresti, B | 1 |
| Chiaranda, M | 1 |
| Bellotti, F | 1 |
| Oppizzi, M | 1 |
| Cossolini, M | 1 |
| Calori, G | 1 |
| Torri, G | 2 |
| Nitu-Whalley, IC | 1 |
| Griffioen, A | 1 |
| Harrington, C | 1 |
| Lee, CA | 1 |
| Santagostino, E | 1 |
| Morfini, M | 1 |
| Rocino, A | 1 |
| Baudo, F | 1 |
| Scaraggi, FA | 1 |
| Gringeri, A | 1 |
| Nielsen, RE | 1 |
| Gortzak, RA | 1 |
| Huijgens, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women: A Randomized Controlled Trial[NCT03820206] | 160 participants (Actual) | Interventional | 2019-01-31 | Completed | |||
| Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy? The RARPEX (Robotic Assisted Radical Prostatectomy With TranEXamic Acid) Study.[NCT04319614] | Phase 4 | 200 participants (Actual) | Interventional | 2020-02-24 | Completed | ||
| Comparative Use of Tranexamic Acid Intravenous and Topical Application in the Treatment of Intertrochanteric Fractures With Proximate Femoral Nail[NCT04696224] | 90 participants (Anticipated) | Interventional | 2020-12-18 | Recruiting | |||
| Efficacy of Tranexamic Acid in Femoral Shaft Fractures Osteosynthesis; A Double Blind Randomized Controlled Trial[NCT04803591] | Phase 4 | 0 participants (Actual) | Interventional | 2021-08-01 | Withdrawn (stopped due to Not approved by Ethics Commettee) | ||
| Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss, Transfusion Index and Complications After Total Hip Replacement. A Prospective, Randomized, Double Blind Clinical Trial[NCT04187014] | Phase 2 | 90 participants (Actual) | Interventional | 2020-02-06 | Completed | ||
| Extended Postoperative Tranexamic Acid Use in Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial[NCT05099276] | Phase 4 | 46 participants (Actual) | Interventional | 2021-12-07 | Active, not recruiting | ||
| Efficacy of Local Hemostatic Management in Implant Surgery in Anticoagulated Patients on Warfarin: a Randomized Clinical Study[NCT04846114] | 71 participants (Actual) | Interventional | 2016-03-31 | Completed | |||
| Efficacy of Tranexamic Acid (TXA) in Humerus ORIF[NCT05802238] | Phase 2 | 130 participants (Anticipated) | Interventional | 2023-04-12 | Recruiting | ||
| Effects of the Application of a New Pharmacological Protocol for Shoulder Arthroscopy in Beach Chair Position[NCT05397652] | Phase 4 | 104 participants (Actual) | Interventional | 2021-05-24 | Completed | ||
| Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass (the OPTIMAL Study)[NCT03782350] | Phase 4 | 3,079 participants (Actual) | Interventional | 2018-12-26 | Completed | ||
| The Effect of Topical Administration of Tranexamic Acid on Postoperative Bleeding and Seroma Formation in Patients Undergoing Mastectomy: A Prospective Placebo-controlled Double Blinded Randomized Study[NCT02627560] | Phase 4 | 202 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| Randomized Study on the Topical Application of Tranexamic Acid to Wound Bed for Hemostasis in the Setting Granulating Wounds Following Mohs Micrographic Surgery[NCT04541303] | Early Phase 1 | 62 participants (Anticipated) | Interventional | 2020-10-08 | Recruiting | ||
| Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage[NCT05554211] | Phase 2 | 30 participants (Anticipated) | Interventional | 2022-07-12 | Recruiting | ||
| Hemostatic Effects of Ulinastatin and Tranexamic Acid in Cardiac Surgery With Cardiopulmonary Bypass: A Pilot Study[NCT01060189] | 426 participants (Actual) | Interventional | 2008-04-30 | Completed | |||
| TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma[NCT05713630] | Phase 3 | 130 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| Does Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Reduce Blood Loss and Transfusion Requirements? A Double-blinded Randomized Controlled Trial[NCT05024253] | Phase 3 | 48 participants (Anticipated) | Interventional | 2021-08-02 | Recruiting | ||
| Is Serum Gentamicin Concentration Modified With Autologous Cell-saved Blood Transfusion After Total Knee Arthroplasty Using Tranexamic Acid: A Randomized Control Trial[NCT04505748] | 40 participants (Actual) | Interventional | 2020-01-01 | Completed | |||
| Comparison of Topical Tranexamic Acid and Floseal® on Blood Loss After Total Knee Arthroplasty in Patients With a Thromboembolic Risk[NCT02865174] | Phase 4 | 90 participants (Anticipated) | Interventional | 2016-09-30 | Not yet recruiting | ||
| Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction[NCT03413891] | Phase 4 | 222 participants (Actual) | Interventional | 2018-02-07 | Terminated (stopped due to Advice from DSMB) | ||
| Comparison Between the Effect of Topical Tranexamic Acid Versus Hydrogen Peroxide on Perioperative Blood Loss in Elective Spine Surgeries[NCT05152186] | Phase 3 | 120 participants (Actual) | Interventional | 2021-06-01 | Active, not recruiting | ||
| Topical Tranexamic Acid (TXA) in Hip Fractures, A Double-Blind, Randomized Controlled Trial[NCT02993341] | Phase 3 | 65 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery Based on Rotational Thromboelastometry (ROTEM®).[NCT03897621] | 50 participants (Actual) | Interventional | 2019-05-20 | Completed | |||
| The Impact of Pre-emptive Large Doses of Methylprednisolone Combined With Gabapentin on Pain Treatment and Convalescence After Total Knee Arthroplasty in Elderly: A Double-blind Randomized Study[NCT04653415] | Phase 4 | 160 participants (Actual) | Interventional | 2019-06-01 | Completed | ||
| The Effects of the Timing of Tranexamic Acid Administration on Blood Loss in Hip Fractures.[NCT04488367] | Early Phase 1 | 120 participants (Anticipated) | Interventional | 2020-07-06 | Recruiting | ||
| Comparative Study of the Efficiency of Oral Tranexamic Tcid vs. Oral Tminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement. A Prospective, Randomized, Double Blinded Controlled Clinical Trial.[NCT03365999] | Phase 2 | 92 participants (Actual) | Interventional | 2017-10-15 | Completed | ||
| Effect of no Drainage Tube on Blood Loss and Recovery After High Tibial Osteotomy[NCT03954860] | 80 participants (Actual) | Interventional | 2018-08-01 | Completed | |||
| Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies: a Randomised Controlled Clinical Trial.[NCT04785651] | 84 participants (Anticipated) | Interventional | 2021-02-22 | Recruiting | |||
| Efficacy of Tranexamic Acid in Reducing Requirement of Blood Transfusion in Lower Limb Trauma Surgery: A Prospective Randomized Controlled Study[NCT04986813] | Phase 4 | 100 participants (Actual) | Interventional | 2017-04-01 | Completed | ||
| Study of the Noninferiority of an Oral vs Intravenous Administration of Tranexamic Acid in Total Hip Arthroplasty[NCT04691362] | Phase 4 | 230 participants (Actual) | Interventional | 2021-01-01 | Completed | ||
| The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery[NCT04951128] | Phase 4 | 50 participants (Anticipated) | Interventional | 2021-08-01 | Not yet recruiting | ||
| Intravenous Administration of Tranexamic Acid Significantly Improved Clarity of Visual Field in Arthroscopic Shoulder Surgery. A Prospective, Double-blind and Randomized Controlled Trial[NCT04025736] | 72 participants (Actual) | Interventional | 2017-06-07 | Completed | |||
| Local Injection of Tranexamic Acid May Reduce Bleeding, Injection Pain, and Other Post-op Complications During Mohs Micrographic Surgery[NCT04630886] | Early Phase 1 | 200 participants (Anticipated) | Interventional | 2021-06-16 | Enrolling by invitation | ||
| Topical Application Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery[NCT05708690] | Phase 4 | 132 participants (Actual) | Interventional | 2022-10-01 | Completed | ||
| Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) Study[NCT03954314] | Phase 3 | 3,242 participants (Actual) | Interventional | 2019-09-17 | Terminated (stopped due to Upon the Data Safety Monitoring Board review of the interim analysis (75% of participants have finished their follow-up) on November 17, 2023, they made a recommendation to stop recruitment into the trial.) | ||
| Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis[NCT05774717] | Phase 1 | 60 participants (Anticipated) | Interventional | 2023-04-01 | Recruiting | ||
| Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial[NCT05325671] | 120 participants (Anticipated) | Interventional | 2022-04-05 | Not yet recruiting | |||
| Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid: a Clinical Trial[NCT03915756] | 42 participants (Anticipated) | Interventional | 2019-08-22 | Recruiting | |||
| The Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin / Hematocrit in Isolated Operative Posterior Wall Acetabular Fractures: a Prospective, Randomized, Double-blinded, Multicenter Study[NCT05357079] | Early Phase 1 | 98 participants (Anticipated) | Interventional | 2017-08-25 | Recruiting | ||
| KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)[NCT05223777] | 50 participants (Anticipated) | Interventional | 2021-09-09 | Recruiting | |||
| Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty[NCT03825939] | Phase 4 | 52 participants (Actual) | Interventional | 2015-04-21 | Terminated (stopped due to Lack of patient enrollment due to only one surgeon that was enrolling.) | ||
| Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): A Randomized, Placebo-controlled Double Blind Trial[NCT02806024] | Phase 4 | 14 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage[NCT04431999] | Phase 3 | 200 participants (Anticipated) | Interventional | 2021-12-04 | Recruiting | ||
| Comparison of the Effect of Two Common Regimens of Administration of Tranexamic Acid on Hemostasis and Clinical Outcome of Patients Undergoing Total Knee Arthroplasty[NCT04443920] | Phase 4 | 86 participants (Actual) | Interventional | 2019-10-29 | Completed | ||
| Range of Motion and Function Following Primary Repair of Traumatic Zone 1 or Zone 2 Digit Flexor Tendon Injuries - Impact of Tranexamic Acid Use - A Prospective Study[NCT04178655] | Early Phase 1 | 48 participants (Anticipated) | Interventional | 2019-11-30 | Not yet recruiting | ||
| Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial[NCT03364491] | Phase 3 | 11,000 participants (Actual) | Interventional | 2018-03-15 | Completed | ||
| Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and[NCT03690037] | Phase 4 | 1,089 participants (Actual) | Interventional | 2016-07-07 | Completed | ||
| The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty[NCT03795649] | 80 participants (Anticipated) | Interventional | 2018-12-18 | Recruiting | |||
| Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.[NCT02579941] | 40 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| Prophylactic Use of Topical Tranexamic Acid to Aid Surgical Haemostasis During Caesarean Sections in Parturients With Moderate to High Risk of Bleeding[NCT02492087] | Phase 3 | 84 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | ||
| Tranexamic Acid in Knee Joint Surgery - a Randomised Controlled Trial[NCT02278263] | Phase 4 | 150 participants (Actual) | Interventional | 2014-12-31 | Completed | ||
| The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty: A Prospective, Double-Blind Randomized, Controlled Trial[NCT03074994] | Phase 2 | 108 participants (Anticipated) | Interventional | 2016-10-31 | Recruiting | ||
| Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial[NCT02739815] | Phase 4 | 200 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
| Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section[NCT02780245] | Phase 4 | 100 participants (Actual) | Interventional | 2016-06-30 | Completed | ||
| Comparison of Combined Topical Tranexamic Acid With Floseal® With Intravenous Tranexamic Acid on Blood Loss in Total Knee Arthroplasty[NCT03328832] | Phase 4 | 70 participants (Actual) | Interventional | 2017-09-12 | Completed | ||
| Tranexamic Acid Comparison in Hip Replacement (TeACH-R) Trial: Comparative Efficacy of Intravenous Versus Topical Tranexamic Acid for Reducing Blood Loss in Elective Primary Total Hip Arthroplasty.[NCT02056444] | 149 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| Blood-saving Effect of Kaolin-based Hemostatic Gauze Combined With Intravenous Tranexamic Acid in Total Knee Arthroplasty[NCT05504577] | Phase 4 | 120 participants (Anticipated) | Interventional | 2022-03-16 | Recruiting | ||
| A Prospective, Randomized, Single-blinded, Non-inferiority Study to Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer Compared to the Unipolar Electrocautery in Primary Unilateral Total Knee Arthroplasty[NCT03952546] | 211 participants (Actual) | Interventional | 2019-05-07 | Completed | |||
| Comparison of Topical and Infusion Tranexamic Acid on Blood Loss and Risk of Deep Vein Thrombosis After Total Knee Arthroplasty[NCT02453802] | Phase 4 | 90 participants (Anticipated) | Interventional | 2015-06-30 | Not yet recruiting | ||
| Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement; A Prospective Triple-blinded Randomized Controlled Trial.[NCT01850394] | 152 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| Blood Loss Reduction After Total Knee Arthroplasty. A Comparison Between Topical Tranexamic Acid and Platelet Rich Plasma: Controlled Clinical Trial[NCT02650856] | Phase 3 | 40 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application, a Comparison With Intravenous Tranexamic Acid Only in Total Hip Arthroplasty[NCT03623789] | Phase 4 | 90 participants (Anticipated) | Interventional | 2018-08-15 | Recruiting | ||
| [NCT02644473] | Phase 4 | 0 participants (Actual) | Interventional | 2016-02-29 | Withdrawn (stopped due to Study did not receive IRB approval, so did not start) | ||
| Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial[NCT02615366] | Phase 4 | 800 participants (Anticipated) | Interventional | 2016-02-29 | Not yet recruiting | ||
| Serial Use of Intravenous and Oral Tranexamic Acid in Primary Total Knee Arthroplasty Patients: A Randomized Controlled Study[NCT03109652] | Phase 4 | 144 participants (Anticipated) | Interventional | 2017-07-10 | Recruiting | ||
| Topical Application of Tranexamic Acid to Reduce Postoperative Blood Loss in Posterior Approach Spinal Surgery[NCT02063035] | Phase 4 | 29 participants (Actual) | Interventional | 2012-08-31 | Completed | ||
| Evaluation of Efficacy and Safety of Perioperative Tranexamic Acid During Primary Total Knee Arthroplasty: A Randomized, Clinical Trial[NCT05919615] | 100 participants (Actual) | Interventional | 2021-07-15 | Completed | |||
| A Randomized Control Trial Evaluating the Use of Topical Tranexamic Acid in Bilateral Breast Reduction Surgery to Prevent Bleeding Complications[NCT04918576] | Phase 3 | 106 participants (Anticipated) | Interventional | 2022-08-31 | Not yet recruiting | ||
| Effects of Tranexamic Acid for Alloplastic Breast Reconstruction: A Randomized Control Trial[NCT04918589] | Phase 3 | 106 participants (Anticipated) | Interventional | 2022-08-31 | Not yet recruiting | ||
| Prospective Randomized Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty[NCT03359525] | Phase 4 | 114 participants (Anticipated) | Interventional | 2017-07-01 | Recruiting | ||
| Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department[NCT02930941] | Phase 4 | 35 participants (Actual) | Interventional | 2016-02-29 | Terminated (stopped due to Terminate due to slow enrollment rate.) | ||
| The Effectiveness Of Intravenous Tranexamic Acid (TXA) on Reducing Perioperative Blood Loss For Patients Undergoing Periacetabular Osteotomy (PAO): A Randomized Double Blind Placebo Controlled Trial[NCT03823417] | Phase 4 | 0 participants (Actual) | Interventional | 2019-07-31 | Withdrawn (stopped due to Investigators decided not to begin the study.) | ||
| The Effect of Topical Administration of Tranexamic Acid, Adrenaline and Bupivacain on Postoperative Bleeding and Pain in Patients Undergoing Breast Surgery. A Four-armed Placebo-controlled Double Blinded Randomized Study[NCT01964781] | Phase 4 | 30 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| Use of TRanEXamic Acid in Reduction Mammoplasty (TREX-ARM): a Double-blinded Randomized Controlled Trial[NCT04947514] | Phase 4 | 98 participants (Actual) | Interventional | 2021-10-29 | Completed | ||
| Role of Tranexamic Acid (TXA) in the Reduction of Post-operative Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty, a Pilot Study.[NCT04902950] | Phase 4 | 9 participants (Actual) | Interventional | 2020-08-17 | Terminated (stopped due to Logistics) | ||
| Pilot RCT: Use of Tranexamic Acid (TXA) in Post Mastectomy Patients for Seroma and Hematoma Prevention[NCT03738527] | Phase 4 | 100 participants (Anticipated) | Interventional | 2019-10-07 | Recruiting | ||
| Analgesic Efficacy of Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA): A Prospective Randomized Trial to Compare Postoperative Clinical Outcomes[NCT02908711] | Phase 4 | 50 participants (Actual) | Interventional | 2016-10-31 | Completed | ||
| Analgesic Efficacy of Quadaratus Lumborum Block (QLB) for Laparoscopic Colectomy Surgery: A Prospective Observational Case Control Trial to Evaluate Clinical Outcomes[NCT03017638] | 14 participants (Actual) | Observational | 2017-02-27 | Completed | |||
| An Ideal End-tidal Carbon Dioxide Level to Control Intraoperative Bleeding and Improve the Quality of Surgical Field Vision in Septorhinoplasty Operations Under General Anesthesia: a Prospective Clinical Study[NCT05497375] | 70 participants (Actual) | Interventional | 2022-08-20 | Completed | |||
| Prophylactic Use of Tranexamic Acid for Preventing Postpartum Hemorrhage: A Randomized, Double-blinded, Placebo-controlled Pilot Trial[NCT03069859] | Phase 2 | 31 participants (Actual) | Interventional | 2018-03-06 | Active, not recruiting | ||
| Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)[NCT03326596] | Phase 4 | 1,000 participants (Anticipated) | Interventional | 2018-04-20 | Recruiting | ||
| Evaluation of Tranexamic Acid Prior to Surgery in the Geriatric Hip Fracture Population for the Reduction of Post-Operative Blood Transfusion[NCT03923959] | Phase 3 | 400 participants (Anticipated) | Interventional | 2020-02-01 | Active, not recruiting | ||
| Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty: A Randomized Controlled Trial[NCT02829346] | Phase 2 | 60 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| The Use of Tranexamic Acid in Chinese Elderly Patients Undergoing Femoral Nailing for Intertrochanteric Fracture: A Randomized Controlled Trial[NCT04290884] | Phase 4 | 120 participants (Anticipated) | Interventional | 2018-05-23 | Active, not recruiting | ||
| Does Tranexamic Acid Significantly Reduce Total Blood Loss During Proximal Femoral Nailing for the Intertrochanteric Femoral Fracture in the Elderly?[NCT05359172] | 100 participants (Actual) | Observational | 2021-04-01 | Completed | |||
| Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid in Patients at High Risk for Blood Transfusion After Spine Surgery[NCT03849443] | Early Phase 1 | 604 participants (Anticipated) | Interventional | 2019-08-26 | Recruiting | ||
| The Effect of Using Tranexamic Acid Soaked Absorbable Gelatin Sponge in Reducing Rectus Sheath Hematoma Formation After Cesarean Section in Patients Using Warfarin Compounds[NCT05439694] | Phase 4 | 63 participants (Actual) | Interventional | 2022-07-03 | Completed | ||
| A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.[NCT03458468] | 100 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| Low Versus High Dose Tranexamic Acid in Adult Spinal Deformity Surgery: A Randomized, Blinded, Controlled Trial[NCT02053363] | Phase 2/Phase 3 | 64 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| Role of Topical Tranexamic Acid in Total Hip Arthroplasty[NCT01866943] | Phase 2 | 41 participants (Actual) | Interventional | 2011-11-30 | Terminated | ||
| The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery[NCT01728636] | Phase 2 | 61 participants (Actual) | Interventional | 2013-01-15 | Completed | ||
| Role of Tranexamic Acid for Reducing Blood Loss in Patients Undergoing Major Gastro-intestinal Surgery[NCT01655641] | Phase 2/Phase 3 | 118 participants (Anticipated) | Interventional | 2012-07-31 | Active, not recruiting | ||
| Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery[NCT01519245] | Phase 3 | 44 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis Using an in Vitro Experimental Model of Fibrinolysis.[NCT02352675] | 40 participants (Actual) | Observational | 2015-04-30 | Completed | |||
| Intravenous Tranexamic Acid to Reduce Blood Loss in Reverse Total Shoulder Arthroplasty[NCT02043132] | Phase 2/Phase 3 | 116 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| The Effect of Intravenous E-Aminocaproic Acid (EACA) on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy (VRO)[NCT02257580] | Phase 4 | 28 participants (Actual) | Interventional | 2015-04-01 | Completed | ||
| A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss[NCT03793153] | 99 participants (Actual) | Interventional | 2018-12-19 | Completed | |||
| Peroperative Tranexamic Acid as Prophylaxis of Haemorrhage in Benign Hysterectomy - a Randomized, Placebo-controlled Trial[NCT01940419] | Phase 4 | 332 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| The Use of Tranexamic Acid in Irrigation Fluid to Improve Arthroscopic Visualization in Shoulder Surgery: A Randomized Controlled Trial[NCT04594408] | Phase 4 | 128 participants (Actual) | Interventional | 2020-09-01 | Active, not recruiting | ||
| The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery[NCT02684851] | Phase 3 | 87 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Benefits on Post-operative Pain of Intravenous, Intraoperative, Tranexamic Acid Injection During Arthroscopic Shoulder Surgery.[NCT05302986] | Phase 3 | 220 participants (Anticipated) | Interventional | 2023-02-24 | Recruiting | ||
| Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.[NCT02319915] | Early Phase 1 | 14 participants (Actual) | Interventional | 2015-02-18 | Completed | ||
| The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients: a Randomized Placebo-controlled Trial[NCT01895101] | Phase 4 | 750 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery a[NCT00888940] | Phase 2 | 243 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Tranexamic Acid Reduces Blood Loss After Off-pump Coronary Artery Bypass Grafting[NCT01064167] | 231 participants (Actual) | Interventional | 2009-02-28 | Completed | |||
| Phase 4 Study of Tranexamic Acid for Elderly Patients Undergoing Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.[NCT00375466] | 63 participants (Actual) | Interventional | 2006-09-30 | Completed | |||
| Tranexamic Acid Reduces Blood Loss in Pediatric Cardiac Surgery[NCT00994994] | 160 participants (Actual) | Interventional | 2006-01-31 | Completed | |||
| The Blood Saving Effect and Wound-related Complications of Tranexamic Acid in Mininally Invasive Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis[NCT02458729] | Phase 4 | 294 participants (Actual) | Interventional | 2012-08-31 | Completed | ||
| Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk[NCT02797119] | Phase 4 | 225 participants (Actual) | Interventional | 2016-03-15 | Terminated (stopped due to Study will be stopped due to the impossibility of reaching the objective of inclusions within a reasonable time frame and taking into account the recommendations of the international WOMAN study) | ||
| The Efficacy of Intravenous Tranexamic Acid in Decreasing Blood Loss in Pediatric Idiopathic Scoliosis Surgery?[NCT01813058] | Phase 1/Phase 2 | 120 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| DEPOSITION: Pilot Study Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery[NCT03376061] | Phase 4 | 97 participants (Actual) | Interventional | 2017-12-21 | Completed | ||
| Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty[NCT01370460] | Phase 2 | 101 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery[NCT03037515] | Phase 4 | 120 participants (Anticipated) | Interventional | 2017-02-15 | Not yet recruiting | ||
| Tranexamic Acid in Surgery of Advanced Ovarian Cancer - a Prospective Randomized Double Blind Placebo Controlled Study[NCT00740116] | Phase 4 | 100 participants (Actual) | Interventional | 2008-03-31 | Completed | ||
| The Effect of Tranexamic Acid (TXA) on Blood Loss and Transfusion Rates in Burn Wound Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT02753816] | 25 participants (Actual) | Interventional | 2016-04-30 | Terminated (stopped due to Study enrollment and goals unable to be reached.) | |||
| Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery - The InCreAS Trial[NCT02598271] | 200 participants (Actual) | Observational | 2016-10-31 | Completed | |||
| Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599] | 40 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT03113253] | Phase 4 | 121 participants (Actual) | Interventional | 2016-09-22 | Active, not recruiting | ||
| Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis[NCT04855110] | 114 participants (Anticipated) | Interventional | 2021-04-19 | Recruiting | |||
| PHASE IV Study of Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After Percutaneous Aortic Valve Implantation. Multicenter Randomized Clinical Trial[NCT01642134] | Phase 4 | 124 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement[NCT01293188] | 434 participants (Actual) | Observational | 2011-01-31 | Completed | |||
| Perioperative Interventions to Optimize Cerebral Oxygen Saturation (rSO2) in High-risk Patients Undergoing Cardiac Surgery Should Have a Beneficial Systemic Effect for Enhancing Global Tissue Perfusion and Improve Outcomes.[NCT01432184] | 200 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
| Prospective Randomised Trial Comparing Intraoperative Topical Quixil and Intravenous Tranexamic Acid, in Reduction of Blood Loss Following Primary Hip & Knee Joint Replacement Surgery.[NCT00378872] | 132 participants (Actual) | Interventional | 2006-06-30 | Completed | |||
| The Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty[NCT01815918] | Phase 4 | 60 participants (Actual) | Interventional | 2011-02-28 | Completed | ||
| Randomized Placebo Controlled Study Using Tranexamic Acid in Revision Total Hip Arthroplasty[NCT00375440] | 0 participants (Actual) | Interventional | 2005-02-28 | Withdrawn (stopped due to Study halted prematurely as investigator left the institution.) | |||
| The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery[NCT01980355] | 76 participants (Actual) | Interventional | 2012-06-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Measured in Days (NCT03825939)
Timeframe: At Hospital Discharge
| Intervention | Days (Mean) |
|---|---|
| Intravenous Tranexamic Acid | 3 |
| Intravenous Placebo | 3 |
| Intravenous Tranexamic Acid Followed by Intravenous Placebo | 3 |
Total number of units of blood transfused (whole blood, platelets, cryoprecipitate, and fresh frozen plasma) intra-operatively is a secondary outcome. (NCT02806024)
Timeframe: Pulled from operative note, completed by the time of discharge.
| Intervention | units (Mean) |
|---|---|
| Treatment Arm (Tranexamic Acid, or TXA) | 5.2 |
| Placebo Arm | 17.6 |
EBL is estimated by the surgeon and anesthesia team at the completion of the surgery (cesarean delivery &/or cesarean hysterectomy). (NCT02806024)
Timeframe: 1-3 hours (will be determined at the completion of the surgery).
| Intervention | cc (Mean) |
|---|---|
| Treatment Arm (Tranexamic Acid, or TXA) | 3116 |
| Placebo Arm | 9420 |
[Key secondary outcome] Change in hemoglobin from the most recent measured before delivery to lowest measured in the 48 hours after delivery (NCT03364491)
Timeframe: from 4 weeks before delivery to 48 hours postpartum
| Intervention | grams per deciliter (Mean) |
|---|---|
| Tranexamic Acid | -1.8 |
| Placebo | -1.9 |
Mother's length of stay from delivery to discharge (NCT03364491)
Timeframe: Until hospital discharge, an average of 3 days
| Intervention | days (Median) |
|---|---|
| Tranexamic Acid | 3 |
| Placebo | 3 |
(NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 35 |
| Placebo | 32 |
This is the number of mothers who were treated with any amount of open-label TXA (not blinded study drug) or another antifibrinolytic (eg., Amicar) (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 108 |
| Placebo | 109 |
This is the number of mothers who required any of the following types of surgical procedures to control bleeding: laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 233 |
| Placebo | 231 |
[Key secondary outcome] This is the number of mothers who received treatments and interventions to control bleeding such as: uterotonics such as prostaglandins or methergine, but excluding oxytocin; open label TXA or other antifibrinolytics; transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets or administration of any factor concentrates; laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 892 |
| Placebo | 986 |
Participants were categorized according to the amount of packed red blood cells or whole blood transfused, either as 0 to 3 units, or 4 or more units (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 20 |
| Placebo | 19 |
This is the number of mothers who received during the first 7 days after delivery a transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets, or received any factor concentrates (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 29 |
| Placebo | 31 |
This is the number of mothers who were treated with uterotonics such as prostaglandins or methergine, but excluding oxytocin, from delivery through 48 hours after delivery. (NCT03364491)
Timeframe: within 48 hours postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 649 |
| Placebo | 732 |
[Key secondary outcome] This is the number of mothers who experienced a thromboembolic event, ischemic stroke, or myocardial infarction during the 6 weeks after delivery. (NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 12 |
| Placebo | 13 |
[Major secondary outcome] The surgeon or anesthesiologist estimated the blood loss during the delivery in milliliters, which was recorded in the anesthesia record and/or operative report (NCT03364491)
Timeframe: From skin incision to transfer from operating room, average of 1 hour
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 339 |
| Placebo | 368 |
Participants were monitored from delivery until hospital discharge or 7 days after delivery (postpartum), whichever is sooner. This is the number of mothers who died for any reason, or had a blood transfusion of 1 or more units (of packed red blood cells, including whole blood or cell saver). (NCT03364491)
Timeframe: by hospital discharge or by 7 days postpartum, whichever is sooner
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 201 |
| Placebo | 233 |
[Key Secondary Outcome] This is the number of mothers who experienced any of the following infectious complications in the 6 weeks after delivery: endometritis, surgical site infection, pelvic abscess (NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 162 |
| Placebo | 125 |
This is the number of mothers who experienced seizure activity, confirmed by central review, whose onset is after enrollment (NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 2 |
| Placebo | 0 |
"The loss of haemoglobin (Hb) was then estimated according to the formula:~Hb(loss) = Blood volume (BV) x (Hbi-Hbe) x 0.001+Hbt~where Hb (loss) (g) is the amount of Hb lost, Hbi (g/L) the Hb concentration before surgery, Hbe (g/L) is the Hbe concentration on the third day after surgery, and Hbt (g) is the total amount of allogeneic Hb transfused. A unit of banked blood is considered to contain a minimum of 40g Hb (Blood component data sheet, New Zealand Blood Services [NZBS]). All units of blood are processed and stored in a nationally standardised manner. The blood loss (ml) was related to the patient's preoperative Hb value (g/L):~Blood loss =1000 x Hb(loss) /Hbi" (NCT02278263)
Timeframe: Post operative day 3
| Intervention | mls (Mean) |
|---|---|
| Control | 1090 |
| Intraarticular | 716 |
| Systemic | 746 |
Day of surgery is counted as Day 0. (NCT02278263)
Timeframe: Average length of stay is expected to be 3 to 5 days
| Intervention | days (Median) |
|---|---|
| Control | 4 |
| Topical | 4 |
| Systemic | 4 |
"Those patients receiving blood products. Standardised protocol is as follows:~The criterion for transfusion of blood products will be a haemoglobin < 80g/L or a haemoglobin <100g/L in a patient with ischaemic heart disease or with significant symptomatology" (NCT02278263)
Timeframe: Participants will be followed for the duration of their hospital stay expected to be an average of 3-5 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 2 |
| Topical | 1 |
| Systemic | 0 |
Intravenous fluid (excluding blood transfusion) given during and first 24 hours after surgery (NCT02278263)
Timeframe: Day 1
| Intervention | mls (Mean) |
|---|---|
| Control | 1765 |
| Topical | 1613 |
| Systemic | 1807 |
Rates of deep vein thrombosis (DVT) and pulmonary embolus (PE) in each group recorded as a percentage (NCT02278263)
Timeframe: Postoperatively within 30 days after surgery
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| DVT | PE | |
| Control | 0 | 0 |
| Systemic | 0 | 1 |
| Topical | 0 | 2 |
Range of motion measured in degrees on postoperative days 1-3 (NCT02278263)
Timeframe: Days 1-3
| Intervention | degrees (Mean) | ||
|---|---|---|---|
| Day 1 | Day 2 | Day 3 | |
| Control | 57 | 71 | 75 |
| Systemic | 58 | 72 | 78 |
| Topical | 65 | 75 | 82 |
Range of motion measured in degrees for postoperative days 1 to 3 (NCT02278263)
Timeframe: Days 1-3
| Intervention | degrees (Mean) | ||
|---|---|---|---|
| Day 1 | Day 2 | Day 3 | |
| Control | 65 | 76 | 82 |
| Systemic | 68 | 80 | 87 |
| Topical | 74 | 81 | 87 |
We will record the event of blood transfusion, and calculate the incidence of transfusion (NCT03328832)
Timeframe: From the operation to the postoperative day 3 or 4
| Intervention | Participants (Count of Participants) |
|---|---|
| Combined Topical TXA and Floseal | 1 |
| Topical TXA Alone | 0 |
The composite of any venous thromoembolism events, ischemic heart attacks, cerebrovascular accidents (NCT03328832)
Timeframe: within 30 days of the operation
| Intervention | Participants (Count of Participants) |
|---|---|
| Combined Topical TXA and Floseal | 0 |
| Topical TXA Alone | 0 |
Total blood loss was calculated according to Nadler et al., which used maximum postoperative reduction of the Hb level adjust for weight and height of the patient. The formula is as follows, Total blood loss = (Total blood volume x [change in Hb level / preoperative Hb level])x1000+volume transfused (NCT03328832)
Timeframe: From the operation to the postoperative day 3 or 4
| Intervention | ml (Mean) |
|---|---|
| Combined Topical TXA and Floseal | 678 |
| Topical TXA Alone | 733 |
"Functional outcomes measured by the 2011 Knee Society Score. The Functional Activities section consists of 4 sub-sections with a total score ranging from 0-100 points. The higher the numerical value the better the outcome. The sub-sections consist of: (1)Walking and Standing 0-30 points (2)Standard Activities 0-30 points (3)Advanced Activities 0-25 points (4)Discretionary Knee Activities 0-15 points." (NCT03952546)
Timeframe: 8 weeks
| Intervention | score on a scale (Mean) |
|---|---|
| Treatment Arm | 56.45 |
| Control Arm | 61.79 |
Postoperative day 1 estimated blood loss as calculated by the Gross' Formula (NCT03952546)
Timeframe: Postoperative day 1
| Intervention | milliliters (Mean) |
|---|---|
| Treatment Arm | 924 |
| Control Arm | 1062 |
Participants were assessed for any wound infection within 90 days of surgery. (NCT03952546)
Timeframe: 90 days postoperatively
| Intervention | Number of events (Number) |
|---|---|
| Saline-Coupled Bipolar Sealer | 1 |
| Unipolar Electrocautery | 3 |
(NCT01850394)
Timeframe: postoperative period (5 days after surgery)
| Intervention | participants (Number) |
|---|---|
| Control Group | 10 |
| TXA-250 Group | 6 |
| TXA-500 Group | 0 |
Total hemoglobin loos measured by difference between hemoglobin preoperatively and the fourth postoperative day (NCT01850394)
Timeframe: 5 days after surgery
| Intervention | g/dL (Mean) |
|---|---|
| Control Group | 2.9 |
| TXA-250 Group | 2.2 |
| TXA-500 Group | 2.2 |
"Knee function score was measured with 2 methods, and were evaluated preoperatively and then postoperatively at 3-month, 6-month, and 1-year period.~Knee Society Knee Score using for rating knee function measurement and subdivided into two parts; knee score and function score 1.1. Knee score : calculated from pain, presence of deformity, total range of flexion, alignment, and stability. Total score is 100 (0-100), more score means better.~1.2. Function score : calculated from patient's ability to walk and climb stairs. The score ranges from 0-100, more score means better.~Western Ontario and McMaster Universities Arthritis Index or WOMAC score : a widely used, standardized questionnaires for evaluating the condition of patients with knee osteoarthritis, including pain (score = 0-20), stiffness (0-8), and functional limitation (0-68). Total score ranges from 0-68, lower score means better." (NCT01850394)
Timeframe: 1 year after surgery
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Knee Society Knee score at 1 year | WOMAC score at 1 year | |
| Control Group | 148.9 | 15.5 |
| TXA-250 Group | 151.2 | 15.1 |
| TXA-500 Group | 150.9 | 14.5 |
"Postoperative complications were measured as an incidence of the following complications;~wound hematoma~surgical site infection~systemic infection~deep vein thrombosis~pulmonary embolism~knee stiffness requiring manipulation~medical complication such as myocardial infarction, congestive hear failure" (NCT01850394)
Timeframe: postoperative 1-year period
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Re-clamp incidence | Re-dressing incidence | Venous thromboembolic complication | Congestive heart failure | |
| Control Group | 6 | 3 | 4 | 0 |
| TXA-250 Group | 1 | 0 | 1 | 1 |
| TXA-500 Group | 0 | 0 | 2 | 0 |
"Drainage blood loss measured by accumulating total drainage volume postoperatively~Calculated total blood loss measured by using specific formula and difference between hematocrit preoperatively and the fourth postoperative day" (NCT01850394)
Timeframe: 5 days after surgery
| Intervention | ml (Median) | |
|---|---|---|
| Drainage blood loss | Calculated total blood loss | |
| Control Group | 546.9 | 329.2 |
| TXA-250 Group | 475.0 | 239.7 |
| TXA-500 Group | 430.2 | 217.2 |
The blood quantification will be taken at 6am every day. (NCT02650856)
Timeframe: up to 2nd day post operative (24 and 48 hrs)
| Intervention | mL (Mean) | |
|---|---|---|
| 24 hours | 48 hours | |
| Group 1 Tranexamic Acid | 246.4 | 120.8 |
| Group 2 Platelet Rich Plasma | 263.2 | 140.2 |
The blood test will be taken at 6am every day. Using the same laboratory parameters. (NCT02650856)
Timeframe: up to 3rd day post operative (Baseline, 24, 48 and 72hrs)
| Intervention | percentage of Hematocrite (Mean) | |||
|---|---|---|---|---|
| Baseline | 24 hours | 48 hours | 72 hours | |
| Group 1 Tranexamic Acid | 41.7 | 31.6 | 29.1 | 28.6 |
| Group 2 Platelet Rich Plasma | 41.5 | 29.8 | 27.7 | 27.3 |
The blood test will be taken at 6am every day. Using the same laboratory parameters. (NCT02650856)
Timeframe: up to 3rd day post operative (Baseline, 24, 48 and 72hrs)
| Intervention | g/dL (Mean) | |||
|---|---|---|---|---|
| Baseline | 24 hours | 48 hours | 72 hours | |
| Group 1 Tranexamic Acid | 13.6 | 10.3 | 9.5 | 9.3 |
| Group 2 Platelet Rich Plasma | 13.6 | 9.9 | 9.2 | 9.1 |
Blood loss following surgery was defined as the total amount of fluid collected from the drain in the wound site during the hospital stay. (NCT02063035)
Timeframe: From end of surgery on Day 1 to end of hospital stay up to approximately 5 days
| Intervention | mL (Median) |
|---|---|
| Tranexamic Acid | 534 |
| Placebo | 530 |
Blood loss was calculated from the difference between the level of hemoglobin at the preoperative appointment and the lowest level during the postoperative hospitalization period. Reported here is the change in hemoglobin level after surgery. A negative number indicates a reduction in hemoglobin level. (NCT02063035)
Timeframe: From preoperative appointment approximately one week before surgery to end of hospital stay up to approximately 5 days after surgery
| Intervention | grams per deciliter (g/dL) (Median) |
|---|---|
| Tranexamic Acid | -3.2 |
| Placebo | -4.6 |
The number of days the participants stayed in the hospital after surgery was recorded. (NCT02063035)
Timeframe: From end of surgery on Day 1 to end of hospital stay up to approximately 2 weeks
| Intervention | days (Median) |
|---|---|
| Tranexamic Acid | 5 |
| Placebo | 6 |
All units of blood transfused during the hospital stay after surgery were recorded. One red blood cell unit contains 300 to 360 mL of whole blood. (NCT02063035)
Timeframe: From end of surgery on Day 1 to end of hospital stay up to approximately 5 days
| Intervention | units of blood (Median) |
|---|---|
| Tranexamic Acid | 0 |
| Placebo | 0 |
Length of stay was defined as time from enrollment in study to discharge from the emergency department (NCT02930941)
Timeframe: During emergency department (ED) visit
| Intervention | minutes (Median) |
|---|---|
| TXA Group | 268 |
| NS Group | 346 |
The number of participants with re-bleeding at 24 Hours was evaluated during follow up phone call (NCT02930941)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| TXA Group | 3 |
| NS Group | 9 |
The number of participants with re-bleeding at one week was evaluated during the follow-up phone call (NCT02930941)
Timeframe: 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| TXA Group | 2 |
| NS Group | 6 |
Patient reported thromboembolic events during follow-up phone calls at 24 hours and at one week (NCT02930941)
Timeframe: 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| TXA Group | 0 |
| NS Group | 0 |
Time to control of bleeding was defined as the time from the start of enrollment and direct pressure and administration of study drug to the resolution of bleeding (NCT02930941)
Timeframe: During emergency department (ED) visit
| Intervention | minutes (Median) |
|---|---|
| TXA Group | 64 |
| NS Group | 42 |
Patient-reported drug-related adverse events during ED visit (NCT02930941)
Timeframe: during emergency department (ED) visit
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Nasal burning | Nasal irritation | Unpleasant taste | |
| NS Group | 0 | 0 | 0 |
| TXA Group | 2 | 0 | 1 |
The number of breasts with clinically significant hematoma (collection of blood under the skin) requiring either conservative management or operative washout was determined. (NCT04947514)
Timeframe: Up to 30 days
| Intervention | breasts (Number) |
|---|---|
| Treatment Side (Right or Left) | 2 |
| Placebo Side (Right or Left) | 1 |
The number of participants requiring blood transfusion was based on the postoperative decline in hematocrit level (NCT04947514)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Side (Right or Left) | 0 |
| Placebo Side (Right or Left) | 0 |
Incidence of clinically significant deep vein thrombosis or pulmonary embolism detected on imaging (ultrasound or CT scan) (NCT04947514)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Side (Right or Left) | 0 |
| Placebo Side (Right or Left) | 0 |
The number of days that the post surgical drains remain in place after the surgery. When less than 30 cc per drain in a 24-hour period, the participants are to call and schedule drain removal. (NCT04902950)
Timeframe: Up to 56 days post operatively.
| Intervention | Days (Mean) |
|---|---|
| Group 1 | 16 |
| Group 2 | 22 |
Return to the operating room for evacuation post surgical operative hematoma or seroma assessed by clinical evaluation to include palpation for ballotable fluid collection and assessment of skin for a shiny/tight appearance suggestive of an underlying fluid collection. (NCT04902950)
Timeframe: Up to 8 weeks postoperatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Group 1 | 0 |
| Group 2 | 0 |
Patients will be monitored clinically at each post-operative visit for signs of post-operative hematoma or seroma. Each patient will be evaluated one week, three weeks, and eight weeks following their procedure to assess overall wound healing. (NCT04902950)
Timeframe: Up to 8 weeks postoperatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Group 1 | 0 |
| Group 2 | 1 |
"To compare the estimated blood loss in patients undergoing complex, reconstructive, spinal fusion surgeries receiving one of two dosing protocols for the anti-fibrinolytic, TXA.~Estimated blood loss was calculated by suction canister volume minus intraoperative irrigation fluid plus blood content in sponges as estimated by weight for all cases." (NCT02053363)
Timeframe: This outcome is measured during surgery, from exposure to wound closure, approximately 8 hours.
| Intervention | mL (Mean) |
|---|---|
| High Dose/Study Group | 2046 |
| Standard of Care/Control | 1596 |
To compare the rates of intraoperative complications and 90 day complications observed in the two groups. (NCT02053363)
Timeframe: Perioperative complications were defined as complications occurring within 90 days of surgery.
| Intervention | Participants (Count of Participants) |
|---|---|
| High Dose/Study Group | 2 |
| Standard of Care/Control | 3 |
To compare the mean volume (mL) of packed red blood cell (PRBC) transfusions given to the two groups. Volumes of RBC vary from bag to bag and real volumes will be recorded as provided by the blood bank. (NCT02053363)
Timeframe: Participants will be followed for the duration of their hospital stay measured from day of surgery to day of discharge from the hospital, approximately 7 days.
| Intervention | mL (Mean) |
|---|---|
| High Dose/Study Group | 1259 |
| Standard of Care/Control | 935 |
Estimated Blood Loss defined as Pre Op Hgb mins the Post Op Day two Hgb. (NCT01866943)
Timeframe: Pre Op, Post Op Day 2
| Intervention | Hemoglobin (grams/deciliter) (Mean) |
|---|---|
| Baseline Population | 2.93 |
Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 2 week
| Intervention | units on a scale (Mean) |
|---|---|
| All Study Participants | 65.76 |
Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 6 week
| Intervention | units on a scale (Mean) |
|---|---|
| All Study Participants | 81.77 |
Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: Preoperative
| Intervention | units on a scale (Mean) |
|---|---|
| All Study Participants | 58.34 |
Measurement of the thigh at the half way point between the prominence of the greater trochanter and the lateral epicondyle of the femur. No data recorded at 2 weeks or 6 weeks for this study population. (NCT01866943)
Timeframe: Pre Op
| Intervention | centimeters (Mean) |
|---|---|
| Baseline Population | 52.99 |
Total additional blood products (fresh frozen plasma, cryoprecipitate, and platelets) transfused in the perioperative period measured in units. (NCT01728636)
Timeframe: 24 hours after skin incision
| Intervention | Units (Mean) |
|---|---|
| Tranexamic Acid | 1 |
| Placebo | 2 |
Estimated Intraoperative blood loss in milliliters (mLs) (NCT01728636)
Timeframe: Incision to skin closure (approximately 10 hours)
| Intervention | Milliliters (Mean) |
|---|---|
| Tranexamic Acid | 1550 |
| Placebo | 1600 |
Number of participants who experienced arterial or venous thromboembolism, neurologic complications (including stroke, seizure,and delirium), infections, and pulmonary renal or cardiac adverse outcomes (demand ischemia, myocardial infarction or new arrhythmia) before another operative procedure or hospital discharge. (NCT01728636)
Timeframe: Time of surgery to date of discharge from hospital (average 7 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 9 |
| Placebo | 9 |
Total operating room time from incision to closure of incision in minutes. (NCT01728636)
Timeframe: Minutes
| Intervention | Minutes (Median) |
|---|---|
| Tranexamic Acid | 602 |
| Placebo | 576 |
Total red blood cells transfused in the intraoperative period in (mL). Total RBC equal packed red blood cells and cell saver infusion. (NCT01728636)
Timeframe: Intraoperative period (approximately 12 hours)
| Intervention | milliliters (Median) |
|---|---|
| Tranexamic Acid | 1140 |
| Placebo | 1460 |
Total milligrams of intravenous tranexamic acid administered during the surgical procedure. (NCT01728636)
Timeframe: Intraoperative period
| Intervention | milligrams (Median) |
|---|---|
| Tranexamic Acid | 1408 |
| Placebo | 0 |
Research participants were to receive a blood transfusion in the Intensive Care Unit (ICU) post-operatively if hemoglobin reached a nadir of 80g/L, or at the discretion of the intensivist or cardiac surgeon according to patient clinical status. Transfusion was quantified based on the number of units of PRBC received. (1 unit = 1 bag of blood, as prepared by Canadian Blood Services). Clinical status of research participants was followed throughout their duration in the ICU only. Participation in this study ended upon transfer out of the ICU, to the Cardiology Ward. (NCT01519245)
Timeframe: From ICU admission to transfer to the Cardiology Ward (placebo group = 24.4 hours; trial group = 24.7 hours)
| Intervention | Unit(s) of PRBC (Number) |
|---|---|
| Trial Drug | 0 |
| Placebo | 0 |
According to standard practice, research participants were be transferred to the intensive care unit (ICU) for post-operative monitoring. Measurement of chest tube output began immediately on arrival to the ICU. Hourly measurements were recorded. Data collection ended upon chest tube removal, or return to the operating room for exploratory surgery due to massive blood loss. As per ICU protocol, chest tubes were be removed when blood loss was recorded to be less than 200mL after six consecutive hours. (NCT01519245)
Timeframe: From ICU admission post-operatively to mediastinal chest tube removal (placebo group = 20.6 hours; trial group = 19.8 hours)
| Intervention | mL (Mean) |
|---|---|
| Trial Drug | 632 |
| Placebo | 789 |
Volume of chest tube loss at 12 hours (assuming the total volume of loss is blood). (NCT01519245)
Timeframe: 12 hours following admission to the Intensive Care Unit
| Intervention | mL (Mean) |
|---|---|
| Trial Drug | 464 |
| Placebo | 570 |
Volume of chest tube loss at 6 hours (assuming the total volume of loss is blood). (NCT01519245)
Timeframe: 6 hours following admission to the Intensive Care Unit
| Intervention | mL (Mean) |
|---|---|
| Trial Drug | 342 |
| Placebo | 417 |
"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Deep venous thrombosis" (NCT02043132)
Timeframe: up to 6-weeks post-operatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 0 |
| Normal Saline | 0 |
"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Hematoma" (NCT02043132)
Timeframe: up to 6-weeks post-operatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 0 |
| Normal Saline | 0 |
"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Infection" (NCT02043132)
Timeframe: up to 6-weeks post-operatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 0 |
| Normal Saline | 0 |
"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Myocardial infarction" (NCT02043132)
Timeframe: up to 6-weeks post-operatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 0 |
| Normal Saline | 1 |
"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Pulmonary Embolism" (NCT02043132)
Timeframe: up to 6-weeks post-operatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 0 |
| Normal Saline | 0 |
Total Blood Loss as calculated according to method as described by Good et al. Total Blood Loss (mL) = 1000 X Hb(loss)/Hb(initial) (NCT02043132)
Timeframe: Preoperative through Postoperative Days 1 and 2
| Intervention | Total Blood Loss (mL) (Mean) |
|---|---|
| Tranexamic Acid | 1122.4 |
| Normal Saline | 1472 |
Total Drain Output as measured postoperatively 0-48 hours (NCT02043132)
Timeframe: 0-48 hours postoperatively
| Intervention | mL (Mean) |
|---|---|
| Tranexamic Acid | 221 |
| Normal Saline | 372 |
Total hemoglobin loss estimated using the formula for total blood volume described by Nadler et al Hb(loss) = blood volume (L) x [Hb(initial)(g/L) - Hb(final)(g/L)] + Hb(transfused) (NCT02043132)
Timeframe: Preoperative through Postoperative Days 1 and 2
| Intervention | g (Mean) |
|---|---|
| Tranexamic Acid | 154.6 |
| Normal Saline | 200.1 |
Incidence of VTE (symptomatic of DVT or PE), infection (superficial, deep), hematoma, seroma, reoperation, and death, measured in person-years ( x cases per 100,000 person years) (NCT02257580)
Timeframe: an expected average of 1 week (post-surgery), Follow-up at 6 weeks
| Intervention | cases per 100,000 person years (Number) |
|---|---|
| E-Aminocaproic Acid (EACA) | 0 |
| Placebo | 0 |
Determined by estimated blood volume, calculated using difference in preoperative and postoperative hemoglobin and applied to the Nadler equation for estimating blood volume while adjusting for transfused hemoglobin to produce a single metric of calculated intraoperative blood loss. (NCT02257580)
Timeframe: Intraoperative (3-6 hours)
| Intervention | mL (Mean) |
|---|---|
| E-Aminocaproic Acid (EACA) | 535.7 |
| Placebo | 628.0 |
Number of participants requiring 1 unit of intraoperative cell saver transfusion. Patients either received or did not receive intraoperative cell saver transfusion. The maximum number of intraoperative units transfused in this study was 1 unit. The count of participants in the data table refers to the number of patients who received this transfusion. (NCT02257580)
Timeframe: Intraoperative, 1 day
| Intervention | Participants (Count of Participants) |
|---|---|
| E-Aminocaproic Acid (EACA) | 7 |
| Placebo | 7 |
postoperative day of discharge after surgery- day of intake. (NCT02257580)
Timeframe: Post-Surgery, an expected average of 1 week
| Intervention | days (Mean) |
|---|---|
| E-Aminocaproic Acid (EACA) | 5.5 |
| Placebo | 5.1 |
24 hour drain output (mL) (NCT02257580)
Timeframe: Post-Surgery, 24 hours
| Intervention | mL (Mean) |
|---|---|
| E-Aminocaproic Acid (EACA) | 72.5 |
| Placebo | 103.3 |
The number of participants that required 1 unit of blood transfused post-operatively. Patients received blood if necessary post operatively, and the maximum number of units a patient received was 1. The count of participants refers to the number of patients who received this transfusion unit. (NCT02257580)
Timeframe: Post-Surgery, an expected average of 1 week
| Intervention | Participants (Count of Participants) |
|---|---|
| E-Aminocaproic Acid (EACA) | 4 |
| Placebo | 3 |
Number of participant received allogenic blood transfusions. (NCT02684851)
Timeframe: post-operative
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic | 21 |
| Placebo | 13 |
To measure average estimate perioperative blood loss (NCT02684851)
Timeframe: perioperative
| Intervention | mL (Mean) |
|---|---|
| Tranexamic | 727.6 |
| Placebo | 560.1 |
Do patients undergoing acetabular ORIF who receive tranexamic acid have a higher risk for thromboembolic events than patients who receive placebo? (NCT02684851)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic | 1 |
| Placebo | 0 |
Average units packed red blood cells transfused among participants (NCT02684851)
Timeframe: perioperative
| Intervention | Units of packed red blood cells (Mean) |
|---|---|
| Tranexamic | 2.65 |
| Placebo | 2.36 |
the secondary objective of this study is to determine whether pericardial lavage with saline gives an improvement in haemostasis, compared with no pericardial lavage, resulting in a reduction of surgical re-explorations and post-operative 12-hour blood loss. The choice for a surgical re-exploration will be decided according to the ICU protocol. (NCT01895101)
Timeframe: participants will be followed for the duration of ICU stay, an expected average of 2 days
| Intervention | participants (Number) |
|---|---|
| Pericardial Lavage With 200 ml Normothermic Saline Solution | 10 |
| No Pericardial Lavage | 9 |
| 2 gr Tranexamic Acid Diluted in 200 ml Normothermic Saline | 12 |
The primary study parameter is 12 hours postoperative blood loss and is assessed by postoperative chest tube production. Postoperative chest tube production 12 hours after surgical procedure (NCT01895101)
Timeframe: 12 hours postoperative
| Intervention | ml (Median) |
|---|---|
| Pericardial Lavage With 200 ml Normothermic Saline Solution | 290 |
| No Pericardial Lavage | 300 |
| 2 gr Tranexamic Acid Diluted in 200 ml Normothermic Saline | 290 |
The amount of red blood cell transfusions the patient receive pre, peri and postoperatively during their stay in the hospital. (NCT01895101)
Timeframe: participants will be followed for the duration of ICU stay, an expected average of 2 days/ And participants will be followed for the duration of hospital stay, an expected average of 3 weeks
| Intervention | IU (Mean) |
|---|---|
| Pericardial Lavage With 200 ml Normothermic Saline Solution | 0.7 |
| No Pericardial Lavage | 1.1 |
| 2 gr Tranexamic Acid Diluted in 200 ml Normothermic Saline | 0.7 |
(NCT00888940)
Timeframe: 12 hours after the end of surgery
| Intervention | mL (Mean) |
|---|---|
| Ecallantide | 1223.2 |
| Cyklokapron(R) | 623.5 |
(NCT00888940)
Timeframe: Over the duration of the study.
| Intervention | events (Number) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| At Least 1 TEAE | At Least 1 Related TEAE | At Least 1 Severe TEAE | At Least 1 Serious TEAE | At Least 1 Related & Serious TEAE | Premature Study Drug Discontinuations Due to TEAE | Related TEAE Resulting in Discontinuation of Drug | TEAE Resulting in Death | Related TEAE Resulting in Death | |
| Cyklokapron(R) | 94 | 5 | 17 | 28 | 1 | 2 | 0 | 4 | 0 |
| Ecallantide | 100 | 5 | 38 | 45 | 4 | 2 | 0 | 13 | 0 |
(NCT01064167)
Timeframe: 1month postoperative
| Intervention | participants (Number) |
|---|---|
| Tranexamic Acid Group | 37 |
| Control Group | 54 |
(NCT01064167)
Timeframe: 24h postoperative
| Intervention | ml (Mean) |
|---|---|
| Tranexamic Acid Group | 654 |
| Control Group | 891 |
Perioperative blood loss (during operation and for entire hospital admission) (NCT01813058)
Timeframe: perioperarively - during entire hospital admission
| Intervention | mL (Mean) |
|---|---|
| Placebo | 1031 |
| Tranexamic Acid | 836 |
Plasma TxA concentrations measured from blood samples taken upon arrival in the ICU (NCT03376061)
Timeframe: on arrival in ICU within 3 hours
| Intervention | microgram per milliliter per kilogram (Mean) |
|---|---|
| Topical TxA (Intervention) | 0.58 |
| Intravenous TxA (Control) | 1.10 |
Number of hours participants spent in the intensive care unit (ICU) (NCT03376061)
Timeframe: Number of hours spent in ICU from arrival to exit (collected at the Post-Operative Visit).
| Intervention | hours (Median) |
|---|---|
| Topical TxA (Intervention) | 23 |
| Intravenous TxA (Control) | 26 |
Cumulative volume (mL) of fluid collected from mediastinal drainage tubes 24 hours after the surgical procedure (NCT03376061)
Timeframe: Fluid collected in the first 24 hours after the surgical procedure
| Intervention | mL (Median) |
|---|---|
| Topical TxA (Intervention) | 500 |
| Intravenous TxA (Control) | 540 |
The occurrence of death due to any cause (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 1 |
| Intravenous TxA (Control) | 1 |
Patients requiring a red blood cell transfusion (NCT03376061)
Timeframe: Intra-operative and post-operative RBC transfusions
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 19 |
| Intravenous TxA (Control) | 23 |
Occurrence of re-operation for the purpose of bleeding or cardiac tamponade (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 0 |
| Intravenous TxA (Control) | 1 |
Patients experiencing a post-operative seizure (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 0 |
| Intravenous TxA (Control) | 1 |
Preoperative and lowest postoperative hemoglobin. Blood loss was calculated taking change in hemoglobin as described (units g/dL) and converting to blood loss (mL) according to the formulas included in the papers cited in this entry (Good 2003 Br J Anesthesia; Nadler 1962 Surgery, http://www.ncbi.nlm.nih.gov/pubmed/21936146). (NCT01370460)
Timeframe: participants will be followed for the duration of hospital stay, an expected average of 3 days
| Intervention | mL (Mean) |
|---|---|
| Placebo | 1293.1 |
| Tranexamic Acid | 940.2 |
Number of patients with symptomatic (tachycardia, hypotension, presyncope) anemia of < 8.0g/dL hemoglobin, or any hemoglobin <7.0 g/dL, precipitated transfusion. (NCT01370460)
Timeframe: participants will be followed for the duration of hospital stay, an expected average of 3 days
| Intervention | participants (Number) |
|---|---|
| Tranexamic Acid | 0 |
| Placebo | 4 |
Median number of red blood cells transfused among those who received RBC transfusions (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks
| Intervention | units (Median) |
|---|---|
| The Placebo Group | 2 |
| The Tranexamic Acid Group | 2 |
Total number of RBC-transfused women in each group (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks
| Intervention | participants (Number) |
|---|---|
| Tranexamic Group | 15 |
| Placebo Group | 22 |
Thromboembolic events including arterial thrombosis, muscle vein thrombosis, superficial and deep venous thrombosis. (NCT00740116)
Timeframe: From time of operation to 5 weeks postoperatively.
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Group | 2 |
| Placebo Group | 5 |
Total number of red blood cells (RBC) transfused across all participants (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks
| Intervention | units (Number) |
|---|---|
| Tranexamic Group | 38 |
| Placebo Group | 53 |
Estimation of total blood loss was based on the estimation of the Hb balance method (Brecher, et al.1997) with the assumption that the body blood volume was normalised on the fifth postoperative day. The haemoglobin level was assessed preoperatively and on the fifth postoperative day. The predicted blood volume (PBV, l) was calculated according to the method described by Nadler et al. (1962), using body weight and height. The extravasation of haemoglobin was calculated taking into account allogenic transfused haemoglobin. Total blood loss perioperatively was related to the patient's preoperative haemoglobin value. Blood loss due to haematomas or a reoperation within the first five days after surgery was also considered. (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks
| Intervention | milliliter (Median) |
|---|---|
| Tranexamic Group | 520 |
| Placebo Group | 730 |
To determine the impact of perioperative administration of Tranexamic Acid on transfusion rates in major burn surgeries. (NCT02753816)
Timeframe: First burn surgery to hospital discharge
| Intervention | Patients with 1 or more transfusions (Number) |
|---|---|
| Tranexamic Acid | 2 |
| Placebo | 3 |
To determine the impact of Tranexamic Acid on total hospital length of stay by comparing the hospital admission date and the hospital discharge date. This determination will take into account current burn size and location, procedures performed and their effect on wound healing and skin graft survival. (NCT02753816)
Timeframe: Hospital admission to hospital discharge
| Intervention | Days (Median) |
|---|---|
| Tranexamic Acid | 23 |
| Placebo | 9 |
To determine the impact of perioperative administration of Tranexamic Acid on blood loss in major burn surgeries. (NCT02753816)
Timeframe: Intraoperative, average 122 minutes
| Intervention | mL (Median) |
|---|---|
| Tranexamic Acid | 100 |
| Placebo | 325 |
Study patients received 100 mg of intravenous hydrocortisone 2 h prior to surgery, and controls received normal saline. Blood samples, drawn pre-incision and at 4 h post tourniquet release, were assayed for PF1.2 and PAP (NCT01815918)
Timeframe: Baseline and up to 4 hours following surgery
| Intervention | ug/L (Mean) | |
|---|---|---|
| Baseline | 4 hs | |
| Placebo | 623.3 | 1086.8 |
| Treatment | 808.4 | 1638.6 |
Study patients received 100 mg of intravenous hydrocortisone 2 h prior to surgery, and controls received normal saline. Blood samples, drawn pre-incision and at 4 h post tourniquet release, were assayed for PF1.2 and PAP (NCT01815918)
Timeframe: Baseline and up to 4 hours following surgery
| Intervention | pMol/L (Mean) | |
|---|---|---|
| Baseline | 4s | |
| Placebo | 263.6 | 935.8 |
| Treatment | 266.5 | 615.9 |
Surgical blood loss estimation (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge
| Intervention | mL (Median) |
|---|---|
| Tranexamic Acid | 450 |
| Placebo | 365 |
To determine the impact of perioperative administration of tranexamic acid on blood loss and transfusion rates in major oncologic surgery (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 8 |
| Placebo | 5 |
92 reviews available for tranexamic acid and Blood Loss, Postoperative
| Article | Year |
|---|---|
The efficacy of Tranexamic Acid Administration in Patients Undergoing Tonsillectomy: An Updated Meta-Analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tonsillectomy; Tran | 2022 |
The Efficacy and Safety of Tranexamic Acid in the Management of Perioperative Bleeding After Percutaneous Nephrolithotomy: A Systematic Review and Meta-Analysis of Comparative Studies.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Nephrolithotomy, Percutaneous; Postoperative | 2022 |
Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
Topics: Aminocaproic Acid; Anaphylaxis; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Su | 2022 |
Tranexamic acid in head and neck procedures: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Postoperative Hemorrhage; Random | 2022 |
Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Component Transfusion; Blood Loss, Surgical; Cardiac Surgical Procedu | 2022 |
The use of tranexamic acid reduces blood loss in osteotomy at knee level: a systematic review.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Osteotomy; Postoperative Hemorrh | 2022 |
Prophylactic Use of Antifibrinolytics During Pediatric Cardiac Surgery With Cardiopulmonary Bypass on Postoperative Bleeding and Transfusion: A Systematic Review and Meta-Analysis.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Component Transfusion; Cardiac Surgical | 2022 |
Impact of direct oral anticoagulants on bleeding tendency and postoperative complications in oral surgery: a systematic review of controlled studies.
Topics: Administration, Oral; Anticoagulants; Humans; Oral Surgical Procedures; Postoperative Hemorrhage; Tr | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Role of Tranexamic Acid (TXA) in Preventing Bleeding Following Sleeve Gastrectomy: a Systematic Review and Meta-analysis.
Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Gastrectomy; Humans; | 2023 |
The Effects of Tranexamic Acid in Breast Surgery: A Systematic Review and Meta-Analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Breast Neoplasms; Female; Hematoma; Humans; Postopera | 2023 |
A systematic review on the efficacy of tranexamic acid in head and neck surgery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tonsillectom | 2023 |
The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy: a network meta-analysis.
Topics: Chitosan; Collagen; Cyanoacrylates; Fibrinolytic Agents; Hemostatics; Humans; Network Meta-Analysis; | 2023 |
Systematic review and meta-analysis of topical tranexamic acid in spine surgery.
Topics: Blood Loss, Surgical; Case-Control Studies; Cross-Sectional Studies; Hemoglobins; Humans; Postoperat | 2023 |
Does tranexamic acid diminish hemorrhage and pain in open elbow arthrolysis? a systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Elbow; Humans; Pain; Postoperative Hemorrhage; Tranex | 2023 |
Efficacy and Safety of Tranexamic Acid in Reducing Blood Loss of Lower Extremity Osteotomy in Peri-acetabulum and High Tibia: A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Humans; Lower Extremity; Osteotomy | 2019 |
Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: a meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hemoglobins; Humans; Intervertebra | 2019 |
Tranexamic Acid in the Perioperative Period: Yes, No, Maybe?
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Dose-Response Relationship, Drug; Humans; Postoperati | 2019 |
The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Fracture Fixation; Hip Fractures; Human | 2020 |
[Fast-track arthroplasty-intra- and post-operative management].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; I | 2020 |
Tranexamic acid is effective in decreasing postoperative intraarticular bleeding in arthroscopic knee surgery.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Postoperative Hemorr | 2020 |
Intravenous Tranexamic Acid Decreases Blood Transfusion in Off-Pump Coronary Artery Bypass Surgery: A Meta-analysis.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Component Transfusion; Coronary Artery B | 2020 |
Prophylactic Topical Tranexamic Acid Versus Placebo in Surgical Patients: A Systematic Review and Meta-analysis∗.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorr | 2021 |
Effectiveness and safety of the use of antifibrinolytic agents in total-knee arthroplasty: A meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2020 |
The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Humans; Postoperative He | 2020 |
Exposure-Response Relationship of Tranexamic Acid in Cardiac Surgery.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Dose-Response Relationsh | 2021 |
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.
Topics: Antifibrinolytic Agents; Blood Component Transfusion; Deamino Arginine Vasopressin; Disease Manageme | 2021 |
Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis.
Topics: Administration, Topical; Blood Loss, Surgical; Clinical Trials as Topic; Drainage; Humans; Length of | 2021 |
Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Child; Humans; Pharmaceutical Prep | 2021 |
Preventing perioperative bleeding in patients with inherited bleeding disorders.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Hemophilia A; Humans; Postoperativ | 2017 |
Intra-articular Tranexamic Acid in Primary Total Knee Arthroplasty: Meta-analysis.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2018 |
Oral tranexamic acid can reduce blood loss after total knee and hip arthroplasty: A meta-analysis.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2017 |
Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2018 |
The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: A systematic review and cumulative meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass, Off-Pump; | 2018 |
[Research progress on tranexamic acid application strategy in total knee arthroplasty].
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2016 |
The efficacy of oral versus intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: A meta-analysis.
Topics: Administration, Intravenous; Administration, Oral; Antifibrinolytic Agents; Arthritis; Arthroplasty, | 2018 |
A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; | 2018 |
The Efficacy and Safety of Intravenous Tranexamic Acid in Reducing Surgical Blood Loss in Posterior Lumbar Interbody Fusion for the Adult: A Systematic Review and a Meta-Analysis.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Human | 2019 |
Tranexamic Acid Plus Low-dose Epinephrine Reduces Blood Loss in Total Knee Arthroplasty: A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; D | 2018 |
Oral tranexamic acid reduces blood loss in total-knee arthroplasty: A meta-analysis.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Su | 2018 |
Tranexamic acid and perioperative bleeding in children: what do we still need to know?
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Child; Dose-Response Relationship, | 2019 |
Topical Use of Tranexamic Acid in Cardiac Surgery: A Meta-Analysis.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Female; | 2020 |
Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; B | 2019 |
Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H | 2013 |
Antifibrinolytic agents in current anaesthetic practice.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced | 2013 |
Antifibrinolytic agents in current anaesthetic practice.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced | 2013 |
Antifibrinolytic agents in current anaesthetic practice.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced | 2013 |
Antifibrinolytic agents in current anaesthetic practice.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2013 |
[Perioperative management of type 2B Von Willebrand's disease in a patient undergoing urgent abdominal surgery].
Topics: Abdomen, Acute; Blood Loss, Surgical; Emergencies; Factor VIII; Female; Heparin, Low-Molecular-Weigh | 2014 |
Post-operative blood management strategies for total hip arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion, Autologous; Drainage; Hu | 2014 |
Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H | 2014 |
Tranexamic acid - a useful drug in ENT surgery?
Topics: Antifibrinolytic Agents; Humans; Otorhinolaryngologic Diseases; Otorhinolaryngologic Surgical Proced | 2014 |
A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl | 2014 |
Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2015 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2014 |
Efficiency of tranexamic acid in perioperative blood loss in hip arthroplasty: a systematic literature review and meta-analysis.
Topics: Adolescent; Adult; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusion; Female; | 2015 |
Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; | 2015 |
What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery?
Topics: Adult; Angina, Unstable; Antifibrinolytic Agents; Blood Loss, Surgical; Coronary Artery Bypass; Dose | 2015 |
[The possibility of using tranexamic acid for the treatment of bleeding in otorhinolaryngology].
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Otorhinolaryngologic Surgical Procedures; Pos | 2015 |
Predicting Blood Loss in Total Knee and Hip Arthroplasty.
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2015 |
[PERIOPERATIVE BLOOD MANAGEMENT STRATEGIES FOR JOINT ARTHROPLASTY].
Topics: Antifibrinolytic Agents; Arthroplasty; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, A | 2015 |
Tranexamic Acid in Hip and Knee Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss | 2015 |
Tranexamic Acid in Hip and Knee Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss | 2015 |
Tranexamic Acid in Hip and Knee Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss | 2015 |
Tranexamic Acid in Hip and Knee Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss | 2015 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He | 2016 |
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Factor IX; Factor VIII; Hemophilia | 2015 |
Surgical treatment of craniosynostosis in infants: open vs closed repair.
Topics: Anesthesia; Antifibrinolytic Agents; Craniosynostoses; Craniotomy; Hemodynamic Monitoring; Humans; I | 2016 |
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis
Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transf | 2016 |
Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Blood Loss, Surgic | 2017 |
Topical fibrin sealant versus intravenous tranexamic acid for reducing blood loss following total knee arthroplasty: A systematic review and meta-analysis.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2016 |
The effectiveness and safety of tranexamic acid in bilateral total knee arthroplasty: A meta-analysis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; M | 2016 |
An Evaluation of the Efficacy of Local Hemostatic Measures in Dental Patients Taking Oral Anticoagulants: A Critical Review of the Literature Over the Past Two Decades.
Topics: Administration, Oral; Anticoagulants; Antifibrinolytic Agents; Hemostatic Techniques; Humans; Oral S | 2016 |
Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug Admin | 2016 |
Topical application of tranexamic acid in anticoagulated patients undergoing minor oral surgery: A systematic review and meta-analysis of randomized clinical trials.
Topics: Administration, Topical; Anticoagulants; Antifibrinolytic Agents; Humans; Oral Surgical Procedures; | 2017 |
Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Postoperative Hemorrhage; Scolio | 2017 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Admi | 2008 |
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Coronary Artery | 2009 |
What influence do anticoagulants have on oral implant therapy? A systematic review.
Topics: Administration, Oral; Administration, Topical; Anticoagulants; Atrial Fibrillation; Contraindication | 2009 |
Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Drug Administrat | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Antifibrinolytics in major orthopaedic surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma | 2010 |
Tranexamic acid in cardiac surgery: is there a cause for concern?
Topics: Animals; Aprotinin; Cardiac Surgical Procedures; Humans; Postoperative Hemorrhage; Tranexamic Acid | 2010 |
Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Hum | 2011 |
Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass, Off-Pump; | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu | 2011 |
[Transfusion for post-partum haemorrhage: what's new in 2011?].
Topics: Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Clinical Trials as Topic; Combined Mod | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu | 2011 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini | 2012 |
Systematic review and meta-analysis of the use of tranexamic acid in tonsillectomy.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tonsillectomy; Tran | 2013 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu | 2006 |
[Local and systemic hemostasis in surgery].
Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Factor VIIa; Fibrin Tissue Adhesive; Hemos | 2007 |
Pharmacologic methods to reduce perioperative bleeding.
Topics: Aminocaproic Acid; Aprotinin; Deamino Arginine Vasopressin; Hemorrhage; Hemostatics; Humans; Meta-An | 2008 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi | 2008 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi | 2008 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi | 2008 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi | 2008 |
Current antifibrinolytic therapy for coronary artery revascularization.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Coro | 2008 |
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac | 1999 |
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac | 1999 |
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac | 1999 |
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac | 1999 |
Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
Topics: Anesthesia, Obstetrical; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Deamino Ar | 2001 |
[Tranexamic acid reduces blood loss and the need of blood transfusion after knee arthroplasty].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H | 2002 |
279 trials available for tranexamic acid and Blood Loss, Postoperative
| Article | Year |
|---|---|
Multimodal Peri-articular Injection with Tranexamic Acid can reduce postoperative blood loss versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2021 |
Use of a Multifunctional Cocktail for Postoperative Bleeding and Pain Control in Spinal Fusion: A Randomized, Double-blind, Controlled Trial.
Topics: Analgesics, Opioid; Blood Loss, Surgical; Double-Blind Method; Hemoglobins; Humans; Pain; Pain Manag | 2022 |
Efficacy and Safety of Postoperative Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2021 |
Synergistic Effect of a Prolonged Combination Course of Tranexamic Acid and Dexamethasone Involving High Initial Doses in Total Knee Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
Adjunctive Topical Tranexamic Acid for Blood Salvage Does Not Reduce Postoperative Blood Loss Compared with Placebo in Patients Who Undergo Palliative Decompressive Spinal Metastasis Surgery: A Randomized Controlled Trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorr | 2022 |
Topical administration of tranexamic acid in elderly patients undergoing short femoral nailing for intertrochanteric fracture: A randomised controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Int | 2022 |
Pre-Emptive Antifibrinolysis: Its Role and Efficacy in Hip Fracture Patients Undergoing Total Hip Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hip Fractures; | 2022 |
Invited Discussion on: Re-evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized double-blinded controlled Trial.
Topics: Blood Loss, Surgical; Double-Blind Method; Humans; Postoperative Hemorrhage; Rhinoplasty; Tranexamic | 2022 |
Tranexamic acid combined with compression dressing reduces blood loss in gluteal muscle contracture surgery.
Topics: Antifibrinolytic Agents; Bandages; Blood Loss, Surgical; Contracture; Humans; Muscles; Postoperative | 2022 |
Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Electiv | 2022 |
Can the prophylactic administration of tranexamic acid reduce the blood loss after robotic-assisted radical prostatectomy? Robotic Assisted Radical Prostatectomy with tranEXamic acid (RARPEX): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Double-Blind Method; Humans; Male; Pilot Projects; Postoperative Hemorrhage | 2022 |
Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Hemoglobins; Humans; Lys | 2022 |
The effect of tranexamic acid injection during anterior cruciate ligament reconstruction surgery on postoperative bleeding, pain and swelling.
Topics: Anterior Cruciate Ligament Injuries; Anterior Cruciate Ligament Reconstruction; Humans; Knee Joint; | 2023 |
Tranexamic acid effects in postoperative bleeding outcomes in laparoscopic sleeve gastrectomy: a controlled study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Blood Loss, Surgical; Gastrectomy; | 2022 |
Clinical trial to determine whether the timing of tranexamic acid administration influences perioperative bleeding in total knee arthroplasty.
Topics: Arthroplasty, Replacement, Knee; Double-Blind Method; Hemoglobins; Humans; Postoperative Hemorrhage; | 2022 |
Topics: Aged; Antifibrinolytic Agents; Arthrodesis; Blood Loss, Surgical; Bone Screws; Fracture Fixation, In | 2022 |
Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study.
Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Dalt | 2023 |
Efficacy of intravenous tranexamic acid administration in medial opening-wedge distal tibial tuberosity osteotomy (MOWDTO) for varus knee osteoarthritis: a randomized control trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Osteoarthritis, | 2023 |
The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; C-Reactive Protein; Hemostatics; Humans; Postoperativ | 2023 |
Medullary cavity application of tranexamic acid to reduce blood loss in tibial intramedullary nailing procedures-a randomized controlled trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Exsanguination; Fracture Fixation, Intramedullary; Hu | 2023 |
Comparative study of carbazochrome sodium sulfonate and tranexamic acid in reducing blood loss and inflammatory response following direct anterior total hip arthroplasty: a prospective randomized controlled trial.
Topics: Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgi | 2023 |
[Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study].
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hematoma; Humans; Postoperative Hemorrhage; Prospecti | 2023 |
Peroperative administration of tranexamic acid in sleeve gastrectomy to reduce hemorrhage: a double-blind randomized controlled trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Hum | 2023 |
Risk of bleeding in anticoagulated patients undergoing dental extraction treated with topical tranexamic acid compared to collagen-gelatin sponge: Randomized clinical trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Collagen; Gelatin; Humans; P | 2023 |
Efficacy of perioperative cryotherapy combined with intra-articular injection of tranexamic acid in total knee arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Injections, | 2023 |
Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.
Topics: Blood Loss, Surgical; Cesarean Section; Female; Humans; Misoprostol; Oxytocin; Postoperative Hemorrh | 2023 |
Effect of Tranexamic Acid on Postoperative Bleeding in Sleeve Gastrectomy: a Randomized Trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Obesity, Morbid; Postoperative Hemorrhage; Tr | 2023 |
The efficacy of temperature intervention combined with tranexamic acid in reducing blood loss and accelerating recovery during spinal fusion.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Postoperative Hemorrhage; Pulmon | 2023 |
Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; | 2019 |
Hemostatic and Anti-Inflammatory Effects of Carbazochrome Sodium Sulfonate in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Topical; Adrenochrome; Anti-Inflammatory Agents; Antifi | 2020 |
Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Topics: Administration, Intravenous; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replace | 2019 |
First Comparative Study of the Effectiveness of the Use of Tranexamic Acid against ε-Aminocapróic Acid via the Oral Route for the Reduction of Postoperative Bleeding in TKA: A Clinical Trial.
Topics: Administration, Oral; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, K | 2021 |
[Effect of tranexamic acid combined flexion position of hip and knee on perioperative bleeding following unilateral total knee arthroplasty].
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2019 |
Monitoring of fibrinolytic system activity with plasminogen, D-dimers and FDP in primary total knee arthroplasty (TKA) after topical, intravenous or combined administration of tranexamic acid.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2020 |
Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2019 |
Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trial.
Topics: Administration, Oral; Anticoagulants; Double-Blind Method; Humans; Postoperative Hemorrhage; Thrombo | 2019 |
Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Drugs, Chinese Herbal; Female; Follow-Up Studie | 2020 |
Tranexamic acid has no advantage in head and neck surgical procedures: a randomised, double-blind, controlled clinical trial.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Humans; Male; Mid | 2019 |
Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedures; Cardi | 2019 |
Tranexamic acid in ENT.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Brain Injuries, Traumatic; Humans; Otolaryngology; Pl | 2019 |
The antifibrinolytic and anti-inflammatory effects of a high initial-dose tranexamic acid in total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, | 2020 |
Trial protocol: preoperative administration of tranexamic acid in sleeve gastrectomy (PATAS) to reduce haemorrhage rates. A randomised controlled trial.
Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Gastrectomy; Humans; Postoperative Hemorrhage; | 2020 |
Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; | 2020 |
Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2021 |
Effects of Intravenous Tranexamic Acid During Rhytidectomy: A Randomized, Controlled, Double-Blind Pilot Study.
Topics: Blood Loss, Surgical; Double-Blind Method; Humans; Pilot Projects; Postoperative Hemorrhage; Prospec | 2021 |
Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal | 2020 |
Tranexamic acid for the Latarjet procedure: a randomized controlled trial.
Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Antifibrinolytic Agents; Blood Loss, Surgica | 2020 |
Results after the application of tranexamic acid intravenous or intra-articular in the control of postsurgical bleeding after total hip arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Su | 2020 |
Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up.
Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypas | 2020 |
Effect of topical tranexamic acid on post-traumatic elbow stiffness in patients treated with open arthrolysis: a prospective comparative study.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Drainage; Elbow; Elbow Joint; Female; Humans; | 2020 |
Topical Tranexamic Acid in Total Knee Arthroplasty: Does It Augment the Effect of the Intravenous Administration in Patients with Moderate-to-High Risk of Bleeding? A Randomized Clinical Trial.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2021 |
Effectiveness of preemptive antifibrinolysis with tranexamic acid in rheumatoid arthritis patients undergoing total knee arthroplasty: a study protocol for a randomized controlled trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthritis, Rheumatoid; Arthroplasty, Replaceme | 2020 |
Tranexamic acid is beneficial for blood management of high tibial osteotomy: a randomized controlled study.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Middle Aged; Osteotomy; Postoperative Hemorrh | 2021 |
Better Treatment Values in Local Application of Tranexamic Acid (TXA) than Intravenous Application with the Same Dose in Total Hip Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Humans; Postoperative | 2020 |
Tranexamic Acid for Blood Loss after Transforaminal Posterior Lumbar Interbody Fusion Surgery: A Double-Blind, Placebo-Controlled, Randomized Study.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Double-Blind Method; Female; Humans; Len | 2020 |
Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy.
Topics: Acetabulum; Administration, Intravenous; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Sur | 2020 |
Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2021 |
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Female; Human | 2020 |
Is Preoperative Administration of Tranexamic Acid Effective on Blood Loss Reduction in Mandibular Fracture Surgeries? A Triple-Blind Randomized Clinical Trial.
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Chicago; Female; | 2021 |
The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial.
Topics: Administration, Intravenous; Adolescent; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Post | 2021 |
Reduction of Blood Loss by Intra-articular Injection of Tranexamic Acid Combined with Knee and Hip Flexion at 45° During Primary Total Knee Arthroplasty: A Randomized Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Hematocri | 2020 |
The influence of topical use of tranexamic acid in reducing blood loss on early operation for thoracolumbar burst fracture: a randomized double-blinded controlled study.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorr | 2021 |
Is serum gentamicin concentration modified with autologous cell-saved blood transfusion after total knee arthroplasty using tranexamic acid? A randomised control trial.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; B | 2021 |
Effects of Different Applications of Tranexamic Acid on Perioperative Blood Transfusion Rate and Postoperative Pain in Unilateral Total Knee Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H | 2021 |
Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled study.
Topics: Administration, Oral; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, H | 2021 |
Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2021 |
Effects of tourniquet use on clinical outcomes and cement penetration in TKA when tranexamic acid administrated: a randomized controlled trial.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Bone Cements; Humans | 2021 |
Tranexamic acid in joint replacement : a randomized trial comparing intravenous oral and topical routes.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; | 2020 |
Are The Applications of Tranexamic Acid in Reverse Hybrid Total Knee Arthroplasty (TKA) The Same as Those in Fully Cemented TKA?: A Randomized Controlled Trial.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H | 2021 |
Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Belgium; Dou | 2021 |
Intravenous tranexamic acid reduce postoperative drainage and pain after open elbow arthrolysis: a randomized controlled trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Drainage; Elbow; Humans; | 2021 |
A randomized comparative evaluation of local infiltration analgesia, extended nerve blocks, and conventional analgesia in pain management after total knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Analgesia; Anesthesia, Local; Anesthesia, Spinal; Anesthetics, Local | 2021 |
Evaluation of efficacy and safety of systemic and topical intra-articular administration of tranexamic acid in primary unilateral total hip arthroplasty.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Tr | 2021 |
Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial.
Topics: Administration, Intravenous; Administration, Topical; Adolescent; Antifibrinolytic Agents; Blood Los | 2021 |
Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2021 |
Determination of Perioperative Blood Loss: Accuracy or Approximation?
Topics: Algorithms; Anthropometry; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surg | 2017 |
Tranexamic Acid Reduces Occult Blood Loss, Blood Transfusion, and Improves Recovery of Knee Function after Total Knee Arthroplasty: A Comparative Study.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; F | 2018 |
The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomark | 2017 |
Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic | 2017 |
Effectiveness and Safety of Batroxobin, Tranexamic Acid and a Combination in Reduction of Blood Loss in Lumbar Spinal Fusion Surgery.
Topics: Adult; Aged; Antifibrinolytic Agents; Batroxobin; Blood Loss, Surgical; Blood Transfusion; Double-Bl | 2018 |
The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Middle Aged; Postoperative Hemorrhage; | 2017 |
Comparison of intravenous and intra-articular tranexamic acid in reducing blood loss in primary total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacemen | 2017 |
Effects of low-dose epinephrine on perioperative hemostasis and inflammatory reaction in major surgical operations: a randomized clinical trial.
Topics: Adrenergic Agonists; Adult; Aged; Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, R | 2018 |
[Comparison of different modes of using tranexamic acid administration on reducing hidden blood loss in total hip arthroplasty].
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl | 2016 |
Effect of knee flexion position and combined application of tranexamic acid on blood loss following primary total knee arthroplasty: a prospective randomized controlled trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2018 |
The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Fracture Fixation, Intramedullary; Hip | 2018 |
Low-Dose Epinephrine Plus Tranexamic Acid Reduces Early Postoperative Blood Loss and Inflammatory Response: A Randomized Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Drug Therapy, Com | 2018 |
Comparison between Intravenous Boluses versus Infusion of Tranexamic Acid (TXA) to Reduce Bleeding in Paediatric Cyanotic Congenital Heart Disease (CHD) Surgeries.
Topics: Administration, Intravenous; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cardi | 2018 |
Comparing the efficacy of intravenous or intra-articular tranexamic acid in reducing blood loss in simultaneous bilateral knee replacement surgery without the use of tourniquet.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2018 |
Use of Tranexamic Acid to Reduce Blood Loss in Liposuction.
Topics: Adult; Blood Loss, Surgical; Double-Blind Method; Female; Hematocrit; Humans; Injections, Intravenou | 2018 |
The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial.
Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Female; Humans; Injections, Intravenous; Postop | 2018 |
Topical use of tranexamic acid in open heart surgery.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical Procedures; Do | 2018 |
Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Su | 2018 |
Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthropla | 2018 |
Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthritis, Rheumat | 2018 |
Similar thromboprophylaxis with rivaroxaban and low molecular weight heparin but fewer hemorrhagic complications with combined intra-articular and intravenous tranexamic acid in total knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Loss, Surgica | 2019 |
Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: A prospective randomized clinical trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2018 |
Using intra-articular tranexamic acid in total knee replacement surgery with and without bleeding control: a prospective randomized double blind study.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2018 |
Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: A randomized clinical trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2018 |
Blood loss after intraarticular and intravenous tranexamic acid in total knee arthroplasty.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; F | 2018 |
Effects of tranexamic acid on short-term and long-term outcomes of on-pump coronary artery bypass grafting: Randomized trial and 7-year follow-up.
Topics: Aged; Antifibrinolytic Agents; Cardiopulmonary Bypass; China; Coronary Artery Bypass; Coronary Arter | 2018 |
The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, Replace | 2018 |
Subcutaneous tranexamic acid in upper eyelid blepharoplasty: a prospective randomized pilot study.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blepharoplasty; Blood Loss, Surgical; Chalazion; D | 2018 |
Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study).
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2019 |
Single Intravenous Administration of Tranexamic Acid in Anterior Cruciate Ligament Reconstruction to Reduce Postoperative Hemarthrosis and Increase Functional Outcomes in the Early Phase of Postoperative Rehabilitation: A Randomized Controlled Trial.
Topics: Adolescent; Adult; Anterior Cruciate Ligament Injuries; Anterior Cruciate Ligament Reconstruction; A | 2019 |
Subcutaneous Injection of Tranexamic Acid to Reduce Bleeding During Dermatologic Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dermatologic Surgical Proced | 2019 |
Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2019 |
Finding the Optimal Regimen for Oral Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Oral; Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement | 2019 |
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac | 2019 |
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac | 2019 |
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac | 2019 |
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac | 2019 |
Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; | 2019 |
Reduced perioperative blood loss in children undergoing craniosynostosis surgery using prolonged tranexamic acid infusion: a randomised trial.
Topics: Anesthesia, General; Antifibrinolytic Agents; Blood Loss, Surgical; Child, Preschool; Craniosynostos | 2019 |
Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty.
Topics: Adolescent; Adult; Double-Blind Method; Epistaxis; Humans; Infusions, Intravenous; Middle Aged; Nasa | 2019 |
2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Drug Administration | 2019 |
Intra-Articular Injection of Tranexamic Acid on Perioperative Blood Loss During Unicompartmental Knee Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2019 |
High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Trans | 2019 |
Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Elective Surgical Procedures | 2013 |
Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Clinical Protocol | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2014 |
[Influence of different tranexamic acid administration methods during and after cardiac surgery on coagulation function and postoperative blood loss].
Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Blood Coagulation; Cardiac Surgical Procedures; Ca | 2013 |
Topical application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study.
Topics: Adenoidectomy; Adolescent; Antifibrinolytic Agents; Child; Child, Preschool; Double-Blind Method; Fe | 2013 |
Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Coagulation Tests; Decompression, Surgical; Female; Humans; Int | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
Tranexamic acid in decreasing blood loss during and after caesarean section.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2013 |
[Diagnosis and correction of hemostasis disorder during surgeries for bile duct diseases].
Topics: Antifibrinolytic Agents; Choledocholithiasis; Drug Administration Schedule; Hemostasis; Humans; Post | 2013 |
Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement.
Topics: Adult; Anesthesia, Epidural; Anesthesia, General; Antifibrinolytic Agents; Arthroplasty, Replacement | 2013 |
Post-operative blood loss in total knee arthroplasty: knee flexion versus pharmacological techniques.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; K | 2014 |
[Effectiveness and safety of tranexamic acid in patients receiving on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation].
Topics: Aged; Aged, 80 and over; Aspirin; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Female; Hu | 2013 |
Topical administration of tranexamic acid in primary total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2014 |
Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Fibrin Tissue Adhesive; Hemo | 2013 |
[Tranexamic acid gel in patients treated with oral anticoagulants].
Topics: Acenocoumarol; Anticoagulants; Antifibrinolytic Agents; Gels; Humans; Postoperative Hemorrhage; Toot | 2014 |
Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Constriction; Dra | 2013 |
Comparison of two tranexamic acid dose regimens in patients undergoing cardiac valve surgery.
Topics: Adult; Antifibrinolytic Agents; Cardiopulmonary Bypass; Double-Blind Method; Female; Follow-Up Studi | 2014 |
Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiopulmonary Bypass; Chest Tubes; Corona | 2013 |
Knee flexion after total knee arthroplasty reduces blood loss.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K | 2014 |
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2014 |
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2014 |
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2014 |
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2014 |
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf | 2014 |
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf | 2014 |
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf | 2014 |
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf | 2014 |
Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2014 |
The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Coagulation | 2015 |
[Topical application of tranexamic acid to prevent post-tonsillectomy haemorrhage].
Topics: Administration, Topical; Adolescent; Adult; Age Factors; Child; Child, Preschool; Female; Hemostasis | 2015 |
Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2014 |
[Effect of priming solution and ultrafiltration on post-operative bleeding and blood transfusion in cardiac surgery. Randomized controlled trial].
Topics: Aged; Aged, 80 and over; Albumins; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion; | 2015 |
Postoperative hemostatic efficacy of gauze soaked in tranexamic acid, fibrin sponge, and dry gauze compression following dental extractions in anticoagulated patients with cardiovascular disease: a prospective, randomized study.
Topics: Administration, Topical; Adult; Aged; Anticoagulants; Brazil; Cardiovascular Diseases; Female; Fibri | 2015 |
Evaluation of the Efficacy of Tranexamic Acid on the Surgical Field in Primary Cleft Palate Surgery on Children-A Prospective, Randomized Clinical Study.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Child, Preschool; Cleft Palate; Double-Blind Method; | 2015 |
The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty.
Topics: Administration, Intravenous; Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agen | 2015 |
Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study.
Topics: Administration, Topical; Aged; Anti-Infective Agents, Local; Antifibrinolytic Agents; Arthroplasty, | 2015 |
Topical application of tranexamic acid reduces postoperative bleeding in open-heart surgery: myth or fact?
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgica | 2015 |
Topical Administration of Tranexamic Acid Plus Diluted-Epinephrine in Primary Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blin | 2015 |
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme | 2015 |
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme | 2015 |
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme | 2015 |
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme | 2015 |
Safety and efficacy of intra-articular tranexamic acid injection without drainage on blood loss in total knee arthroplasty: A randomized clinical trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2015 |
Topical Application of Tranexamic Acid Plus Diluted Epinephrine Reduces Postoperative Hidden Blood Loss in Total Hip Arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema | 2015 |
[A PROSPECTIVE RANDOMIZED SELF-CONTROLLED STUDY ON EFFECT OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS IN TOTAL KNEE ARTHROPLASTY].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H | 2015 |
Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Cardiopulmonary Bypass; Female; Humans; Male; Mid | 2015 |
The Efficacy of Preoperative Oral Tranexamic Acid on Intraoperative Bleeding During Rhinoplasty.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Me | 2016 |
Staple Line Bleeding in Sleeve Gastrectomy-a Simple and Cost-Effective Solution.
Topics: Adult; Antifibrinolytic Agents; Female; Gastrectomy; Humans; Laparoscopy; Male; Obesity, Morbid; Pos | 2016 |
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
[The Effect of Tranexamic Acid on Blood Loss after Primary Unilateral Total Knee Arthroplasty. Prospective Single-Centre Study].
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2015 |
The effect of local and systemic application of tranexamic acid on the amount of blood loss and allogeneic blood transfusion after total knee replacement.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Rel | 2015 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Topical vs Intravenous Tranexamic Acid in Reducing Blood Loss After Bilateral Total Knee Arthroplasty: A Prospective Study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses.
Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood | 2016 |
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2016 |
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2016 |
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2016 |
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2016 |
Effect of Topical and Intravenously Applied Tranexamic Acid Compared to Control Group on Bleeding in Primary Unilateral Total Knee Arthroplasty.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2017 |
What is the optimal approach for tranexamic acid application in patients with unilateral total hip arthroplasty?
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Dose-Response | 2016 |
Effectiveness and Safety of Fixed-Dose Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2016 |
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2016 |
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2016 |
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2016 |
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2016 |
The Assessment of Blood Loss During Total Knee Arthroplasty When Comparing Intravenous vs Intracapsular Administration of Tranexamic Acid.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2016 |
Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomark | 2016 |
Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2016 |
Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.
Topics: Administration, Intravenous; Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthropl | 2016 |
Using tranexamic acid soaked absorbable gelatin sponge following complex posterior lumbar spine surgery: A randomized control trial.
Topics: Adult; Aged; Antifibrinolytic Agents; Female; Gelatin Sponge, Absorbable; Humans; Lumbar Vertebrae; | 2016 |
Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: A prospective clinical study.
Topics: Administration, Intravenous; Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Tran | 2016 |
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T | 2016 |
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T | 2016 |
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T | 2016 |
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T | 2016 |
Topical tranexamic acid versus autotransfusion after total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion, Autologous; Cost- | 2016 |
Combined Administration of IV and Topical Tranexamic Acid is Not Superior to Either Individually in Primary Navigated TKA.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2017 |
The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2017 |
Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2017 |
Optimizing effectivity of tranexamic acid in bilateral knee arthroplasty - A prospective randomized controlled study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2017 |
Additional effects of topical tranexamic acid in on-pump cardiac surgery.
Topics: Administration, Intravenous; Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Tr | 2017 |
Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Bone Plates; Bone Scr | 2016 |
Additional intraarticular tranexamic acid further reduced postoperative blood loss compared to intravenous and topical bathed tranexamic acid in total hip arthroplasty: a retrospective sequential series study.
Topics: Administration, Intravenous; Administration, Topical; Aged; Arthroplasty, Replacement, Hip; Female; | 2017 |
Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery.
Topics: Administration, Intravenous; Administration, Topical; Adolescent; Antifibrinolytic Agents; Blood Coa | 2017 |
Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Decompression, Surgical; Double-Blind Me | 2017 |
Effects of five treatment regimens on blood loss and blood transfusion in total knee arthroplasty: a preliminary study in China
.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Lo | 2017 |
Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Shoulder; Blood Loss, Surgical; Blood Tran | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty.
Topics: Accidental Falls; Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem | 2017 |
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2017 |
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2017 |
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2017 |
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl | 2017 |
What is the Ideal Route of Administration of Tranexamic Acid in TKA? A Randomized Controlled Trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T | 2017 |
The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Coagulation; Blood Transfusion; Cardiopulmonary Bypa | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra | 2008 |
The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Topics: Antifibrinolytic Agents; Aprotinin; Blood Component Transfusion; Blood Loss, Surgical; Drug Administ | 2009 |
Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery.
Topics: Adult; Aged; Blood Volume; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Female; Humans; Ma | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Double-Bli | 2009 |
PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Cardiac Surgical Procedures; Case-Control Studies; Female; | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal | 2009 |
Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Topics: Aged; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Elective Su | 2009 |
The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia.
Topics: Anesthesia, Epidural; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Double-Blind Method; | 2010 |
Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion, Autologous; Dose- | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion; | 2011 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement | 2010 |
[Tranexamic acid reduces haematomas but not pain after total knee arthroplasty].
Topics: Aged; Anesthesia, General; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Hematom | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2011 |
Local and systemic application of tranexamic acid in heart valve surgery: a prospective, randomized, double blind LOST study.
Topics: Aged; Antifibrinolytic Agents; Blood Component Transfusion; Cardiac Surgical Procedures; Double-Blin | 2011 |
A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Topics: Aged; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double-Blind Method | 2012 |
Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Aged; Antifibrinolytic Agents; Chest Tubes; Chi-Square Distribution; China; Coronary Artery Bypass, | 2012 |
Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Antifibrinolytic Agents; Aortic Valve; Blood Transfusion; Coro | 2012 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Postoperative bleeding after dental extraction in liver pretransplant patients.
Topics: Adult; Antifibrinolytic Agents; Cross-Sectional Studies; Dental Care for Chronically Ill; Female; He | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl | 2012 |
Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion.
Topics: Adult; Analysis of Variance; Aprotinin; Blood Transfusion; Chest Tubes; Double-Blind Method; Drainag | 2012 |
Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bone Cements; Case-Co | 2012 |
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion | 2012 |
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion | 2012 |
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion | 2012 |
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion | 2012 |
Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Dou | 2012 |
Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical | 2013 |
Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Double-Blind Method; Female; Humans; Postoperative | 2013 |
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Female; Hemostatics; Humans; Male; Middle Aged; O | 2012 |
No effect of fibrin sealant on drain output or functional recovery following simultaneous bilateral total knee arthroplasty: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Bli | 2013 |
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl | 2013 |
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl | 2013 |
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl | 2013 |
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl | 2013 |
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion; | 2003 |
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion; | 2003 |
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion; | 2003 |
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion; | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth | 2003 |
[Dental extraction in patients with bleeding disorders. Proposal of a protocol based on the type of anesthesia used].
Topics: Adolescent; Adult; Aged; Anesthesia, Dental; Anesthesia, General; Anesthesia, Local; Anticoagulants; | 2003 |
[Prevention of postoperative bleeding in patients taking oral anticoagulants. Effects of tranexamic acid].
Topics: Acenocoumarol; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolyti | 2003 |
[Usefulness of tranexamic acid in cranial remodeling surgery].
Topics: Anesthesia Recovery Period; Blood Component Transfusion; Blood Loss, Surgical; Craniosynostoses; Fem | 2003 |
Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study.
Topics: Adult; Aged; Anticoagulants; Blood Loss, Surgical; Dental Care for Chronically Ill; Drug Interaction | 2003 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Tranexamic acid mouthwash--a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions.
Topics: Administration, Topical; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Dental Care for Chron | 2003 |
Tranexamic acid in primary CABG surgery: high vs low dose.
Topics: Aged; Antifibrinolytic Agents; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Postoperat | 2004 |
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery.
Topics: Adolescent; Aminocaproic Acid; Antifibrinolytic Agents; Blood Coagulation Tests; Blood Transfusion; | 2004 |
Intraoperative moderate acute normovolemic hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery.
Topics: Aged; Anesthesia; Antifibrinolytic Agents; Blood Cell Count; Blood Transfusion; Blood Volume; Cardia | 2004 |
Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery.
Topics: Administration, Topical; Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Female; Fibrin F | 2003 |
Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
Topics: Aged; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Blood Loss, S | 2004 |
Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Topics: Antifibrinolytic Agents; Blood Transfusion, Autologous; Cardiopulmonary Bypass; Coronary Artery Bypa | 2004 |
Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Dental Care for Chronically Ill; Dental Scaling; Double | 2005 |
[Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
Topics: Administration, Cutaneous; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgica | 2005 |
Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemostatic Tech | 2005 |
Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Coronary Artery Bypass, Off-Pump; Cr | 2005 |
A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
Topics: Antifibrinolytic Agents; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Effect of topical tranexamic acid in open heart surgery.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P | 2006 |
Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets.
Topics: Administration, Oral; Aged; Anticoagulants; Blood Coagulation; Cardiovascular Diseases; Cellulose, O | 2006 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me | 2005 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema | 2006 |
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Topics: Adult; Aprotinin; Blood Loss, Surgical; Erythrocyte Transfusion; Female; Fibrinolysis; Hemostatics; | 2006 |
Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting.
Topics: Aged; Angina Pectoris; Antifibrinolytic Agents; Chemoprevention; Coronary Artery Bypass, Off-Pump; F | 2006 |
Tranexamic acid does not correct the haemostatic impairment caused by hydroxyethyl starch (200 kDa/0.5) after cardiac surgery.
Topics: Antifibrinolytic Agents; Cardiopulmonary Bypass; Female; Humans; Hydroxyethyl Starch Derivatives; Ma | 2006 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion | 2007 |
Effects of tranexamic acid and autotransfusion in coronary artery bypass.
Topics: Adult; Blood Transfusion; Blood Transfusion, Autologous; Coronary Artery Bypass; Female; Hemostatics | 2007 |
[Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
Topics: Antifibrinolytic Agents; Biomarkers; Blood Loss, Surgical; Blood Proteins; Cardiac Surgical Procedur | 2007 |
Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Female | 2008 |
Does tranexamic acid reduce blood loss in off-pump coronary artery bypass?
Topics: Adult; Antifibrinolytic Agents; Blood Coagulation; Blood Transfusion; Coronary Artery Bypass, Off-Pu | 2007 |
Tranexamic acid and primary coronary artery bypass surgery: a prospective study.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; Coro | 2007 |
Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial.
Topics: Aged; Antifibrinolytic Agents; Cardiopulmonary Bypass; Case-Control Studies; Double-Blind Method; Fe | 2007 |
[Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty].
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Bl | 2007 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card | 2008 |
Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Double-Blind Method; Drainage; Female; Huma | 2008 |
Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Tests; Blood L | 1995 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo | 1996 |
Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Coagulation; Blood Transfusion; Cardiopulmonary Bypass; | 1996 |
Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
Topics: Aminocaproic Acid; Aprotinin; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion; Cardiopulm | 1996 |
The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Aspirin; Coronary Artery Bypass; Dose-Respons | 1997 |
Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
Topics: Antifibrinolytic Agents; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion; Blood Volume; C | 1997 |
The effectiveness of low dose tranexamic acid in primary cardiac surgery.
Topics: Analysis of Variance; Antifibrinolytic Agents; Blood Coagulation; Blood Loss, Surgical; Blood Transf | 1998 |
Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.
Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiopulmonary Bypass; Chest Tubes; Coronary | 1998 |
[Comparative effect of tranexamic acid on the reduction of bleeding during and after cardiac surgery].
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmo | 1998 |
The effect of tranexamic acid (cyclokapron) on blood loss after third molar extraction under a day case general anaesthetic.
Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, General; Antifibr | 1999 |
Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.
Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Double-Blind Met | 2000 |
Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Deamino Arginine Vasopressin; D | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho | 2000 |
[Hemostatic wound management in marcumar patients. Collagen fleece vs. tranexamic acid].
Topics: Adult; Aged; Aged, 80 and over; Alveolar Process; Anticoagulants; Collagen; Hemostasis, Surgical; He | 2000 |
Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiopulmonary Bypass; Humans; Middle Aged; Postoperati | 2000 |
Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Cardiopulmonary Bypass; Comorbidity; Double | 2001 |
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.
Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Ad | 2001 |
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Topics: Adult; Antigens; Blood Loss, Surgical; Child; Child, Preschool; Drug Administration Schedule; Electi | 2001 |
262 other studies available for tranexamic acid and Blood Loss, Postoperative
| Article | Year |
|---|---|
Dose tranexamic acid reduce blood loss associated with simultaneous bilateral distal tibial tubercle-high tibial osteotomy?
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Case-Control Studies; Hu | 2021 |
The Efficiency of Simultaneous Systemic and Topical Use of Tranexamic Acid in Spinal Fusion Surgery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Spinal Fusio | 2022 |
Tranexamic acid in cardiac surgery: Are low doses enough?
Topics: Antifibrinolytic Agents; Cardiac Surgical Procedures; Humans; Postoperative Hemorrhage; Prospective | 2021 |
Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty.
Topics: Adenosine; Administration, Intravenous; Animals; Antifibrinolytic Agents; Arthroplasty, Replacement, | 2021 |
Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replace | 2022 |
Acute normovolemic hemodilution in combination with tranexamic acid is an effective strategy for blood management in lumbar spinal fusion surgery.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hemodilution; Humans; Intraopera | 2022 |
Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Bone Neoplasms; Humans; Postoperative Hemorrhage; Ret | 2022 |
Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss in opening wedge high tibial osteotomy procedure: A retrospective case-control study.
Topics: Activities of Daily Living; Administration, Intravenous; Administration, Topical; Antifibrinolytic A | 2022 |
Comparison of weight-based versus standard dosing of tranexamic acid for blood loss and transfusion amount in knee arthroplasty without tourniquet.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Female; Hemoglobins; | 2022 |
Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors.
Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blo | 2022 |
Comparison of blood loss between tranexamic acid-soaked absorbable Gelfoam and topical retrograde injection via drainage catheter plus clamping in cervical laminoplasty surgery.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Catheters; Constriction; Drainage; Gelatin Sponge, Ab | 2022 |
The Effect of Tranexamic Acid on Operative and Postoperative Blood Loss in Transforaminal Lumbar Interbody Fusions.
Topics: Adult; Blood Loss, Surgical; Child; Humans; Lumbar Vertebrae; Postoperative Hemorrhage; Retrospectiv | 2022 |
Effectiveness of prophylactic doses of tranexamic acid in reducing hemorrhagic events in sleeve gastrectomy.
Topics: Gastrectomy; Humans; Laparoscopy; Obesity, Morbid; Postoperative Complications; Postoperative Hemorr | 2022 |
[Effects of oral and intravenous tranexamic acid on perioperative blood loss after lumbar spinal canal decompression and fusion].
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Decompression; Humans; Postoperative Hemorrhage; Spin | 2022 |
Effect of Topical Administration of Tranexamic Acid on Intraoperative and Postoperative Blood Loss during Posterior Cervical Laminectomy and Fusion Surgery: A Retrospective Study.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hemostatics; Humans; | 2023 |
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Breast Neoplasms; Female; Humans; Male; Mastectomy; M | 2022 |
Optimal Release Timing of Drain Clamping to Reduce Postoperative Bleeding after Total Knee Arthroplasty with Intraarticular Injection of Tranexamic Acid.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Constriction; Draina | 2022 |
Does the clamping method in local and systemic TXA applications in total knee arthroplasty change the game?: A retrospective comparative cohort study.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cohort Studie | 2022 |
Does living at high altitude increase the risk of bleeding events after total knee arthroplasty? A retrospective cohort study.
Topics: Altitude; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Fibrin Fib | 2023 |
Tranexamic acid in pertrochanteric fractures: a retrospective analysis of perioperative outcomes after fixation with a proximal femoral nail.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Femoral Fractures; Humans; Postoperative Hemorrhage; | 2022 |
Use of tranexamic acid may reduce the need for routine tourniquet use in total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; P | 2022 |
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae | 2023 |
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae | 2023 |
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae | 2023 |
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae | 2023 |
Tranexamic acid in total knee arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2023 |
Preliminary outcome of use of parenterally administered tranexamic acid during primary total knee replacement.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
Topical administration of tranexamic acid reduces postoperative blood loss and inflammatory response in knee arthroscopic arthrolysis: a retrospective comparative study.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroscopy; Blood Loss, Surgical; Hemarthrosis; H | 2023 |
Topical tranexamic acid reduces postoperative hematomas in reduction mammaplasties.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Breast Neoplasms; Cohort Stu | 2023 |
The efficacy and safety of intravenous administration of tranexamic acid in patients undergoing cardiac surgery: Evidence from a single cardiovascular center.
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical | 2023 |
Efficacy and safety of using aminocaproic acid and tranexamic acid during the perioperative period for treating trochanteric fractures in elderly femurs.
Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Posto | 2023 |
Treatment of post-tonsillectomy hemorrhage with nebulized tranexamic acid: A retrospective study.
Topics: Adult; Antifibrinolytic Agents; Child; Hemorrhage; Humans; Postoperative Hemorrhage; Retrospective S | 2023 |
Postoperative clinical outcomes with and without short-term intravenous tranexamic acid after posterior lumbar interbody fusion: A prospective cohort study.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae | 2023 |
Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Arthralgia; Arthroplasty, Replacement, | 2019 |
Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Human | 2020 |
Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; B | 2020 |
Factor XIII deficiency leading to preseptal haematoma post-strabismus surgery.
Topics: Antifibrinolytic Agents; Child; Exotropia; Eyelid Diseases; Factor XIII Deficiency; Female; Hematoma | 2019 |
Topical Injection of Tranexamic Acid via a Drain Plus Drain-Clamping to Reduce Blood Loss in Degenerative Lumbar Scoliosis Surgery.
Topics: Aged; Antifibrinolytic Agents; Decompression, Surgical; Drainage; Female; Humans; Injections, Intra- | 2020 |
Tranexamic Acid Reduces Total Blood Loss and Inflammatory Response in Computer-Assisted Navigation Total Knee Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2019 |
Nebulized tranexamic acid for post-tonsillectomy hemorrhage in children: a promising game changer.
Topics: Antifibrinolytic Agents; Child; Humans; Nebulizers and Vaporizers; Postoperative Hemorrhage; Tonsill | 2020 |
Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review.
Topics: Antifibrinolytic Agents; Bone Neoplasms; Femur; Humans; Plastic Surgery Procedures; Postoperative He | 2020 |
Intravenous Combined with Topical Tranexamic Acid Administration Has No Additional Benefits Compared with Intravenous Administration Alone in High Tibial Osteotomy: A Retrospective Case-Control Study.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Case-Control St | 2020 |
Safety and efficacy of tranexamic acid with epinephrine for prevention of blood loss following surgery for trochanteric femoral fractures.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Epinephrine; Female; Fractur | 2020 |
[A comparative study of Taylor spatial frame and unilateral external fixator in treatment of tibiofibular open fractures].
Topics: Blood Loss, Surgical; External Fixators; Fracture Fixation, Internal; Fracture Healing; Fractures, O | 2020 |
Postoperative administration of tranexamic acid as approach to reduce blood loss after open-heart surgery.
Topics: Aged; Antifibrinolytic Agents; Cardiopulmonary Bypass; Female; Humans; Male; Postoperative Hemorrhag | 2020 |
Postoperative Intravenous Iron Supplementation Does Not Improve Hemoglobin Level and Transfusion Rate Following Staged Bilateral Total Knee Arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cohort Studies; Diet | 2020 |
[Analysis of hemostatic effect and safety of tranexamic acid in primary simultaneous bilateral total hip arthroplasty].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemostatics; Humans; | 2020 |
Efficacy of intravenous tranexamic acid administration in revision hip arthroplasty.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Su | 2021 |
Tranexamic acid in hip hemiarthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Female; Hemiarthropla | 2020 |
Tranexamic Acid Reduces the Rate of Periprosthetic Joint Infection After Aseptic Revision Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthritis, Infectious; Arthroplasty, Replacement; Blood Transfusion; | 2020 |
Letter on the article "Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty".
Topics: Epistaxis; Humans; Postoperative Hemorrhage; Rhinoplasty; Tranexamic Acid | 2021 |
Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2020 |
Efficacy of topical versus intravenous tranexamic acid in spinal deformity.
Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Child; Hu | 2020 |
Is tranexamic acid effective on hidden blood loss in patients during total knee arthroplasty?
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood L | 2020 |
Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Aspirin; Blood Los | 2020 |
Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts.
Topics: Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Platelets; Factor V Deficiency; Fibrinol | 2020 |
[Analysis of hemostatic effect of intra-articular injection of tranexamic acid after minimally invasive unicompartmental knee arthroplasty].
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Female; Hemost | 2020 |
Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Female; Femoral Neoplasms; Femur Neck; Follow-Up Stud | 2021 |
Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Ecchymosis; Humans; Lipectomy; Postoperative Hemorrha | 2021 |
Does Not Use of Closed Suction Drainage in Total Knee Arthroplasty with Tranexamic Acid Reduce Blood Loss?
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Drainage; Female; Hu | 2020 |
Hockey: a pain in the butt! Isolated superior gluteal artery rupture following blunt pelvic trauma - an unusual case.
Topics: Aneurysm, False; Antifibrinolytic Agents; Buttocks; Computed Tomography Angiography; Embolization, T | 2021 |
Effects of disusing closed suction drainage in simultaneous bilateral total hip arthroplasty: A retrospective cohort study.
Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Humans; M | 2021 |
Comparing the effect of tourniquet and tranexamic acid on the tibial cement mantle thickness in total knee arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ | 2022 |
Safety and Efficacy of Topical Administration of Tranexamic Acid in High-Risk Patients Undergoing Posterior Lumbar Interbody Fusion Surgery.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiovascular Disease | 2021 |
Post-tonsillectomy hemorrhage control with nebulized tranexamic acid: A retrospective cohort study.
Topics: Antifibrinolytic Agents; Child; Hemorrhage; Humans; Postoperative Hemorrhage; Retrospective Studies; | 2021 |
Benefits of Tranexamic Acid in Total Knee Arthroplasty: A Classification and Regression Tree Analysis in Function of Instrumentation, BMI, and Gender.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
[Study on the safety and effectiveness of low-dose tranexamic acid in operation of multi-level continuous thoracic ossification of ligament flavum].
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Ligaments; Osteogenesis; Postoperative Hemorr | 2021 |
[Application of tranexamic acid in the treatment of intertrochanteric fracture of femur].
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Femur; Hip Fractures; Humans; Postoperative Hemorrhag | 2021 |
Comparison of topical and intravenous Tranexamic acid for high tibial osteotomy: A retrospective study.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Follow- | 2021 |
Significantly reducing blood loss via a peri-articular injection of tranexamic acid during total knee arthroplasty: a retrospective study.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2021 |
[Can venous iron and tranexamic acid reduce the transfusion need? Report on a non randomized, case control study].
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Transfusion; Case-Control Studies | 2017 |
Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo | 2017 |
Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Blood Coagul | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; | 2017 |
Tranexamic Acid Effectively Reduces Blood Loss and Transfusion Rates during Simultaneous Bilateral Total Knee Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2018 |
Efficacy and Safety of Topical Use of Tranexamic Acid in Reducing Blood Loss During Primary Lumbar Spinal Surgery: A Retrospective Case Control Study.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Case-Control Studi | 2017 |
Reducing Postoperative Bleeding After Craniosynostosis Repair Utilizing a Low-Dose Transexamic Acid Infusion Protocol.
Topics: Adolescent; Antifibrinolytic Agents; Blood Transfusion; Child; Child, Preschool; Craniosynostoses; D | 2017 |
An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Aprotinin; Arthroplasty, Replacement, Hip; Blo | 2017 |
Quantitative efficacy of topical administration of tranexamic acid on postoperative bleeding in total knee arthroplasty.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Computer Simulati | 2017 |
What Should Define Preoperative Anemia in Primary THA?
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; | 2017 |
Limitations of Preoperative PFA-200 as a Predictor of Postoperative Blood Loss in Total Knee Arthroplasty: According to Use of Tranexamic Acid.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; Blood Tr | 2017 |
Periarticular Injection of Tranexamic Acid Reduces Blood Loss and the Necessity for Allogeneic Transfusion After Total Knee Arthroplasty Using Autologous Transfusion: A Retrospective Observational Study.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2018 |
Tranexamic Acid Should be Considered in Fracture Surgery.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Drug Administration Routes; Fracture Fixation; Fractu | 2017 |
Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl | 2018 |
Topical use of tranexamic acid can effectively decrease hidden blood loss during posterior lumbar spinal fusion surgery: A retrospective study.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusi | 2017 |
Clinical Research of Combined Intravenous Administration and Topical Application of Tranexamic Acid to a Surgical Wound During Posterior Lumbar Fusion.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Sur | 2018 |
Low-Dose Epinephrine Infusions and Tranexamic Acid During Lower-Extremity Total Joint Arthroplasty: Commentary on an article by Wei-Nan Zeng, MD, et al.: "Low-Dose Epinephrine Plus Tranexamic Acid Reduces Early Postoperative Blood Loss and Inflammatory Re
Topics: Antifibrinolytic Agents; Arthroplasty; Epinephrine; Humans; Postoperative Hemorrhage; Tranexamic Aci | 2018 |
Matched cohort study of topical tranexamic acid in cementless primary total hip replacement.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, | 2018 |
Supportive topical tranexamic acid application for hemostasis in oral bleeding events - Retrospective cohort study of 542 patients.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anticoagulants; Blood | 2018 |
Intravenous tranexamic acid only versus combined intravenous and intra-articular tranexamic acid for perioperative blood loss in patients undergoing total knee arthroplasty.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replace | 2018 |
Letter to the Editor. Tranexamic acid for reducing intra- and postoperative blood loss in posterior lumbar interbody fusion: Is it safe enough?
Topics: Antifibrinolytic Agents; Humans; Lumbosacral Region; Postoperative Hemorrhage; Tranexamic Acid | 2018 |
Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum.
Topics: Animals; Antifibrinolytic Agents; Blood Pressure; Dog Diseases; Dogs; Hemoperitoneum; Postoperative | 2018 |
Minimizing Blood Loss and Transfusions in Total Knee Arthroplasty.
Topics: Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; Epoetin Alfa; Fibrin Tissu | 2018 |
[Effect on time of temporarily-closed wound drainage on blood loss of primary total knee arthroplasty after intravenous and intra-articular injection of tranexamic acid].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; D | 2017 |
Tranexamic acid administration to older patients undergoing primary total hip arthroplasty conserves hemoglobin and reduces blood loss.
Topics: Age Factors; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood | 2018 |
Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery.
Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplas | 2019 |
Transfusion rate using intravenous tranexamic acid in hip revision surgery.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, | 2018 |
DIAGNOSTICS AND CORRECTION OF THROMBOHEMORRHAGIC DISORDERS IN PATIENTS WITH GIANT UTERINE MYOMA AT THE PERIOPERATIVE STAGE OF TREATMENT.
Topics: Antifibrinolytic Agents; Drug Administration Schedule; Female; Humans; Leiomyoma; Middle Aged; Perio | 2016 |
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid | 2018 |
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid | 2018 |
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid | 2018 |
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid | 2018 |
Management of Single Uncomplicated Dental Extractions and Postoperative Bleeding Evaluation in Patients With Factor V Deficiency: A Local Antihemorrhagic Approach.
Topics: Adult; Aged; Antifibrinolytic Agents; Factor V Deficiency; Female; Gelatin Sponge, Absorbable; Hemos | 2018 |
Comment on: "Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: A prospective clinical study".
Topics: Administration, Intravenous; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoper | 2018 |
CORR Insights®: Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
Topics: Antifibrinolytic Agents; Humans; Osteotomy; Postoperative Hemorrhage; Tranexamic Acid | 2018 |
Management of dental extractions in patients on warfarin and antiplatelet therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Clopidogrel; Female; Hum | 2018 |
Tranexamic acid is effective for blood management in open-wedge high tibial osteotomy.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Blood Volume; Case-Control Studies | 2018 |
Dose optimization of topical tranexamic acid for primary total hip arthroplasty: A prospective cohort study.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Cohort Studi | 2019 |
Nebulized Tranexamic Acid Use for Pediatric Secondary Post-Tonsillectomy Hemorrhage.
Topics: Administration, Inhalation; Antifibrinolytic Agents; Child, Preschool; Humans; Male; Postoperative H | 2019 |
Tranexamic Acid in Total Hip Arthoplasty: Management of Complications and Use.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Drug Dosage Calculations; Drug-Relat | 2017 |
Tranexamic acid and post-tonsillectomy hemorrhage: propensity score and instrumental variable analyses.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Databases, Factual; Female; Humans; Incidence; Japan; Ma | 2019 |
The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Bone Transplantation; China; Decom | 2018 |
Blood loss of total knee arthroplasty in osteoarthritis: an analysis of influential factors.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, | 2018 |
[Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures].
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl | 2018 |
Total Knee Arthroplasty Is Safe in Jehovah's Witness Patients-A 12-Year Perspective.
Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Los | 2020 |
Role of intravenous tranexamic acid in reducing blood loss during caesarean section: Study at tribal-dominated area hospital in Chhattisgarh, India.
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; | 2019 |
Do tourniquet and drainage influence fast track in total knee arthroplasty? Our results on 151 cases.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2019 |
Tranexamic Acid Reduces Postoperative Blood Loss in Distal Femoral Osteotomy.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Bone Malalignment; Female; Femur; Humans; Male; M | 2020 |
[Case-control study on effect of early intermittently closing drainage tube for blood loss after total knee arthroplasty].
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2019 |
[Effect of tranexamic acid on blood loss and soft-tissue swelling following cemented total hip replacement].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Humans; Length of Sta | 2019 |
A comparison of the effects on postoperative bleeding of the intra-articular application of tranexamic acid and adrenalin in total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Epinephrine; Female; Hematocrit; Hem | 2019 |
Effects of topical tranexamic acid during open reduction and internal fixation of acetabular fractures: A retrospective study.
Topics: Acetabulum; Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusio | 2019 |
Utilization and Real-world Effectiveness of Tranexamic Use in Shoulder Arthroplasty: A Population-based Study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Shoulder; Blood Loss, Surgical; Blood Tran | 2019 |
Topical tranexamic acid in elderly patients with femoral neck fractures treated with hemiarthroplasty: efficacy and safety? - a case-control study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Case-Cont | 2019 |
Short-term safety of tranexamic acid use in posterior cervical decompression and fusion surgery.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Ce | 2019 |
Implementation of tranexamic acid reduces red blood cell utilization in orthopedic surgeries.
Topics: Academic Medical Centers; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgi | 2019 |
Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2019 |
Intra-articular 1 g tranexamic acid administration during total knee arthroplasty is safe and effective for the reduction of blood loss and blood transfusion.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Blood Volume; Con | 2019 |
Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains?
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2014 |
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K | 2014 |
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K | 2014 |
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K | 2014 |
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K | 2014 |
[Local application of tranexamic acid reduces blood less in unilateral total knee arthroplasty: a retrospective comparison analysis].
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; M | 2013 |
[Management of massive bleeding in 2013: seven questions and answers].
Topics: Acute Disease; Blood Component Transfusion; Combined Modality Therapy; Disease Management; Erythrocy | 2013 |
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl | 2014 |
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl | 2014 |
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl | 2014 |
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl | 2014 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty | 2013 |
Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2014 |
Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl | 2014 |
Antifibrinolytic thereapy.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Fi | 2014 |
Utility of thromboelastography in managing acquired Factor VIII inhibitor associated massive haemorrhage.
Topics: Antifibrinolytic Agents; Blood Coagulation Factors; Blood Transfusion; Endometrial Neoplasms; Factor | 2013 |
A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Coagulation; Case-Control Studies; D | 2014 |
Tranexamic Acid Tamponade to Control Postoperative Surgical Hemorrhage.
Topics: Anticoagulants; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tooth Extraction; Tranexamic | 2015 |
Does tranexamic acid reduce blood loss in total knee arthroplasty? Commentary on an article by X. Aguilera, MD, et al.:"Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty. A randomized con
Topics: Arthroplasty, Replacement, Knee; Female; Fibrin Tissue Adhesive; Hemostatics; Humans; Male; Postoper | 2013 |
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma | 2014 |
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma | 2014 |
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma | 2014 |
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma | 2014 |
Tranexamic acid: more evidence for its use in joint replacement surgery.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Tran | 2014 |
Risk of bleeding after dentoalveolar surgery in patients taking anticoagulants.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Apicoectomy; Dental Implant | 2014 |
Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2014 |
Effect of intra-articular injection of tranexamic acid on postoperative hemoglobin in total hip arthroplasty.
Topics: Aged; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; He | 2014 |
Repeated doses of intravenous tranexamic acid are effective and safe at reducing perioperative blood loss in total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; Postope | 2014 |
Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
Topics: Aged; Combined Modality Therapy; Deamino Arginine Vasopressin; Embolization, Therapeutic; Erythrocyt | 2015 |
Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Rel | 2014 |
Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Fibrin Ti | 2014 |
[A rare case of thalassemia concomitant with chronic decompensated tonsillitis].
Topics: Adolescent; Anemia, Hypochromic; Antifibrinolytic Agents; Chemoprevention; Chronic Disease; Female; | 2014 |
Cost analysis of use of tranexamic Acid to prevent major bleeding complications in hip and knee arthroplasty surgery.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss | 2014 |
Assessment of the introduction of a blood management program in orthopaedic surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Ban | 2015 |
Topical versus intravenous tranexamic acid in total knee arthroplasty.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R | 2015 |
Letter to the Editor: Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Osteoarthritis, Knee | 2014 |
[Effectiveness of tranexamic acid in total knee arthroplasty].
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2014 |
Topical tranexamic acid was noninferior to intravenous tranexamic acid in controlling blood loss during total knee arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Female; Humans; Male | 2015 |
Authors' reply.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Osteoarthritis, Knee | 2014 |
Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
Topics: Antifibrinolytic Agents; Child; Child, Preschool; Fibrinolysis; Heart Defects, Congenital; Hemorrhag | 2015 |
Pharmaceuticals: private prescription.
Topics: Antifibrinolytic Agents; Antithrombins; Dabigatran; Formularies, Dental as Topic; Humans; Postoperat | 2015 |
Effect of a single injection of tranexamic acid on blood loss after primary hybrid TKA.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion, Autologous; Dose- | 2015 |
Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Aortic Valve Stenosis; Drug Administration | 2015 |
Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy?
Topics: Acetabulum; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Dru | 2015 |
CORR Insights(®): Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy?
Topics: Acetabulum; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Female; Hip Dislocatio | 2015 |
Minimizing Blood Transfusion in Total Hip and Knee Arthroplasty Through a Multimodal Approach.
Topics: Aged; Aged, 80 and over; Algorithms; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip | 2016 |
The effectiveness of tranexamic acid at reducing postoperative blood loss following cesarean section: a systematic review of quantitative evidence protocol.
Topics: Antifibrinolytic Agents; Cesarean Section; Female; Humans; Postoperative Hemorrhage; Pregnancy; Preg | 2015 |
An In Vivo Study of Low-Dose Intra-Articular Tranexamic Acid Application with Prolonged Clamping Drain Method in Total Knee Replacement: Clinical Efficacy and Safety.
Topics: Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Drainage; Female; Humans; Injections, I | 2015 |
Tranexamic acid decreases blood loss after total shoulder arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement; Blood Loss, Surgical; Blood Transfusion; Female; | 2016 |
Comparison between topical and intravenous administration of tranexamic acid in primary total hip arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, | 2016 |
Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty?
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; F | 2016 |
"Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial".
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic | 2016 |
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic | 2016 |
Is there a need for routine post-operative hemoglobin level estimation in total knee arthroplasty with tranexamic acid use?
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2016 |
Low dose tranexamic acid reduces blood transfusion rate after total knee arthroplasty: A population-based study in Taiwan.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2017 |
Topical Tranexamic Acid May Improve Early Functional Outcomes of Primary Total Knee Arthroplasty.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Trans | 2016 |
In Reply: Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value.
Topics: Antifibrinolytic Agents; Arthroplasty; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood | 2016 |
Postoperative cerebral bleeding in a boy with suspected mild deficiency of fibrinogen and FXIII.
Topics: Adolescent; Afibrinogenemia; Antifibrinolytic Agents; Blood Coagulation; Factor XIII Deficiency; Fib | 2016 |
The impact of mild peri-operative hypothermia on the effectiveness of tranexamic acid in total hip arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Cohort Studies; Female; Humans; Hypot | 2017 |
Tranexamic acid in total joint arthroplasty.
Topics: Antifibrinolytic Agents; Arthroplasty; Arthroplasty, Replacement; Blood Loss, Surgical; Humans; Post | 2016 |
Topical administration of tranexamic acid in hip arthroplasty.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2017 |
Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery.
Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Databases, Factu | 2016 |
Controversy in Tranexamic Acid Administration Route Continues: Commentary on an article by Zeng Yi, MD, et al.: "Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Si
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2016 |
Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2017 |
The Efficacy Comparison of Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty at Different Dosage Time.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L | 2017 |
Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Trans | 2017 |
CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Blood Coag | 2016 |
Effects of tranexamic acid on coagulation indexes of patients undergoing heart valve replacement surgery under cardiopulmonary bypass.
Topics: Adolescent; Blood Coagulation; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary By | 2016 |
Topical Tranexamic Acid in Total Knee Arthroplasty Patients with Increased Thromboembolic Risk.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, | 2017 |
A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Drainage; Female; | 2016 |
Surgery: Use of tranexamic acid in coronary surgery.
Topics: Antifibrinolytic Agents; Arteries; Humans; Postoperative Hemorrhage; Tranexamic Acid | 2017 |
Comparative effectiveness of epsilon-aminocaproic acid and tranexamic acid on postoperative bleeding following cardiac surgery during a national medication shortage.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cohort Studies; Comparative | 2016 |
High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Case-Cont | 2017 |
Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Platelets; Card | 2016 |
Intraarticular Administration of Tranexamic Acid is Safe and Effective in Total Knee Arthroplasty Patients at High-Risk for Thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss | 2016 |
Tranexamic acid versus fibrin sealant in primary total hip replacement: a comparative study.
Topics: Aerosols; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood | 2017 |
Can tranexamic acid reduce blood loss in cervical laminectomy with lateral mass screw fixation and bone grafting: a retrospective observational study.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Bone Screws; Bone Transplantation; Cervical Ver | 2017 |
The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Databases, Factual; Erythrocyte Transfusion; Female; | 2017 |
Reply to letter to the editor on "Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomised controlled noninferiority trial".
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2017 |
Letter to editor "Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomized controlled noninferiority trial".
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2017 |
Other benefits of intra-articular injection of tranexamic acid in primary total knee arthroplasty apart from reducing blood transfusion rates.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion | 2017 |
Safety of aprotinin (again).
Topics: Aprotinin; Cardiac Surgical Procedures; Hemostatics; Humans; Italy; Postoperative Hemorrhage; Safety | 2008 |
Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey.
Topics: Anticoagulants; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedures; Heparin; Human | 2008 |
Routine preoperative coagulation screening detects a rare bleeding disorder.
Topics: Antifibrinolytic Agents; Blood Component Transfusion; Blood Loss, Surgical; Child; Factor X Deficien | 2009 |
Evaluation of a fibrin preparation containing tranexamic acid (Adhexil) in a rabbit uterine horn model of adhesions with and without bleeding and in a model with two surgical loci.
Topics: Animals; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrin; He | 2010 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Heart Valve Prosthesis Implantation; Hemostasis, Surgical; Humans; Platelet Aggregation Inhibitors; | 2009 |
Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
Topics: Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Coagulation; Blood Loss, Surg | 2009 |
[Type A hemophilia in a man undergoing liver resection for metastasis: implications for anesthetic management].
Topics: Adenocarcinoma; Aged; Anesthesia, General; Blood Loss, Surgical; Colorectal Neoplasms; Deamino Argin | 2009 |
[Tranexamic acid and dentoalveolar surgery].
Topics: Anticoagulants; Blood Loss, Surgical; Fibrinolytic Agents; Hemostatics; Humans; Oral Surgical Proced | 2009 |
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine 2008; 33: 2577-80.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Humans; Orthopedic Procedures; P | 2009 |
Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aprotinin; Blood Component Transfusion; Cardiac Surgic | 2009 |
The effect of the suspension of the license for aprotinin on the care of patients undergoing cardiac surgery: a survey of cardiac anesthesiologists' and surgeons' opinions in the United Kingdom.
Topics: Anesthesiology; Antifibrinolytic Agents; Aprotinin; Attitude of Health Personnel; Health Care Survey | 2010 |
[Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
Topics: Adult; Anticoagulants; Aprotinin; Blood Transfusion; Blood Transfusion, Autologous; Cardiac Tamponad | 2010 |
Efficiency of preoperative tranexamic Acid in coronary bypass surgery: an analysis correlated with preoperative clopidogrel use.
Topics: Aged; Antifibrinolytic Agents; Blood Transfusion; Clopidogrel; Confidence Intervals; Coronary Artery | 2010 |
Efficient strategy for controlling postoperative hemorrhage in total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Arthroplasty, Replacement, Knee; Blood Loss, Surgical | 2011 |
ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Topics: Algorithms; Aminocaproic Acid; Anesthesia; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; | 2011 |
Commentary on an article by Jean Wong, MD, FRCPC, et al.: "Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial".
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Humans; Postopera | 2010 |
Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion | 2011 |
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical Procedures; Cardiopu | 2011 |
High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement.
Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Aortic Valve; Drug Administrati | 2011 |
Conference discussion: Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiopulmonary Bypass; | 2011 |
Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgica | 2011 |
Safety of tranexamic acid in pediatric cardiac surgery: what we do not know.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiac Surgical Procedures; Female; Humans; Male; Posto | 2011 |
Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement.
Topics: Antifibrinolytic Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Blood Loss, Surgica | 2011 |
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
Topics: Age Factors; Analysis of Variance; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac | 2012 |
Use of tranexamic acid in pediatric cardiac surgery: we really need more.
Topics: Blood Loss, Surgical; Cardiac Surgical Procedures; Female; Humans; Male; Postoperative Hemorrhage; T | 2012 |
Comparative analysis of antifibrinolytic medications in pediatric heart surgery.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Cardiac Surgical Procedures; Chi-Square Distribu | 2012 |
Congenital diaphragmatic hernia: to repair on or off extracorporeal membrane oxygenation?
Topics: Antifibrinolytic Agents; Extracorporeal Membrane Oxygenation; Female; Hernia, Diaphragmatic; Hernias | 2012 |
Management of a dentigerous cyst in a medically compromised geriatric patient: a case report.
Topics: Aged; Anesthetics, Local; Antifibrinolytic Agents; Aspirin; Bicuspid; Dental Care for Chronically Il | 2012 |
Successful in vitro fertilization and pregnancy in Glanzmann thrombasthenia.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Fertilization in Vitro; Humans; Infant, Ne | 2012 |
[Local use of tranexamic acid in ENT surgery].
Topics: Antifibrinolytic Agents; Humans; Otorhinolaryngologic Surgical Procedures; Postoperative Hemorrhage; | 2012 |
[Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study].
Topics: Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cohort Studies; Female; Humans; Male; Mi | 2013 |
Tranexamic acid therapy in pediatric cardiac surgery: a single-center study.
Topics: Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child, Preschool; Dose | 2012 |
Tranexamic acid for routine use in off-pump coronary artery bypass surgery: evidence base "fait accompli" or more research needed?
Topics: Antifibrinolytic Agents; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Female; Humans; | 2012 |
Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Bone Cements; Constriction; Drainage; Fema | 2012 |
[Pharmacological reduction of bleeding during hip endoprosthetic replacement].
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, | 2012 |
Coronary artery bypass grafting after aprotinin: are we doing better?
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiopulmonary B | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom | 2013 |
[Perioperative management based on kinetics of bleeding during total primary arthroplasty].
Topics: Aged; Anesthesia, General; Anesthesia, Spinal; Anticoagulants; Arthroplasty, Replacement, Hip; Arthr | 2013 |
Otolaryngologic surgery in children with von Willebrand disease.
Topics: Adenoidectomy; Adolescent; Antifibrinolytic Agents; Child; Child, Preschool; Deamino Arginine Vasopr | 2002 |
Strategies for managing anticoagulated patients requiring dental extractions: an exercise in evidence-based clinical practice.
Topics: Anticoagulants; Antifibrinolytic Agents; Dental Care for Chronically Ill; Evidence-Based Medicine; H | 2002 |
More information on patients with factor XI deficiency.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Factor XI Deficiency; Hemostasis; Humans; Postoperati | 2004 |
Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies.
Topics: Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Anticoagulants; Blood Component Transfusion; Bloo | 2004 |
Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002).
Topics: Adolescent; Adult; Aged; Child; Clinical Protocols; Deamino Arginine Vasopressin; Dental Care for Ch | 2005 |
Continuous infusion of factor VIIIc during heart surgery in a patient with haemophilia A.
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Coronary | 2004 |
Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Drug Therapy, Combina | 2005 |
Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
Topics: Adolescent; Adult; Child; Deamino Arginine Vasopressin; Dental Care for Chronically Ill; Factor VIII | 2005 |
[Dental avulsions and blood coagulation disorders].
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Deamino Arginine Vasopressin; | 2005 |
[CRASH-2: the Clinical Randomization of an Antifibrinolytic in Significant Haemorrhage trial].
Topics: Adult; Antifibrinolytic Agents; Child; Hemorrhage; Humans; Multicenter Studies as Topic; Patient Sel | 2005 |
The risk associated with aprotinin in cardiac surgery.
Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr | 2006 |
The risk associated with aprotinin in cardiac surgery.
Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr | 2006 |
The risk associated with aprotinin in cardiac surgery.
Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr | 2006 |
The risk associated with aprotinin in cardiac surgery.
Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr | 2006 |
Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass.
Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Heterozygote; Humans; Male; Postoperative Hemo | 2006 |
[The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Substitutes; Bloo | 2006 |
If you prick us, do we not bleed?
Topics: Aprotinin; Hemostatics; Humans; Orthopedic Procedures; Postoperative Hemorrhage; Tranexamic Acid | 2006 |
CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management?
Topics: Antifibrinolytic Agents; Aprotinin; Coronary Artery Bypass; Fibrinolytic Agents; Hemostatics; Humans | 2008 |
[Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Topics: Adult; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical | 2007 |
Acquired transitory factor XI inhibitor after gynaecological surgery.
Topics: Adult; Antifibrinolytic Agents; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Factor | 2008 |
Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
Topics: Aged; Cardiopulmonary Bypass; Female; Homozygote; Humans; Male; Middle Aged; Plasminogen Activator I | 2008 |
Amoxicillin-related postextraction bleeding in an anticoagulated patient with tranexamic acid rinses.
Topics: Aged; Amoxicillin; Anticoagulants; Antifibrinolytic Agents; Dental Care for Chronically Ill; Drug In | 1996 |
Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Drug Evaluation; Female; | 1997 |
[Mouth-washing with tranexamic acid in patients treated with oral anticoagulants subjected to oral surgery procedures].
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Loss, Surgical; Dental S | 1998 |
Re: Devani et al. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary?
Topics: Anticoagulants; Antifibrinolytic Agents; Drug Administration Schedule; Hemostatic Techniques; Humans | 1998 |
Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Femal | 1999 |
Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease.
Topics: Acute Disease; Adult; Deamino Arginine Vasopressin; Female; Hemostatics; Humans; Hyponatremia; Hyste | 2000 |
Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Chi-Square Distribution; Couma | 2001 |
[A patient with thrombocytopenia: what do I do?].
Topics: Adult; Antifibrinolytic Agents; Humans; Male; Methylprednisolone; Oral Hemorrhage; Postoperative Car | 1999 |